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ABSTRACT 
Asymmetric Synthesis of SL0101, Cyclitol and Jadomycin 
Minde Shan 
      The carbohydrate portion of natural products plays a crucial role in biology, such as target 
binding, solubility, tissue targeting, and membrane transportation. The O’Doherty group has 
developed a de novo methodology to build the desired functionality and stereochemistry within 
each sugar, in contrast to the traditional approach using known carbohydrates as starting 
materials. This methodology relies on a highly diastereoselective palladium(0)-catalyzed 
glycosylation reaction to control the stereochemistry at the anomeric center and post-
glycosylation transformation to introduce the corresponding functionality in the sugar moiety.  
      Continuing our investigations on the utility of this strategy, we turned our attention to the 
syntheses of the bioactive carbohydrate-based natural product analogues. The targets we chose 
are the p90 ribosomal S6 kinase (RSK) inhibitors SL0101 and its analogues. We developed a 
practical 7-10 step diastereoselective route for the syntheses of six different analogues of SL0101 
in either enantiomeric form without using any protecting groups in the sugar moieties.  
      C-glycosides are carbohydrates where one of the acetal oxygens has been replaced with a 
methylene group. These non-hydrolyzable sugar mimics have long been recognized as an 
important pharmacophore. Cyclitols/Carbasugars are an important subset of the C-glycoside 
structural motif where the endo-acetal ring oxygen has been replaced with a methylene group.  In 
particular, polyhydroxylated cyclohexane cyclitols that mimic pyrano-sugars are ubiquitous in 
many biologically important natural products. We successfully developed a pratical route to 
achieve rhamno-carbasugars in either enantiomeric and diastereomeric form (e.g., α-L, β-L, α-D, 
β-D) starting with quinic acid. Three cyclitol/carbasugar monosaccharides and five carbasugar C-
1 phosphates have been synthesized. 
      In order to further facilitate the medicinal structure-activity relationship (SAR) study of 
SL0101, we also turned our attention to the synthesis of carbsugar glycoside analogues of 
 SL0101. A practical palladium(0)-catalyzed cyclitolization/C-in ring-glycosylation and a post-
cyclitolization transformation has been successfully developed. This methodology has been 
utilized to synthesize six carbasugar analogues of SL0101 in either enantiomeric form. 
      Efforts have been made toward the synthesis of biologically important jadomycin A and B. A 
practical approach has been successfully developed to achieve α-digitoxose, the sugar moiety of 
jadomycin B by employing a new post-glycosylation reactions following palladium(0)-catalyzed 
glycosylation reaction. Jadomycin A, the aglycone part of jadomycin B, has been successfully 
synthesized. The key transformations included an oxidative ring closure of dihydropyridine 
followed by acid induced lactonization to form an oxazolone ring.  
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Chapter I. De Novo Asymmetric Syntheses of SL0101 and Its Analogues*,1 
      In an effort to find specific inhibitors of p90 Ribosomal S6 Kinase (RSK), Smith and Hecht 
screened an extensive collection of botanical extracts derived from rare plants.2  Using a dual 
high-throughput screen they found only one extract, which inhibited the RSK2 isoform (RSK2) 
without inhibiting the tyrosine kinase (FAK).  The active extract was from a South American 
dogbane plant named Forsteronia refracta. More detailed bioactive fractionization revealed the 
active constituent to be a kaempferol glycoside, which was given the name SL0101 (Figure 1).2  
SL0101 (I-1a) is a member of a class of acylated kaempferol L-rhamnosides which occur 
naturally with various degrees of acylation (e.g., I-1a to I-1e).3  SL0101 sans acetyl groups (I-1b) 
is also known as afzelin.3a The kaempferol glycosides, like most flavonoids, have received a 
great deal of attention because they are believed to induce many positive biological effects.4 
 
 R1 R2 R3 IC50 (RSK2) 
I-1a Ac Ac H 89 nM 
I-1b H H H -------- 
I-1c Ac Ac Ac -------- 
I-1d Ac H H 189 nM 
I-1e Ac H Ac 580 nM 
 
Figure 1. Rsk2 inhibitory activities of SL0101 (I-1a) and its analogues (I-1b to I-1e) 
       
      In addition to this unique activity, our interest in SL0101 (I-1a) was peaked by the report that 
it displayed some 150 times greater activity than the simple aglycon, kaempferol.  Similarly, we 
                                                            
1 
 
* Reproduced with permission from Org. Lett. 2006, 8, 5149-5152. Copyright 2006, American Chemical Society. 
2 
 
were intrigued by the importance of the specific placement of acetyl groups on the L-rhamnose 
and its effect on the structure-activity relationship (SAR) of SL0101 (Figure 1).5  As part of an 
effort to elucidate the role of the sugar and acetyl portion of SL0101 to its activity, we decided to 
prepare both enantiomers of SL0101 (I-1a) and its analogues I-1b to I-1e (Figure 1). 
      Not long after the isolation and structure elucidation of SL0101 (I-1a), its first synthesis was 
reported by Professor Hecht. 5 The Hecht synthesis derived the absolute and relative 
stereochemistry from L-rhamnose.  In contrast, we were interested in the possibility of preparing 
all five members of this class of kaempferol glycosides (I-1a to I-1e) via asymmetric catalysis.  
This de novo approach would have the additional advantage of preparing both the D- and the L-
enantiomers for biological testing. 
      Recently we reported a diastereoselective palladium-catalyzed glycosylation reaction that 
used alcohols as nucleophiles and Boc-pyranones such as I-4α as glycosyl donors.6 We have 
also found several post glycosylation transforms, which subsequently install the desired sugar 
stereochemistry.7  This methodology also works well for other N- and O-nucleophiles, such as 6-
chloropurine/benzimidizole and phenol.8  In order to produce this class of interesting compounds 
for activity studies, we decided to apply this methodology toward the syntheses of the flavone 
glycosides, SL0101 (I-1a) and its analogues (I-1b to I-1e).  In addition to providing material for 
biological study, this effort should also allow us to study flavon-3-ol as a nucleophile in the 
palladium-catalyzed glycosylation.  
 
 
 
 
 
 
Scheme 1. Retrosynthetic analysis of kaempferol rhamnosides (I-1a to I-1e) 
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      Retrosynthetically, we envisioned that pyranone I-2 could be derived from a palladium(0)-
catalyzed glycosylation between flavonol I-3 and pyranone I-4α (Scheme 1).  Subsequent 
application of NaBH4 reduction and Upjohn dihydroxylation (OsO4/NMO)9 would install the 
manno-stereochemistry.10  The selective introduction of the C-4 acetyl group should occur by 
introducing an acylation reaction between the NaBH4 reduction and dihydroxylation.  All that 
would remain would be to differentiate the C-2 hydroxyl group from the C-3 hydroxyl group.  
For this, we planned to use a combination of selective orthoester hydrolysis11 and acyl migration 
reactions.12  Since pyranone I-4α has been prepared in either enantiomeric form, this procedure 
should be amenable to the preparation of both enantiomers of I-1a to I-1e.  In this chapter, we 
will describe our successful efforts at the implementation of this strategy to this class of 
kaempferol glycosides (I-1a to I-1e), which is noteworthy in that the various acetyl groups in I-
1a to I-1e are installed without any hydroxyl protecting groups on the sugar. 
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Scheme 2. Synthesis of aglycone 
 
      Our synthesis started with the known perbenzylated kaempferol I-3, which was synthesized 
from narringin I-6 in three steps (Scheme 2).5 Benzylation of narrigin I-6 by BnBr in the 
K2CO3/acetone reflux condition with concomitant β-elimination afforded enone I-7, which was 
subjected to oxidative cyclization to enone I-8 under I2/DMSO condition. The cyclic enone was 
oxidized to epoxide by in situ produced DMDO in a basic buffer, which underwent acid-induced 
rearrangement to give aglycone flavonol I-3.  
Scheme 3. Synthesis of Boc-pyranones as sugar donors 
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      For the synthesis of the Boc-pyranone, we started with the achiral acylfuran (Scheme 3). 
Noyori reduction of acetylfruan I-5 by using Noyori (S,S) catalyst in the presence of complex of 
formic acid and triethylamine as hydride source produced the furfuryl alcohol I-9 in 93% yield 
with high enantiomeric excess (> 96% ee).  An Achmatowiz rearrangement transformed the 
furfuryl alcohol to hemi-acetal I-10 in 91% yield.  The hemiacetal was then protected as t-butyl 
carbonate I-4α and I-4β at low temperature in 78% yield with 3:1 (α/β) diastereomeric ratio, 
which could be easily separated to give the L-sugar precursor.  It is worth noting that by simply 
switching the catalyst Noyori (S,S) to Noyori (R,R), we are able to synthesize the D-sugar 
precursor.     
Scheme 4. Synthesis of kaempferol-3-α-L-rhamnoside (I-1b)  
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     The glycosylation was carried out with flavonol I-3 and L-Boc-pyranone I-4α under catalysis 
of 2.5 mol% Pd2(dba)3•CHCl3 and 10 mol% of PPh3 in CH2Cl2 at 0 °C, which afforded 
glycosylated pyranone I-2 in 85% yield with complete α-selectivity (Scheme 4).  Reduction of 
the enone I-2 by NaBH4 at –78 °C in CH2Cl2/MeOH resulted in allylic alcohol I-11 in 73% yield 
with excellent diastereoselectivity (dr > 20:1). The rhamno-stereochemistry in I-1b was 
diastereoselectively introduced upon exposure of I-11 to the Upjohn conditions (OsO4/NMO, 
96%).  Debenzylation of resulted I-12 using Pearlman’s catalyst (10% Pd/C) in the presence of 
hydrogen gave kaempferol-3-α-L-rhamnoside (I-1b) in 80% yield. 
      In addition to the unacylated rhamno-sugar I-1b, the peracylated sugar I-1c could also be 
easily prepared in two steps from triol I-12 (Scheme 5).  Exhaustive acylation of the triol I-12 
with the excess acetic anhydride in presence of pyridine and 10 mol% DMAP gave triacetate I-
13 in 86% yield. Debenzylation of triacetate I-13 by hydrogen using Pearlman’s catalyst (10% 
Pd/C) again produced kaempferol-3-α-L-2’’,3’’,4’’-O-triacetylrhamnoside (I-1c) in 86% yield. 
Scheme 5. Synthesis of kaempferol-3-α-L-2’’,3’’,4’’-O-triacetylrhamnoside (I-1c) 
 
      The selective installation of the C-4 acetyl group in I-1d was easily achieved without the 
need of additional protecting groups from the previously described allylic alcohol I-11 (Scheme 
4).  In this route (Scheme 6), the NaBH4 reduction of enone I-2 was followed by an acylation of 
the resulting allylic alcohol with acetic anhydride in the presence of pyridine and DMAP.  This 
two-step procedure afforded acetate I-14 in 70% overall yield.  Once again, dihydroxylation 
using the Upjohn condition stereoselectively converted allylic acetate I-14 into the rhamno-diol 
I-15 in 77% yield.  Global deprotection was accomplished under hydrogenolysis conditions by 
6 
 
exposure of diol I-15 to 1 atm of H2 in the presence of Pearlman’s catalyst (Pd/C), which 
furnished kaempferol-3-α-L-4’’-O-acetylrhamnoside (I-1d) in 87% yield. 
Scheme 6. Synthesis of kaempferol-3-α-L-4’’-O-acetylrhamnoside (I-1d) 
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      Acylation of the C-2 axial hydroxyl group of diol I-15 was selectively achieved by using 
orthoester chemistry in excellent yield (99%) (Scheme 7).11 Exposure of diol I-15 to trimethyl 
orthoacetate in the presence of 10% p-TsOH in CH2Cl2 followed by hydrolysis with excess 90% 
HOAc/H2O afforded diacetate I-16 (Scheme 5). Once again, reductive debenzylation of I-16 
with hydrogen and 10% Pd/C produced kaempferol-3-α-L-2’’,4’’-O-diacetylrhamnoside (I-1e) in 
88% yield. 
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Scheme 7. Synthesis of kaempferol-3-α-L-2’’,4’’-O-diacetylrhamnoside (I-1e) 
 
      In contrast to the selective C-2 acylation of the axial alcohol in I-15 (Scheme 7), our 
synthesis of SL0101 required the selective acylation of the C-3 equatorial alcohol (Scheme 8).  
Unfortunately, all of our attempts with Ac2O/Py at various temperature only furnished mixtures 
of diacetate I-17 and I-16, as well as triacetate I-13 (~1:1:1). Since we could achieve I-16 with 
high regioselectivity, we turned our attention to the acetyl group shift from the less stable axial 
C-2 acetate in I-16 to the more stable equatorial C-3 acetate in I-17.   
      All attempts to shift the axial acetyl group of diacetate I-16 to the equatorial position by 
using 10 mol% p-TsOH in CH2Cl2 at room temperature failed to give desired diacetate I-17 
(Scheme 8).  In contrast, more promising results were seen with basic conditions.  For instance, 
analysis of crude 1H NMR of dilute toluene solutions of I-16 with one equiv of DBU showed 
clean conversion to a 2:1 mixture of I-17 and I-16.  In practice good yields of I-17 (62%) could 
be obtained along with recovered starting material (34%) after SiO2 chromatography.  Finally, 
debenzylation of I-17 under the similar condition as before produced SL0101 (I-1a) in 91% yield.   
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Scheme 8. Synthesis of SL0101 (I-1a) 
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      To synthesize the D-sugar analogue of SL0101, we started our synthesis by simply switching 
the α-L-Boc-pyranone to α-D-Boc-pyranone (Scheme 9). Palladium(0)-catalyzed glycosylation of 
perbenzylated aglycone I-3 with α-D-Boc-pyranone (ent)-I-4α afforded glycosylated pyranone 
(ent)-I-2 in 71% yield and absolute stereocontrol. NaBH4 reduction of (ent)-I-2 followed by the 
dihydroxylation of the resulted allylic alcohol upon Upjohn condition furnished triol (ent)-I-8 in 
60% yield over two steps. Debenzylation of the triol (ent)-8 under Pd/C hydrogenation condition 
produced SL0101 α-D-sugar analogue (ent)-1b in 90% yield. Our synthetic products (I-1a to I-1e) 
were physically and spectroscopically identical to the isolated natural materials in terms of 
melting point, optical rotation, Rf, 1H NMR, 13C NMR and MS.3,5 
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Scheme 9. Synthesis of SL0101 D-sugar analogue 
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In conclusion, a divergent and highly enantio- and diastereoselective procedures for the 
preparation of naturally occurring SL0101 (I-1a) as well as four kaempferol rhamnoside 
analogues (I-1b to I-1e) and one enantiomeric analogue ((ent)-1b) has been developed. This 
approach provides all the kaempferol glycosides without protecting any of the sugar hydroxyl 
groups.  Our approach relied upon a diastereoselective palladium(0)-catalyzed glycosylation 
followed by a sequence of reduction/dihydroxylation reaction, as well as acylation. An acetyl 
group shift from an axial position to an equatorial position provided an alternative way for 
selective acylation of the equatorial hydroxyl group of a cis-diol in carbohydrate chemistry.  
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Chapter II. Asymmetric Synthesis of Cyclitol/Carbasugar 
II.1. Cyclitol/Carbasugar monosaccharide†,13  
      C-glycosides are carbohydrates where one of the acetal oxygens has been replaced with a 
methylene group. 14  These non-hydrolyzable sugar mimics have long been recognized as an 
important pharmacophore.15   Cyclitols are an important subset of the C-glycoside structural 
motif where the endo-acetal ring oxygen has been replaced with a methylene group. 16   In 
particular, polyhydroxylated cyclohexane cyclitols that mimic pyrano-sugars are ubiquitous in 
biologically important natural products (e.g., aminoglycosides, validamycins, acarbose, 
pyralomicins, pancratistatin).16  
Scheme 10. Existing routes to cyclitol pyranose sugar 
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† Reproduced in part with permission from Synthesis, 2008, 3171-3179. Copyright 2008, Georg Thieme Verlag KG 
Stuttgart New York.  
      Because of their pharmacological importance, there has been a myriad of approaches to the 
cyclitols (Scheme 10).16,17 These various routes have used both chiral (e.g., sugars and quinic 
acid) and achiral (e.g., arenes, furans, dienes) molecules as starting materials, with carbohydrates 
dominating this list of starting materials.16,17  
Scheme 11.  Our approach to normal pyranose carbohydrates 
 
      For the last ten years, we have been interested in developing de novo approaches to pyranose 
sugars using dienoates and furans as starting materials.18  The dienoate route uses an iterative 
Sharpless asymmetric dihydroxylation to prepare galacto-lactones. The furan route uses 
asymmetric catalysis to a furan alcohol II-3, followed by an Achmatowicz rearrangement to a 
pyranone II-2, which in turn can be converted into various pyranose sugars II-1 (Scheme 11).19 
Of these two approaches, the route that uses furans as starting materials has the advantage of 
being more flexible in terms of substitution pattern and stereochemistry.  
Scheme 12. Pseudoenantiomeric enones from quinic acid 
 
      As part of our continuing efforts to develop new approaches to biologically important 
carbohydrates, we desired a new approach to cyclitol sugars.  In particular, we were interested in 
developing an approach to the cyclitols that had the same structural flexibility as our furan 
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approach.  In particular, we desired a route that uses enones as cyclitol pyranones analogues that 
could similarly be converted into various cyclitol stereoisomers.  While we ultimately want to 
develop a de novo asymmetric approach, we chose to use quinic acid II-5 as our starting material, 
because it was already known to be easily converted into pseudoenantiomeric enones II-4 and II-
6 (Scheme 12).20 Herein, we describe our approach to cyclitol sugars II-7, II-8, (ent)-II-7 from 
known enones II-4 and II-6 (Figure 2). 
 
Figure 2. Targeted carbasugar monosaccharide 
      Our initial plan to install the methyl group for these target molecules was to use enolate 
chemistry to introduce a methyl group at the α-position of α,β-unsaturated ketone either through 
in situ generated enolate or silylenol ether.  We envisioned the stereochemistry of methylation 
could be controlled by the other substituents in the ring. Finally, the desired sugar 
stereochemistry could be established by subsequent transformation, akin to our pyranone to 
sugar chemistry.18,19  
      Our synthesis started with enone II-4, which was easily prepared from D-quinic acid II-5 in 4 
steps with 60% overall yield.20 Unfortunately, all attempts at 1,4-reduction and direct alkylation 
of enone II-4 were unsuccessful.  For instance, the Tsuda-Saegusa catalytic copper hydride 1,4-
reduction proceeded smoothly, but in situ alkylation of the enolate intermediate with methyl 
iodide failed to cleanly give the desired α-methyl ketones II-11a/II-11b (Scheme 13).21  The in 
situ use of Stryker’s reagent for 1,4-hydrosilyation of II-4 also proved to be problematic.22 
      Alternatively, we envisioned that a cyclopropanation and ring opening process could lead to 
the formation of α-methyl ketone. 23  Thus, one pot hydrosilylation of enone II-4 
(RhCl(PPh3)3/PhMe2SiH, 60 °C) 2  4 followed by Simmons-Smith cyclopropanation 
(ZnEt2/CH2I2) 25  of the resulting silylenol ether at 0 °C gave an inseparable mixture of 
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cyclopropanol silyl ethers, which when desilylated under acidic conditions (p-TsOH/MeOH) 
furnished two readily separable diastereoisomers II-9a/II-9b in 83% overall yield with dr ~1:1  
(Scheme 13). With the cyclopropanol in hand, we next turned our attention to the ring opening of 
cyclopropanol.  
Scheme 13. Cyclopropanation and attempts to ring-opening  
II-5 II-4 II-9a II-9b
O
O
H
O
O
HO
H
83%
(3 steps )
O
O
O
i) RhCl(PPh)3
PhMe2SiH
ii) Et2Zn, CH2I2
iii) TsOH
II-9a
80 oC
86%
O
O
O
O
O
O
II-10a/II-10b
1:2
II-10a
H2, Pd/C
O
O
O
CH3
II-11a II-11b
II-11a/II-11b
3:1
II-10b
II-9a
Pd(OAc)2, Py.
quinone, 80 oC
or Pd/C, RT
Pd(OAc)2, Py.
II-11a/II-11b
0.5 M NaOH/THF
OH
O
CH3
COOH
OHHO
OH
HO
4 steps
60%
OH
O
CH3
+
+
+
II-12a II-12b
O
O
O
CH3
+
II-10a
II-12a/II-12b
2:3
0 oC
HO
88%
II-11a/II-11b
1:10
89%
85%
H2
Pd/C
II-10a II-10b
II-11a + II-11b
 
      Unfortunately, all attempts to open the three membered ring using acid or base failed to give 
the desired α-methyl ketone.26  The ring opening promoted by Pd(OAc)2 in the presence of 
pyridine at 80 °C resulted in a mixture of separable exo- and endo-α,β-unsaturated ketone (II-
10a/II-10b 1:2) in 86% yield.27 When this reaction was carried out under similar conditions with 
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ocess. 
the addition of two equivalents of quinone, II-10a was the only enone product produced in 70% 
yield along with 10% recovered starting material, which could prevent palladium(0) catalyzed 
isomerization of II-10a to II-10b.  Interestingly, the cyclopropanol could also be opened by 
stoichiometric Pd/C at RT to afford II-10a exclusively. With access to enones 10a and 10b, we 
next explored their hydrogenation to prepare the α-methyl ketones II-11a/II-11b. Thus, 
hydrogenation of II-10a under typical conditions (H2, Pd/C) afforded an inseparable 
diastereomeric mixture of α-methyl ketone II-11a/II-11b in 88% yield (dr 3:1), while 
hydrogenation of II-10b under the same conditions produced II-11a/II-11b in 89% yield with 
opposite diastereoselectivity (dr 1:10). In order to skirt the separation problem at this point, we 
continued our synthesis with the diastereomeric mixture of II-11a/II-11b. Base promoted β-
elimination of II-11a/II-11b (dr 3:1) (0.5 M NaOH/THF, 0 °C) furnished a mixture of allylic 
alcohol II-12a/II-12b (dr 2:3) in 85% yield, 28  which were also difficult to separate. These 
results forced us to reinvestigate the cyclopropanol ring opening pr
Scheme 14. Synthesis of α-D-5a-carba-rhamnose 
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      We thought a direct hydrogenation with Pd/C of the cyclopropanol ring could avoid 
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formation of the enone intermediate II-10a by preventing β-hydride elimination.  That is to say, 
we hoped the Pd-homoenolate intermediate might be trapped by the Pd-bound hydrogen.29 To 
our delight, hydrogenation of II-9a with Pd/C under balloon pressure of H2 resulted in II-11a as 
a single diastereomer (dr >100:1) in 80% yield (Scheme 14).  Deprotection of II-11a under 
acidic conditions (10% HCl/THF) produced diol II-13. Alternatively, the diol could be achieved 
as a single diastereomer by first deprotection of acetonide in 9a (10% HCl/THF, 82%), then 
followed by the isomerization of the resulted triol 14 under the same hydrogenation condition 
(Pd/C, H2, 82%).  
      With the methyl group having been set, we next tried to install the α-D-rhamnose 
stereochemistry. Thus, the diol II-13 was acylated with Boc-anhydride followed by β-
elimination to afford enone II-15 in 83% yield over two steps. The carbonyl group of II-15 was 
diastereoselectively reduced with LiAlH4 at –78 °C to provide allylic alcohol II-16 in 91% yield 
(dr 11:1) with easy removal of the minor diastereomer by column chromatography. 
Dihydroxylation of cyclohexene II-16 under Upjohn conditions produced triol II-17 as a single 
diastereomer with good yield (87%). Reductive removal of the t-butyl carbonate group with 
LiAlH4 resulted in 5a-carba-α-D-rhamnopyranose II-7 in 83% yield.  
      In order to prepare the β-D-carbasugar, we switched the starting material to enone II-6 
(Scheme 15).  Enone II-6 could also be readily prepared from D-quinic acid II-5 in 5 steps in 
50% yield. 30  As with enone II-4 (c.f. Scheme 13), a one pot hydrosilylation and 
cyclopropanation of II-6, followed by desilylation under acidic conditions gave a diastereomeric 
mixture of cyclopropanol II-18a/ II-18b (dr ~1:1) in 85% overall yield.  Although these two 
cyclopropanol isomers were inseparable, a direct cyclopropanol ring opening of this mixture by 
Pd/C under hydrogenation conditions (balloon pressure of H2, 6 h, RT) afforded a diastereomeric 
mixture of α-methyl ketones II-19a/II-19b (63% yield, dr 2:1) along with some recovered 
cyclopropanol II-18b (20%, as a single diastereomer). The mixture of II-19a and II-19b could 
be separated by a combination of crystallization and silica gel chromatography resulting in a 
diastereomerically enriched mixture of II-19a (dr >13:1) and diastereomerically pure II-19b. X-
ray crystallography analysis of II-19b confirmed its stereochemistry. 
Scheme 15. Synthesis of β-D-5a-carba-digitoxose 
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X-ray of II-19b 
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      With the II-19b in hand, we next turned our attention to install the β-D-digitoxose 
stereochemistry. Thus, deprotection of II-19b in acidic condition (90% TFA/H2O) gave crude 
diol (albeit with some C-5 epimerization, dr ~15:1), which underwent acylation with Boc-
anhydride, and subsequent β-elimination to afford enone II-20 (79% yield from II-19b, dr ~ 
15:1). While pure isomer II-20 could be obtained by careful chromatography, the diastereomeric 
mixture of II-20 could be directly used in the diastereoselective reduction (LiAlH4 at –78 °C), 
resulting in an allylic alcohol in 82 % yield, with the minor diastereomers readily removed by 
chromatography, which was then treated in Meyer’s reductive rearrangement condition to 
provide olefin II-21 in good yield (73%, two steps).31 Dihydroxylation of the olefin II-21 under 
the Upjohn dihydroxylation conditions (OsO4/NMO) afforded an inseparable diastereomeric 
mixture of diol (dr 11:1), which was derivatized as an acetonide II-22 (81% for two steps), with 
the minor diastereomer removed by chromatography.  Finally, reduction of the Boc-carbonate by 
LiAlH4 and removal of acetonide in acid condition (10% HCl/THF) afforded 5a-carba-β-D-
digitoxopyranose II-8 in 85% yield. 
      Our efforts toward the L-carbasugars, commenced with the synthesis of α-methyl ketone II-
19a (Scheme 16). Acid hydrolysis of the bis-ketal in II-19a (dr ~10:1) afforded diol II-23 in 
70% yield. It was difficult to prevent some epimerization of the axial methyl group in II-23 
under the reaction conditions (dr ~8:1 for crude II-23). However, the minor diastereomer could 
be removed by silica gel chromatography. Then the diol II-23 subsequently underwent acylation 
with Boc-anhydride and β-elimination under basic condition to furnish enone (ent)-II-15 (90% 
overall yield, two steps). Thus, this enantiomer of II-15 could be converted into 5a-carba-α-L-
rhamnopyranose (ent)-II-7 using the same 3-step reaction sequence for the conversion of II-15 
to II-7. 
 
 
 
 
Scheme 16. Synthesis of α-L-5a-carba-rhamnose 
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      Alternatively, the L-series of carbasugar could be prepared from cyclopropanol II-9b 
(Scheme 4). We first deprotected the acetonide of II-9b under acidic conditions (10%HCl/THF) 
to give triol II-24 in 82% yield (Scheme 16). Exposure of the cyclopropanol II-24 to similar 
hydrogenation conditions (Pd/C, H2) as before afforded the α-methyl ketone II-25 in 80% yield 
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as a single diastereomer. An X-ray crystallography analysis of II-25 clearly confirmed the 
formation of α-methyl ketone and its stereochemistry. Dehydration of diol II-25 through 
carbonate formation and β-elimination furnished allylic alcohol II-12b in 73% yield over two 
steps. In order to prepare the α-sugar, we need to invert the stereochemistry of the C-1 hydroxyl 
group. Thus, Mitsunobu reaction of II-12b with p-nitrobenzoic acid in the presence of DIAD and 
PPh3 gave the ester II-26 in excellent yield (95%) with desired inverted stereochemistry. 32   
Diastereoselective reduction of the enone II-26 (LiAlH4, –78 °C) afforded allylic alcohol II-27 
in 90% yield (dr 11:1) with the minor isomer easily removed by chromatography. 
Dihydroxylation of the allylic alcohol II-27 produced triol II-28 in 94% yield with complete 
stereocontrol. Saponification of ester II-28 under basic conditions (LiOH/MeOH) afforded 5a-
carba-α-L-rhamnopyranose (ent)-II-7 in 85% yield.33 
      In conclusion, three carbasugars in D/L and α/β forms have been successfully synthesized 
starting with D-(–)-quinic acid. This synthesis highlights a novel diastereospecific Pd/C catalyzed 
cyclopropanol ring opening, diastereoselective reduction and dihydroxylation. Mitsunobu 
reaction and Myers’ reductive rearrangement were also used to install the desired carbasugar 
stereochemistry. 
 
 
 
 
 
 
 
 
II.2. Carbasugar C-1 Phosphate‡,34 
      Carbohydrates are a recurring structural motif in many bioactive natural products (e.g., 
antimicrobial and anticancer agents). 35  Often the sugar portion of the molecule is a crucial 
element for the activities of these compounds; for instance, many aglycons of biologically active 
natural products are void of activity.36  A cursory structure activity relationship analysis of the 
carbohydrate containing natural products points to the use of rare and deoxysugars (Scheme 
17).37  The removal or stereochemical inversion of the various sugar hydroxyl groups can impart 
significant in vitro-stability by lessening the abilities of naturally occurring glycosidase enzymes 
to degrade the structure.  In fact, our ongoing interest in the de novo synthesis of carbohydrates 
is aimed at being able to provide new glycosylated natural products for medicinal chemistry 
studies. 38  An alternative approach is to alter the biosynthesis of the glycosylated natural 
products.39 
Scheme 17. Biosynthesis of glycosyltransferase inhibitors 
 
      In an effort to understand and ultimately alter the microbial biosynthesis of rare/deoxy-sugar 
containing natural products various C-glycoside analogues of the NDP-sugars have been 
prepared.40  Most of these efforts have been focused on the synthesis and use of C-glycoside 
analogues with exo-acetal oxygen replaced with a methylene group (Y = CH2).40 In contrast, 
there is only one report that describes the use of the endo-acetal oxygen C-glycoside (X = CH2, 
cyclitol).41  To these ends, we have initiated an effort to develop an approach to these cyclitol 
sugar phosphates (X = CH2) in a manner that would mimic our de novo approach to 
carbohydrates (i.e., one that is amenable to both enantiomers of either α- or β-isomers).  Herein 
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‡ Reproduced in part with permission from Org. Lett. 2008, 10, 3381-3384. Copyright 2008, American Chemical 
Society. 
we described our successful efforts towards these aims.  
 
Figure 3. The target cyclitol sugar phosphates 
      To address these aims, we targeted the synthesis of four α-sugars and one β-sugar. These 
structures are outlined in Figure 3: 2,3-dideoxy-4-oxo-5a-carba-α-D-rhamnopyanose phosphate 
(II-31), 2,3-dideoxy-5a-carba-α-D-rhamnopyranose phosphate (II-32), 5a-carba-α-D-
rhamnopyranose phosphate (II-33), 5a-carba-β-D-digitoxopyranose phosphate (II-34) and 5a-
carba-α-L-rhamnopyranose phosphate ((ent)-II-33).  
Scheme 18. Retrosynthetic analysis  
 
      Retrosynthetically, we envisioned that the desired carbasugar phosphates stereoisomers II-35 
could be achieved from both enantiomers of the cis- and trans-diastereomers of the enone γ-
phosphate II-36 (Scheme 18). We thought II-36 could be derived from corresponding allylic 
alcohol II-37 which are readily available or could be easily synthesized from suitable 
intermediates we already achieved during the synthesis of carbasugar monosaccharide.  
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Scheme 19. Synthesis of 2,3-dideoxy-4-oxo-5a-carba-α-D-rhamnopyanose 1-phosphate (II-32)   
 
      We started the synthesis of the D-carbasugar phosphates with diol II-13. Carbonate formation 
of II-13 using triphosgene followed by β-elimination in basic condition resulted in allylic alcohol 
II-38 in 73% yield (Scheme 19). Phosphorylation of the alcohol II-38 with N, N-diethyl 
dibenzylphosphoramidite in the presence of 1H-tetrazole gave a phosphite intermediate which 
was oxidized by addition of 30% H2O2 to form dibenzyl phosphate II-39 in 76% yield.  
Debenzylation and reduction of double bond under hydrogenation condition (H2, Pd/C) failed to 
give the desired dihydrogen phosphate II-31, presumably due to hydrogenolysis of the allylic 
phosphate.  Attempts at hydrogenation of II-39 with diimide (NBSH/Et3N) proved unsuccessful. 
Thus we decided reduce the double bond before introduction of the phosphate functional group.  
Hydrogenation of II-38 (H2, Pd/C) gave saturated alcohol II-40 in 72% yield.  Phosphorylation 
of II-40 in the same condition described before gave dibenzyl phosphate II-41 in 70% yield.   
Then debenzylation under typical hydrogenation condition (H2, Pd/C) afforded the 2,3-dideoxy-
4-oxo-5a-carba-α-D-rhamnopyanose phosphate (II-31) in 73% yield. While analysis of the crude 
product showed diastereomerically clean material, upon sitting the product slowly epimerized to 
a ~2:1 of methyl diastereomers. 
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Scheme 20. Synthesis of 2,3-dideoxy-5a-carba-α-D-rhamnopyranose 1-phosphate (II-32), 5a-
carba-α-D-rhamnopyranose 1-phosphate (II-33) 
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To synthesize the phosphate II-32 and II-33, we returned to enone II-39 (Scheme 20).  A 
diastereoselective reduction with LiAlH4 at –78 °C gave the equatorial alcohol II-42 in good 
yield (87%) and diastereoselectivity (dr 11:1).  Diimide reduction (NBSH/Et3N) of II-42 resulted 
in saturated alcohol II-43 in 60% yield with 20% starting material back.  Hydrogenation of II-43 
on Pd/C furnished 2,3-dideoxy-5a-carba-α-D-rhamnopyranose phosphate (II-32) in 83% yield.  
Alternatively, dihydroxylation of allylic alcohol II-42 under Upjohn condition42 resulted in a 
single diastereomeric triol II-44 in 86% yield, which similarly underwent hydrogenolysis to 
afford 5a-carba-α-D-rhamnopyranose phosphate (II-33) in 87% yield. 
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      In order to achieve the β-D-digitoxose phosphate II-34, we started with Boc-carbonate II-22 
(Scheme 21). Reduction of Boc-carbonate II-22 by LiAlH4 gave alcohol II-45 in 93% yield 
which was then phosphorylated to give dibenzyl phosphate II-46 in 74% yield.  The acetonide 
deprotection of II-46 in acid condition produced diol II-47 with excellent yield (95%), which 
under typical hydrogenation conditions (H2, Pd/C) resulted in 5a-carba-β-D-digitoxopyranose 
phosphate (II-34) in 78% yield. 
Scheme 21. Synthesis of 5a-carba-β-D-digitoxopyranose 1-phosphate (II-34) 
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      In order to access the L-series of carbasugar phosphate, we started with the intermediate II-
27. TBS-protection and ester hydrolysis of II-27 gave alcohol allylic alcohol II-48 in good 
overall yield (85% for 2 steps) (Scheme 22). Phosphorylation of alcohol II-48 afforded dibenzyl 
phosphate II-49 in 66% yield.  Dihydroxylation of II-49 under Upjohn conditions produced diol 
in 81% yield as a single diastereomer, which after acid deprotection (p-TsOH/MeOH) provided 
triol II-50 in excellent overall yield (79% for two steps). Finally hydrogenation of 
dibenzylphosphate II-50 resulted in 5a-carba-α-L-rhamnopyranose phosphate ((ent)-II-33) in 
81% yield. 
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Scheme 22. Synthesis of 5a-carba-α-L-rhamnopyranose 1-phosphate ((ent)-5) 
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In conclusion, five carbasugar phosphates have been successfully synthesized in either D or L, 
α or β form from D-(–)-quinic acid. This synthesis includes a novel highly diastereospecific Pd/C 
catalyzed cyclopropanol ring opening, which may be a useful alternative for the introduction of 
methyl groups alpha to ketones.  Diastereoselective reduction, dihydroxylation, Mitsunobu 
reaction and Myers’ reductive rearrangement were also used to install the desired sugar 
stereochemistry. The biological evaluation of these cyclitol phosphates is ongoing.  
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Chapter III. Methodology and Synthesis of Carbasugar Analogues of SL0101 
III.1. Methodology development of carbasugar glycoside 
      In order to facilitate the medicinal structure-activity relationship (SAR) study of SL0101, we 
turned our attention to the carbasugar glycoside analogues of SL0101 (Figure 4). The advantage 
is that because these carbasugar analogues are not hydrolyzable because the ring oxygen has 
been replaced with a methylene group, and the biological activities of these carbasugar analogues 
will provide very important information to the structure-activity relationship (SAR) study of 
SL0101, particularly it may help us to understand the function of the sugar moiety.   
 
Figure 4. Carbasugar glycoside analogues of SL0101 
      Over these years, O’Doherty group has successfully developed a de novo approach to 
synthesize carbohydrates by using a palladium(0)-catalyzed glycosylation to introduce the 
glycosidic bond and post-glycosylation transformations to install corresponding stereochemistry 
of all kinds of glycosides.43 We want to develop a practical method to synthesize carbasugar or 
cyclitol glycoside, which is compatible to our method in the synthesis of normal carbohydrates 
(Scheme 23). To do this, we have two problems that need to be addressed. First, we want to 
know whether or not the palladium(0)-catalyzed glycosylation (i.e. Palladium(0)-catalyzed 
cyclitolization) from III-4 to III-5 would still work well without a ring oxygen. Second, we want 
to know whether or not a post-glycosylation (i.e. post-cyclitolization) could be developed to 
convert enone III-5 to the corresponding carbasugar III-6 accordingly as we did for normal 
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carbohydrates, since the anomeric effect no longer exists when the ring oxygen was replaced by 
a methylene group.  
Scheme 23. Proposed carbasugar synthesis 
 
      As we mentioned in chapter II of this dissertation, we already synthesized both α-L-Boc-
enone (III-4) and α-D-Boc-enone ((ent)-III-4) from quinic acid. Our carbasugar synthesis was 
carried out by first testing the palladium(0)-catalyzed cyclitolization. In practice, α-D-Boc-enone 
((ent)-III-4) was reacted with BnOH in CH2Cl2 in the presence of 10 mol% Pd(PPh3)2 at 0 ⁰C for 
10 hours. As a result, the reaction afforded glycosylated enone III-7 in a reasonable 60% yield 
(Scheme 24).  
Scheme 24. Palladium(0)-catalyzed cyclitolization or C-in ring glycosylation  
 
      In order to produce SL0101 carbasugar analogues we next examined the cyclitolization 
reation of SL0101 aglycone (Scheme 25). Reaction between flavonol aglycone III-8 and α-D-
Boc-enone ((ent)-III-4) went smoothly in CH2Cl2 in the presence of Pd(PPh3)2 catalyst to afford 
desired glycosylated enone (ent)-III-9 in 84% yield. In reality, this reaction finished in half an 
hour at 0 ºC with only 5 mol% Pd loading. 
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Scheme 25. Palladium(0)-catalyzed cyclitolization of the SL0101 aglycone 
 
     Since the palladium(0)-catalyzed cyclitolization reaction between flavonol III-8 and the Boc-
enone (ent)-III-4 worked very well, we believe a testing of the substrate scope will be useful for 
us to understand this reaction in terms of the electronic and steric effect from the stubstrates, 
which also would broaden its application to the synthesis of carbasugar glycoside analogues of 
many biologically important natural glycosides. For this purpose, a number of phenols and enols 
with different substitution patterns were chosen for testing (Scheme 26). From the experiments, 
the palladium(0)-catalyzed cyclitolization overall gave reasonable to excellent yields including 
phenols such as III-10 to III-17 and coumarin III-19, enols such as naphthaquinone-2-ol (III-20) 
and flavonol III-8. Tentatively, we could conclude that (1) Phenols with electron donating 
groups tend to give higher yield for the cyclitolization than those with electron withdrawing 
groups, and for the extreme case, highly electron deficient p-nitrophenol did not react at all; (2) 
Steric hinderance did not greatly affect those phenols with electron donating groups even with a 
t-butyl group in ortho position such as III-14; but for those with electron withdrawing groups 
such as III-16, the steric hinderance might be responsible for the lower yield; (3) Highly electron 
deficient enol such as III-20 also gave high yield of cyclitolization, which we did not expect that 
before.  
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Scheme 26. Palladium(0)-catalyzed cyclitolization for phenols and enols 
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      Once the palladium(0)-catalyzed cyclitolization has been developed, we next turned our 
attention to the post-cyclitolization transformation to install desired stereochemistry of the 
carbasugars. In particularly, we hope to develop a practical way to the rhmannose 
stereochemistry since the sugar moiety in SL0101 and its analogues are rhmannose. The first 
thing we wanted to do was the reduction of the glycosylated enone such as III-7 to allylic 
alcohol with high diastereoselectivity (Scheme 27). NaBH4 reduction with or without CeCl3 at -
78 ºC, which are usual conditions we used to reduce pyranones in our normal carbohydrate 
synthesis, had some selectivity of III-31 over III-32 but not that satisfying.  We next examined 
DIBAL-H, which gave a 1:1 ratio of these two allylic alcohols. The more bulky lithium tri-t-
butoxyaluminohydride did not increase the selectivity too much. Fortunately, LiAlH4 reduction 
at -78 ºC resulted in a reasonable diastereoselectiviy of 11:1 to afford allylic alcohol III-31 with 
85% yield, when the temperature was lowered down to -100 ºC, the selectivity slightly increased 
to 12:1.  
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Scheme 27. Reduction of glycosylated enone  
X
O
OBn
X
OH
OBn
X
OH
OBn
III-7 III-31 III-32
+
Reduction condition
X=CH2
 
Entry Reduction condition Ratio of III-31/ III-32 
1 NaBH4/-78 ºC                    3             :               1    
2 NaBH4/CeCl3/-78 ºC              1.5           :              1              
3 DIBAL-H/-78 ºC                 1              :               1  
4 LiAlH(t-BuO)3/-78 ºC             3.5           :               1 
5 LiAlH4/-78 ºC                   11            :               1 
6 LiAlH4/-100 ºC                  12            :               1 
 
      To install the rhmannose stereochemistry, olefin III-31 was then converted to diol III-33 
(Scheme 28). In practice, dihydroxylation of the allylic alcohol III-31 upon Upjohn condition 
(OsO4/NMO) condition at 0 ºC afforded triol III-33 in 90% yield with complete stereocontrol. 
Scheme 28. Dihydroxylation of allylic alcohol III-31 
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III.2. Synthesis of carbasugar glycoside analogues of SL0101 
      Once the methodology of palladium(0)-catalyzed cyclitolization and post-cyclitolization 
transformation had been successfully developed, we next started the synthesis of carbasugar 
analogues of SL0101. Treatment of tribenzylated kaempferol III-8 with α-L-Boc-enone III-4 in 
the presence of 5 mol% Pd catalyst in CH2Cl2 at 0 ºC for 30 minutes furnished the glycosylated 
enone III-9 with 84% yield (Scheme 29).  
Scheme 29. Palladium(0)-catalyzed cyclitolization of SL0101 aglycone  
 
      Reduction of the enone III-9 by LiAlH4 at -78 ºC afforded allylic alcohol III-34 in 89% yield 
with the diastereoselectivity of 11:1 (Scheme 30). Acylation of the resulted allylic alcohol gave 
allylic acetate IV-24 in 93% yield. Dihydroxylation of the olefin in IV-24 furnished the diol IV-
25 in 73% yield as a single diastereomer. The diol IV-25 was then converted to one of our 
desired carbasugar analogues of SL0101, C-4 monoacetate IV-1 after debenzylation on Pd/C 
hydrogenation condition in 68% yield. 
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Scheme 30. Synthesis of α-L carbasugar analogue of SL0101 (C-4 monoacetate) 
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      In order to achieve the diacetate carbasugar analogues of SL0101, we thought a selective 
acylation could be carried out on intermediate diol III-36 by an orthoacetate formation and 
kinetic hydrolysis just like what we did in the synthesis of SL0101 (Scheme 31). Treatment of 
diol with trimethyl orthoacetate in the presence of catalytical amount of p-toluenesulfonic acid 
followed by the hydrolysis by using 90% aqueous acetic acid furnished a mixture of 2,4-
diacetate III-37 and 3,4-diacetate III-38 in a 1.5:1 ratio, which was in contrast to the completely 
regioselective acylation of the axial hydroxy group in the synthesis of SL0101. This result 
clearly indicated the ring flip of cyclohexane ring is much easier due to the loss of anomeric 
effect which helps control the sugar conformation. Fortunately, we could separate these two 
regioisomers on silica gel column chromatrography. Then, debenzylation of III-37 and III-38 
was carried out by hydrogenation to produce SL0101 C-2,C-4-diacetate carbasugar analogue III-
2 and C-3,C-4-diacetate carbasugar analogue III-3 respectively. 
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Scheme 31. Synthesis of diacetate carbasugar analogues of SL0101 
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      In order to access D-series of carbasugar analogues of SL0101, we first coupled the aglycone 
kaempferol III-8 with the α-D-Boc-enone (ent)-III-4 by using palladium(0)-catalyzed 
cyclitolization condition to furnish glycosylated enone (ent)-III-9 in 85% yield (Scheme 32). 
Scheme 32. Palladium(0)-catalyzed cyclitolization of SL0101 aglycone with α-D-Boc-enone 
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      Reduction of enone (ent)-III-9 by LiAlH4 at -78 ºC afforded allylic alcohol (ent)-III-34 in 
89% yield with the diastereoselectivity 11:1 (Scheme 33). Acylation of the resulted allylic 
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alcohol gave allylic acetate (ent)-III-35 in 98% yield. Dihydroxylation of the olefin (ent)-III-35 
upon Upjohn condition furnished the diol (ent)-III-36 in 82% yield as a single diastereomer. The 
diol (ent)-III-36 was then converted to one of α-D carbasugar analogues of SL0101, C-4 
monoacetate (ent)-III-1 after debenzylation on Pd/C hydrogenation condition in 73% yield.  
Scheme 33. Synthesis of monoacetate of α-D-carbasugar analogue of SL0101 
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      To synthesize the diacetate of  α-D carbasugar analogues of SL0101, an orthoacetate 
formation and kinetic hydrolysis was performed on the diol intermediate (ent)-III-36 (Scheme 
34). Treatment of diol with trimethyl orthoacetate in the presence of catalytic amount of p-
toluenesulfonic acid followed by hydrolysis using 90% aqueous acetic acid furnished 2,4-
diacetate (ent)-III-37 and 3,4-diacetate (ent)-III-38 in about 1:1 ratio. After separation of these 
two regioisomers, (ent)-III-37 and (ent)-III-38 were debenzylated by the hydrogenation to 
produce SL0101 C-2,C-4-diacetate of α-D carbasugar analogue (ent)-III-2 and C-3,C-4-diacetate 
of α-D carbasugar analogue (ent)-III-3, respectively.  
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Scheme 34. Synthesis of diacetate of α-D-carbasugar analogues of SL0101 
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      In conclusion, a palladium(0)-catalyzed cyclitolization and post-cyclitolization 
transformation have been successfully developed. Six carbasugar analogues of SL0101 including 
three α-L and three α-D forms have been synthesized by utilizing this methodology.  
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Chapter IV. Efforts toward the Total Synthesis of Jadomycin A and B 
IV.1. Introduction 
       Jadomycins are a group of angucycline-derived antibiotics that were produced by 
Streptomyces venezuelae following heat shock, ethanol shock or phage infection.44 The unique 
structural feature of these class of antibiotics is the pentacyclic 8H-benz[b]oxazolo[3,2-f]-
phenanthridine backbone, which consists of a dihydropyridine ring and an oxazolone ring. The 
formation of these two unique rings are believed to arise from the condensation of a biosynthetic 
aldehyde intermediate, which is derived from anguclinone, with amino acid followed by a series 
of transformations.45 The jadomycins exhibited a multitude of activities such as antibacterial, 
antiyeast, cytotoxicity against cancer cell lines, antivirus, and enzyme inhibitory activities.44,46 
O
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N O
HO
O
O
OH
HO
O
Jadomycin A (IV-1) Jadomycin B (IV-2)
H
O
O
N O
HO
OH
O
H
 
Figure 5. Structural Features of Jadomycin A and Jadomycin B 
      Jadomycin A and B (Figure 5) were the first jadomycins that were isolated from 
Streptomyces venezulae ISP5230 when grown in an isoleucine containing medium under stress 
conditions by Prof. Ayer in 1991 and 1993 respectively.44 Jadomycin A is the aglycone of 
jadomycin B, which is an α-L-digitoxoside. The sugar moiety, α-L-digitoxose in jadomycin B is 
believed of great importance for some biological activities such as anti-yeast, which jadomycin 
A does not have.44c,47  Since the discovery of jadomycin A and B, many analogues of jadomycin 
B have been produced by the fermentation in medium with variant non-natural and natural 
aminoacids. All these jadomycin analogues were called jadomycins and their biological activities, 
as well as their biosynthetic pathway have been broadly investigated.45,48,49 
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     Although they are structurally unique and biologically important, so far no total synthesis of 
jadomycins including jadomycin A, B and their analogues have been reported. We believe a 
practical synthetic approach to these structures as well as the ease to incorporate different 
aminoacid and sugar moiety would significantly enhance the medicinal structure-activity 
relationship (SAR) studies of this class of antibiotics.  
Scheme 35. Retrosynthetic analysis of jadomycin B 
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      Retrosynthetically, we think the jadomycin B (IV-2) could be disconnected on the glycosidic 
bond between the sugar moiety and aglycone (Scheme 35). The successful synthesis of the 
aglycone of jadomycin B could be used to determine the structure of jadomycin A (IV-1), which 
was not clearly identified in the isolation paper in terms of the stereochemistry of the methyl 
group in the aminoaicd. We envisioned that the glycosidic bond could be installed via our 
palladium(0)-catalyzed glycosylation reaction between jadomycin A (IV-1) and Boc-pyranone 
(IV-3), while a post-glycosylation transformation from glycosylated pyranone to α-digitoxose 
need to be developed. We believed the aglycone part could be achieved from three components 
juglone IV-4, benzaldehyde IV-5, and the aminoacid IV-6. The connection between juglone part 
and benzaldehyde part could be achieved by using some sort of cross coupling reactions or direct 
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nucleophilic addition reactions. The aminoacid part could be introduced at due course, although 
we don’t know the stereochemistry of the methyl group, it is reasonable for us to start with 
natural isoleucine.  
 
IV.2. De novo asymmetric synthesis of α-digitoxose  
Scheme 36. Limitation of our current methodology to digitoxose  
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      In order to synthesize the sugar moiety of jadomycin B, first we need to develop a practical 
method to achieve α-digitoxose in terms of installation of the correct stereochemistry. As part of 
efforts to search for more potent digitoxin analogues for the anti-cancer agents, we successfully 
developed a route to β-digitoxose (Scheme 36). 50  The approach features a palladium(0)-
glycosylation to a β-pyranone IV-7, which subsequently underwent reduction to allylic alcohol 
IV-8, Myers’ 1,3-transposition to olefin IV-9, and dihydroxylation of the resulted olefin. This 
approach afforded exclusively the desired β-digitoxose IV-10. When it comes to the α-digitoxose 
case, after reduction of an α-pyranone IV-11 to allylic alcohol IV-12, 1,3-transposition of the 
double bond and dihydroxylation of the resulted olefin IV-13 will produce a diastereomeric 
mixture of desired α-digitoxose IV-14 and undesired sugar IV-15 with the undesired 
diastereomer as the major product. This limitation clearly indicated that a new practical post-
glycosylation transformation should be needed to prepare α-digitoxose.       
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Scheme 37. Proposed approach to α-digitoxose 
 
     We envisioned that since the reduction of the α-pyranone gave an allylic alcohol IV-12 which 
has the same stereochemistry as required in jadomycin B (IV-2), the hydroxyl group could 
possibly direct the introduction of adjacent hydroxy group by a cyclic carbonate formation from 
IV-16 to IV-17 to set up the second hydroxy group which after suitable transformation could be 
converted to α-digitoxose (scheme 37). After searching in the literature, similar transformations 
could be seen.51 But all these transformations from allyl carbonate to cyclic carbonate involved 
the use of very strong electrophile such as I(Collidine)2ClO4, which limited the compatibility of 
this approach. We started to investigate more general electrophiles that could promote the 
formation of cyclic carbonate IV-17 from a mixed carbonate IV-16, at the same time it might be 
compatible with the aromatic ring such as aglycone in jadomycin B.  
Scheme 38. Asymmetric Synthesis of Boc-pyranone 
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      We started the synthesis with the achiral acylfuran (Scheme 38).  Noyori reduction of 
acylfruan IV-18 by using Noyori (R,R) catalyst in the presence of complex of formic acid and 
triethylamine as hydride source produced the furyl alcohol IV-19 in 93% yield with high 
enantiomeric excess (> 96% ee).  An Achmatowiz rearrangement transformed the furfyl alcohol 
to hemicacetal IV-20 in 91% yield.  The hemiacetal was then protected as t-butyl carbonate IV-
22α and IV-22β at low temperature in 78% yield with 3:1 (α/β) diastereomeric ratio, which could 
be easily separated to give the D-sugar precursor.52  It worth noting that by simply switching the 
catalyst Noyori (R,R) to Noyori (S,S), we are able to synthesize the L-sugar precursor.  
Scheme 39.  Synthesis of the allyl carbonate 
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    Palladium(0)-catalyzed glycosylation reaction developed in our lab diastereoselectively 
installed glycosidic bond at the anomeric center with complete α selectivity (IV-22α to IV-23) 
(Scheme 39). NaBH4 reduction of the enone IV-23 at -78 ºC resulted in the allylic alcohol IV-24 
with high diastereoselectivity (dr > 20:1). Acylation of the allylic alcohol IV-24 with either 
CbzCl or Boc2O afforded carbonate IV-25 and IV-26 respectively, which are ready for the 
screening of iodo-carbonation. 
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Scheme 40.  Screening for the halo-carbonation of allyl carbonate 
 
Entry R Solvent Electrophile Lewis Acid Yield 
1 Boc CH2Cl2 NBS  NR 
2 Boc CH2Cl2 NIS  NR 
3 Boc CH2Cl2 I2  NR 
4 Boc CH2Cl2 PhNMe3Br3  NR 
5 Boc CH2Cl2 NIS LiClO4 Trace amount 
6 Boc CH2Cl2 NIS MgBr2•Et2O 26% 
7 Boc CH2Cl2 NIS ZnI2 NR 
8 Boc CH2Cl2 NIS Zn(OTf)2 decompose 
9 Boc CH2Cl2 NIS Sc(OTf)3 decompose 
10 Boc CH2Cl2 NIS BF3•Et2O decompose 
11 Cbz CH2Cl2 NIS LiClO4 NR 
12 Cbz CH2Cl2 NIS MgBr2•Et2O NR 
13 Cbz CH2Cl2 NIS ZnI2 NR 
14 Cbz CH2Cl2 NIS Zn(OTf)2 NR 
15 Cbz CH2Cl2 NIS Sc(OTf)3 Not clean reaction 
16 Cbz CH2Cl2 NIS BF3•Et2O decompose 
17 Boc HOAc NIS  96% 
18 Cbz HOAc NIS  51% 
 
      At the beginning, we screened this cyclic carbonate formation in CH2Cl2 by using halogen 
sources such as NBS, NIS, I2, and PhNMeBr3 as electrophiles and t-butyl allyl mixed carbonate 
IV-25 as substrate (Scheme 40). No reaction was observed by TLC as shown in entry 1-4. Next, 
we tried to use Lewis acid to promote the cyclization reactions. Therefore, a number of Lewis 
acid such as LiClO4, MgBr2•Et2O, ZnI2, Zn(OTf)2, Sc(OTf)3, BF3•Et2O were used as the 
43 
 
promoters in term of their attenuated Lewis acidity. The screening was carried out in a 0.05 M 
solution of substrate in CH2Cl2 with one eqivalent NIS as electrophile and 30 mol% Lewis acid  
as promoter. As a result, MgBr2•Et2O was found having some activity in promoting the 
conversion of mixed carbonate IV-25 to cyclic carbonate IV-27, while LiClO4 case also gave 
trace amount of desired product, although both conversions were not complete, and most 
substrate remained untouched. ZnI2 showed no reactivity probably due to its poor Lewis acidity. 
The stronger Lewis acid such as Zn(OTf)2, Sc(OTf)3, BF3•Et2O caused the decomposition of the 
substrate. We also examinated the substrate of benzyl allyl mixed carbonate IV-26. This time the 
LiClO4, MgBr2•Et2O, ZnI2, Zn(OTf)2 did not give any conversion, instead, Sc(OTf)3 afforded 
some products but the reaction was not clean. Once again, the BF3•Et2O caused the 
decomposition of substrate.  
      Fortunately, when we switched the solvent from CH2Cl2 to HOAc without any Lewis acid, 
the t-butyl allyl mixed carbonate IV-25 was converted to the desired iodo-carbonate IV-27 
cleanly with high yield. When the benzyl allyl mixed carbonate IV-26 was used as the substrate, 
the reaction also had reasonable conversion in the same condition as used for IV-25.  
Scheme 41.  Synthesis of α-digitoxose  
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      Encouraged by the preliminary results, we next carried out our synthesis of α-digitoxose 
(Scheme 41). The iodocarbonate IV-27 could be obtained from carbonate IV-25 with NIS/HOAc 
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condition in 96% yield or NIS/MgBr2/CH2Cl2 condition in 25%. And also the carbonate IV-26 
could be converted to IV-27 in 51% yield. Iodine in iodocarbonate IV-27 was reductively 
removed by tris(trimethylsilyl)silane upon heating in the presence of AIBN as a radical initiator 
to afford cyclic carbonate IV-28,53 which was subjected to basic hydrolysis to furnish benzyl α-
digitoxoside (IV-29)   
        To sum up this part, a highly diastereoselective route to α-digitoxose has been developed. 
The route relies on a palladium(0)-catalyzed glycosylation reaction and post-glycosylation 
transformation. The asymmetry of α-digitoxose originated from Noyori reduction of acylfuran 
and subsequent introduction of other stereogenic centers. An iodo-carbonate formation is the key 
step for the construction of α-digitoxose stereochemistry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV.3. Synthesis of Jadomycin A 
      With the approach to α-digitoxose having been successfully developed, we next turned our 
attention to synthesize jadomycin A, the aglycone part of the jadomycin B. Our first strategy to 
the jadomycin A (IV-1) was shown in Scheme 42, which features an oxazolone ring formation as 
the key step to connect the three building blocks together (i.e. from IV-32 or IV-33 and IV-34 to 
IV-30 or IV-31 respectively). Once the oxazolone ring was formed, the dihydropyridine ring 
formation could be achieved via direct Michael addition or Heck reaction (i.e. from IV-30 or IV-
31 to IV-1). 
Scheme 42. First strategy to jadomycin A 
 
 
      We started the synthesis with the benzaldehyde part IV-34 (Scheme 43). By a modification 
of the reported method in the literature,54 benzoate IV-37 was produced in 56% overall yield in 
three steps from acetopyruvate (IV-35). Protection of phenol IV-37 as TBS ether followed by 
LiAlH4 reduction delivered benzyl alcohol IV-38 in 89% yield over two steps, which upon 
MnO2 oxidation to aldehyde IV-39 (84%) and deprotection of TBS ether in acid condition 
afforded 3-hydroxyl-5-methyl benzaldehyde (IV-34) in 93% yield. 
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Scheme 43. Synthesis of 3-hydroxyl-5-methyl benzaldehyde 
 
      Our next synthetic intermediate is the juglone part IV-43 (Scheme 44). Isoleucine (IV-6) was 
first protected as t-butyl ester IV-40.  3-bromojuglone (IV-42) was synthesized from juglone IV-
41 according to the reported method in 80% yield.55  Introducing the aminoacid into the 3-
position of the juglone was successfully achieved in 67% yield by mixing IV-40 and IV-42 in 
CH2Cl2 in the presence of triethylamine. 56  The resulted aminojuglone IV-43 was then 
brominated by Br2 in ethanol to afford 2-bromo-3-aminojuglone IV-44 in 87% yield.57 
Scheme 44. Synthesis of bromojuglone IV-44 
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      With the two building blocks in hand, we turned our attention to the investigation of the 
oxazolone ring formation (Scheme 45). Bromoaminojuglone IV-44 was first chosen to test this 
reaction. The t-butyl ester was deprotected by exposure to trifluoroacetic acid, which afforded 
free carboxylic acid IV-33. The carboxylic acid was then heated with benzaldehyde IV-34 in 
benzene in the presence of p-toluenesulfonic acid by using Dean-Stark trap technique, or direct 
distillation. Unfortunately, no desired oxazolone was formed. We thought it might be due to the 
steric hinderance from the bromine. Therefore, we examinated the reaction between 
benzaldehyde IV-34 and the free acid IV-32, which came from the deprotection of t-butyl ester 
IV-43, by using the same technique of Dean-Stark trap. Once again, no reaction was observed.   
Scheme 45.  Tries on oxazolone ring formation  
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      Due to the difficulty we ran into during the synthesis of the aglycone by forming oxozalone 
ring, we next examined the possibility of direct coupling of the two components, which will 
significantly facilitate the formation of the dihdropyridine ring and oxazolone ring as well 
(Scheme 46). Therefore, benzaldehyde IV-34 was first protected as acetal by 1,3-propanediol in 
the presence of acid (84%), which was then further protected as MOM ether in the condition of 
MOMCl/DIPEA (68%). The MOM ether IV-45 was converted to stannane IV-46 by a directed 
lithiation followed by reacting the anion intermediate with tributyltin chloride in 49% yield with 
the recovery of 35% starting material. A Stille coupling was carried out between bromojuglone 
IV-44 and stannane IV-46 in the presence of palladium(0) and cocatalyst CuI, 58  but 
unfortunately, no desired product was observed.    
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Scheme 46. First try of Stille coupling  
 
      The failure of the Stille coupling between aminobromojuglone IV-44 and stannane IV-46 
suggested that the steric hinderance should be an important factor here. We now believed that a 
coupling between the juglone part and benzaldehyde should be needed before the introduction of 
the aminoacid part. Therefore, we turned our attention to the synthesis of 2-bromojuglone (IV-50) 
by following the reported method.59 Naphthalenediol IV-47 was converted to diacetate IV-48 in 
the presence of acetic chloride/pyridine in 92% yield (Scheme 47). Diacetate IV-48 was oxidized 
by NBS to 2-bromojuglone acetate IV-49 in 80% yield, which was hydrolyzed in acid condition 
to produce 2-bromojuglone (IV-50) in 75% yield. With the 2-bromojuglone in hand, the 
coupling between it and stannane IV-46 was then tested by following the conditions reported in 
the literature.58 In practice, the coupling was carried out in the presence of 5 mol% palladium(0) 
and 20 mol% CuI as cocatalyst in THF at elevated temperature, which afforded the coupled 
product IV-51 in 76% yield.  
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Scheme 47. Stille coupling between 2-bromojuglone and stannane 
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      With the juglone part and benzaldehyde having been coupled. We then investigated the 
introduction of the aminoacid (Scheme 48). A direct aza-Michael addition to achieve IV-52 
proved to be not successful by mixing the juglone part IV-51 and aminoacid IV-40. We next 
tried to knock off the protecting group to produce aldehyde, which then possibly help 
introduction of the aminoacid part. To our surprise, deprotection of the acetal and MOM ether by 
treatment of IV-51 with TFA caused the decomposition of the starting material. Upon a short 
time heating of IV-51 in aqueous HCl/THF, around 20% yield of aldehyde IV-53 was obtained. 
Mixing the aldehyde IV-53 with aminoacid IV-40 in toluene at RT, over two days, the starting 
material disappeared. After passing the mixture through a short column, a crude product was 
obtained, which was then treated with TFA furnished jadomycin A (IV-1). The crude NMR data 
showed that the product was a mixture of diastereomers at a ratio of 6 to 1 with the major isomer 
matching very well with the reported data of jadomycin A. This also confirmed that the 
stereochemistry of the methyl group is the same as it is in natural isoleucine. 
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Scheme 48. Synthesis of jadomycin A 
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      In conclusion, a model study for synthesis of α-digitoxose, the sugar moiety of jadomycin B 
has been successfully carried out by preparing benzyl α-digitoxoside, which relies upon a 
palladium(0) catalyzed glycosylation, post-glycosylation featuring an iodo-carbonation and 
corresponding transformations. Jadomycin A, the aglycone part of jadomycin B, has also been 
successfully synthesized and structurally defined by the comparison of our spectral data with the 
reported one from isolation. This synthesis features a Stille cross coupling reaction, a tandem 
imine formation/dihydropyridine ring formation during the incorporation of the aminoacid. 
Efforts toward the synthesis of the jadomycin B will be continued by applying the newly 
developed methodology for installation of α-digitoxose to the jadomycin A. 
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Chapter V. Experimental Section 
V.1. General methods and materials  
1H and 13C spectra were recorded on 270 MHz and 600 MHz spectrometers. Chemical shifts 
were reported relative to benzene-d6 (δ 7.16 ppm), CDCl3 (δ 7.26 ppm), CD3OD (δ 3.31 ppm), 
acetone-d6 (δ 2.05 ppm), D2O (δ 4.80 ppm) for 1H, and benzene-d6 (δ 127.68 ppm), CDCl3 (δ 
77.0 ppm), CD3OD (δ 49.15 ppm), acetone-d6 (δ 29.92 ppm) for 13C, and H3PO4 in D2O (δ 0.00 
ppm) as external reference for 31P. Optical rotations were measured with a digital polarimeter in 
the solvent specified. Infrared (IR) spectra were obtained on a FT-IR spectrometer. Flash column 
chromatography was performed on 60-200 mesh silica gel. Analytical thin-layer chromatography 
was performed with precoated glass-backed plates and visualized by quenching of fluorescence 
and by charring after treatment with panisaldehyde or phosphomolybdic acid or potassium 
permanganate stain. Rf values were obtained by elution in the stated solvent ratios (v/v). Ether, 
THF, methylene chloride, toluene and triethylamine were dried by passing through activated 
alumina (8 x 14 mesh) column with argon gas pressure. Commercial reagents were used without 
purification unless otherwise noted. Air and/or moisture-sensitive reactions were carried out 
under an atmosphere of argon/nitrogen using oven/flamed-dried glassware and standard 
syringe/septum techniques. 
 
 
 
 
 
 
 
V.2. Chapter I experimental  
(E)-1-(2,4-bis(benzyloxy)-6-hydroxyphenyl)-3-(4-(benzyloxy)phenyl)prop-2-en-1-one (I-7)5 
BnO
OBn
OH
O
OBn
 
To a solution of 4.0 g 4’, 5, 7-trihydroxyflavanone I-6 (14.7 mmol) in 50 mL acetone was added 
5.3 mL BnBr (44.4 mmol) and 12.2 g K2CO3 (88.2 mmol). The reaction mixture was heated 
under reflux for 6 hours, then cooled down to room temperature. The mixture was concentrated 
under reduced pressure to give a residue which was then partitioned between 150 mL EtOAc and 
80 mL H2O. The water layer was extracted by EtOAc (100 mL × 3). The organic layer was 
pooled, then washed by saturated brine, dried over Na2SO4 and concentrated under reduced 
pressure to give a crude product. Recrystallization and further chromatography for the mother 
liquid eluting with hexane-EtOAc (6:1) gave pure phenol I-7 (6 g, 75%): Yellow solid; Rf = 0.51 
(3:1 (v/v) hexane/EtOAc); 1H NMR (CDCl3, 270 MHz) δ 7.75 (dd, J = 15.6, 15.3 Hz, 2H), 7.53-
7.30 (m, 15H), 7.00 (d, J = 8.9 Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 6.22 (d, J = 2.5 Hz, 1H), 6.17 
(d, J = 2.5 Hz, 1H), 6.13 (d, J = 10.2 Hz, 1H), 5.10 (s, 2H), 5.08 (s, 2H), 5.05 (s, 2H); 13C NMR 
(CDCl3, 67.5 MHz) δ 192.6, 168.8, 165.1, 161.7, 160.3, 142.7, 136.5, 135.9, 135.5, 130.1, 128.9, 
128.8, 128.7, 128.6, 128.6, 128.5, 128.3, 128.1, 127.7, 127.4, 125.2, 115.0, 106.3, 95.0, 92.5, 
71.4, 70.3, 70.0.  
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4H-chromen-4-one (I-8)5  
BnO
OBn
O
O
OBn
 
53 
 
2.76 g phenol I-7 (5.09 mmol) was dissolved in 6 mL dry DMSO, and a catalytic amount of I2 
(41 mg, 0.16 mmol) was added into the solution. The reaction mixture was heated to 110 °C and 
kept stirring at this temperature for 24 hours. Then it was cooled down to the room temperature. 
10 mL saturated aqueous NaHCO3 was added to quench the reaction. The water layer was 
extracted with EtOAc (30 mL × 3). The organic layer was pooled, then washed by 10 mL 
saturated brine, dried over Na2SO4, and concentrated the organic layer under reduced pressure to 
give a crude product. Chromatography eluting with hexane-EtOAc (2:1) afforded desired flavone 
I-8 (2.10 g, 76%): Yellow solid; Rf = 0.20 (2:1 (v/v) Hexane/EtOAc); 1H NMR (CDCl3, 600 
MHz) δ 7.81 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.4 Hz, 2H), 7.46-7.28 (m, 13H), 7.07 (d, J = 8.4 
Hz, 2H), 6.64 (d, J = 1.8 Hz, 1H), 6.58 (s, 1H), 6.49 (d, J = 2.4 Hz, 1H), 5.23 (s, 2H), 5.14 (s, 
2H), 5.11 (s, 2H); 13C NMR (CDCl3, 67.5 MHz) δ 177.3, 162.8, 161.1, 160.6, 159.6, 136.4, 
136.2, 135.7, 128.7, 128.6, 128.5, 128.4, 128.2, 127.6, 127.4, 126.5, 124.0, 118.0, 115.2, 109.7, 
107.7, 98.3, 94.2, 70.7, 70.4, 70.1.  
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-hydroxy-4H-chromen-4-one (I-3)5  
BnO
OBn
O
O
OBn
OH
 
150 mL solution of freshly generated DMDO in acetone (~ 0.1 M) was dried by 3 Å MS at -
20 °C under the protection of argon, and into this solution was added a solution of 2.3 g flavone 
I-8 (4.26 mmol) in 20 mL dry CH2Cl2 at this temperature via a cannula.  Then allow it warm up 
to 0 °C and keep stirring at 0 °C overnight. The solvent was evaporated under reduced pressure 
to give brown-yellowish solid, which was then redissolved in 20 mL CH2Cl2. Into this solution 
was added 2 mg TsOH·H2O and it was then kept stirring at room temperature for 1 hour. The 
reaction mixture was concentrated under reduced pressure to a residue, which was then subjected 
to chromatography. Elution with hexane-EtOAc (5:1) gave perbenzylated flavonol I-3 (1.2 g, 
50%) and elution with hexane-EtOAc (2:1) recovered 0.7 g starting material.  
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Alternative procedure: 
A solution of 1.5 g (2.77 mmol) enone I-8 in 54 mL CH2Cl2 and 27 mL acetone was added a 
buffer solution of 3.6 g NaHCO3 and 7.5 g Na2CO3 in 189 mL H2O at RT. When vigorous 
stirring, the mixture was slowly added a solution of 16.2 g (26.4 mmol) oxone 
(2KHSO5•KHSO4•K2SO4) in 189 mL H2O over 2 hour. Then it was stirred for another 10 min. 
Then it was separated and the aqueous layer was extracted with CH2Cl2 80 mL X 2. The 
combined organic layer was washed subsequently with 120 mL aqueous solution of Na2S2O3 (30 
mL saturated aqueous Na2S2O3 plus 90 mL H2O), 120 mL saturated brine and then was dried 
over Na2SO4.  Into the solution, 9 mg (0.05 mmol) p-TsOH•H2O was added at RT, and the 
mixture was stirred for 20 min. It was then diluted with 200 mL Et2O followed by washing with 
saturated aqueous NaHCO3, saturated brine, and dried over Na2SO4. After removal of the solvent, 
a viscous residue was obtained. Then addition of several mL of CH2Cl2 into the mixture and 
stirring resulted in solid formation, which was filtered and rinsed with hexane-EtOAc (1:1, v/v) 
to afford 380 mg product I-3 (25%). The mother liquid was concentrated and once again addition 
of CH2Cl2 induced the solid formation, which after filtration delivered another 140 mg product I-
3 (9%).     
Perbenzylated flavonol I-3: Yellow solid; Rf = 0.35 (3:1 (v/v) Hexane/EtOAc); 1H NMR (CDCl3, 
600 MHz) δ 8.17 (d, J = 9.6 Hz, 2H), 7.61 (d, J = 7.2 Hz, 2H), 7.47-7.30 (m, 13H), 7.10 (d, J = 
9.0 Hz, 2H), 6.64 (d, J = 1.8 Hz, 1H), 6.49 (d, J = 1.8 Hz, 1H), 5.24 (s, 2H), 5.15 (s, 2H), 5.12 (s, 
2H); 13C NMR (CDCl3, 67.5 MHz) δ 171.8, 163.2, 159.8, 159.4, 158,7, 142.2, 137.6, 136.5, 
136.2, 135.6, 128.9, 128.8, 128.6, 128.5, 128.1, 127.8, 127.6, 127.5, 126.7, 123.8, 114.9, 106.8, 
97.6, 93.7, 70.7, 70.6, 70.0.  
 
(S)-1-(furan-2-yl)ethanol (I-9)60 
O
OH
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 104.9, 63.3, 
21.1.  
 
(2S, 6R)-6-hydroxy-2-methyl-2H-pyran-3(6H)-one (I-10)60  
To a solution of 15 g acylfuran I-5 (136.4 mmol) in 20 mL CH2Cl2 was added a prepared 
solution of formic acid/triethylamine (40 mL, 2:1(mol/mol)) and Noyori asymmetric transfer 
hydrogenation catalyst (R)-Ru(η6-mesitylene)-(S, S)-TsDPEN (0.2 g, 0.25 mol%). 61  The 
resulting solution was stirred at room temperature for 24 h. Then it was diluted with water (90 
mL) and extracted with Et2O (200 mL x 3). The pooled organic layer was washed with 50 mL 
saturated aqueous NaHCO3, 50 mL saturated brine, dried over Na2SO4 and then concentrated 
under reduced pressure to give a residue. Flash chromatography on silica gel eluting with 
hexane-Et2O (1:1) gave furan alcohol I-9 (14 g, 92%): Colorless oil; Rf = 0.45 (7:3 (v/v) 
Hexane/EtOAc); [α]D25 = −21 (c = 1.0, CH2Cl2); 1H NMR (600 MHz CDCl3) δ 7.30 (d, J = 1.8, 
1H), 6.26 (dd, J = 3.0, 1.8 Hz, 1H), 6.15 (d, J = 3.0, 1H), 4.78 (dq, J = 6.6, 6.6 Hz, 1H), 3.11 (s, 
1H), 1.46 (d, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 157.7, 141.6, 109.9,
O
O
OH  
To a solution of 14 g furan alcohol I-9 (125 mmol) in 416 mL THF-H2O (3:1) was added 21 g 
NaHCO3 (250 mmol), 17 g NaOAc•3H2O (125 mmol), and 22.3 g NBS (125 mmol) at 0 °C. The 
reaction mixture was kept stirring at this temperature for 1 hour, then at 0 °C 200 mL saturated 
aqueous NaHCO3 was added to quench the reaction. The reaction mixture was directly extracted 
with Et2O (300 mL × 3) and the organic layer was pooled, washed by 100 mL saturated brine, 
dried over Na2SO4 and then concentrated reduced pressure to give a residue, which was rapidly 
subjected to flash chromatography on silica gel. Elution with hexane-EtOAc (1:1) afforded 
pyranone alcohol I-10 (14.4 g, 90%, α:β=2.8:1): White solid; Rf = 0.25 (7:3 (v/v) hexane/EtOAc); 
[α]D25 = +44 (c = 1.0, CH2Cl2); 1H NMR (600 MHz, CDCl3, α isomer) δ 6.82 (dd, J = 10.2, 3.0 
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, 1.23 (d, J = 
7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3, α isomer) δ 197.6, 145.3, 126.6, 87.2, 74.8, 15.1.  
(2S,6S)-t-butyl -5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl carbonate (I-4α)60  
Hz, 1H), 5.96 (d, J = 10.2, 1H), 5.48 (d, J = 3.0 Hz, 1H), 3.99 (q, J = 7.2 Hz, 1H)
O
O
OBoc  
To a solution of 7.4 g pyranone alcohol I-10 (57.8 mmol) in 80 mL CH2Cl2 was added 528 mg 
DMAP (4.33 mmol) at -78 °C. A pre-cooled solution of 25.2 g (Boc)2O (115.6 mmol) in 30 mL 
CH2Cl2 was dropwised into the reaction mixture via a cannula. The reaction mixture was stirred 
at -78 °C for 12 hours. The reaction was quenched by 100 mL saturated aqueous NaHCO3 and 
then extracted with Et2O (300 mL × 3). The organic layers were pooled, then washed by 70 mL 
saturated aqueous NaCl, dried over Na2SO4 and concentrated under reduced pressure to give a 
residue. Flash chromatography on silica gel eluting with hexane-Et2O (100:7) gave Boc 
c 1.0, CH2Cl2); H NMR 
(600 MHz, CDCl3) δ 6.78 (dd, J = 10.2, 3.6 Hz, 1H), 6.22 (d, J = 3.6 Hz, 1H), 6.09 (d, J = 10.2 
z, 1H), 4.53 (q, J = 6.6 Hz, 1H), 1.40 (s, 9H), 1.28 (d, J = 6.6 Hz, 3H); 13C NMR (150.8 MHz, 
CDCl3) δ 195.5, 151.7, 140.9, 128.2, 89.1, 83.3, 72.0, 27.5, 15.1;  
3-((2S,6S)-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yloxy)-5,7-bis(benzyloxy)-2-(4-
(benzyloxy)phenyl)-4H-chromen-4-one (2) 
protected α-pyranone I-4α (7.8 g, 60%). Elution with hexane-Et2O (10:1) gave β-isomer I-4β 
(2.5g, 19%).  
α-pyranone I-4α: Rf = 0.60 (7:3 (v/v) hexane/EtOAc); [α]D25 = +98 ( 1
H
 
BnO
OBn
O
O
OBn
O
O
O  
To a solution of 875 mg perbenzylated flavonol I-3 (1.6 mmol) and 537 mg pyranone I-4α (2.4 
mmol) in 8 mL CH2Cl2 was added a solution of 41 mg Pd2(DBA)3•CHCl3 (0.04 mmol) and 41 
mg PPh3 (0.16 mmol) in 1 mL CH2Cl2 at 0 °C. The reaction mixture was stirred at 0 °C for 3 
hours and then quenched by 15 mL saturated aqueous NaHCO3, followed by extraction with 
Et2O (25 mL×3). The organic layer was pooled, then washed by 15 mL saturated aqueous NaCl, 
dried over Na2SO4 and concentrated under reduced pressure to give crude product. 
Chromatography on silica gel, eluting with hexane-EtOAc (3:1) gave glycosylated pyranone I-2 
(888 mg, 85%): Yellow solid, mp: 75-77 °C;  Rf = 0.50 (2:1 (v/v) hexane/EtOAc); [α]D25 -63 (c 
0.93, CHCl3); IR (thin film, cm-1) 3063, 2921, 1699, 1636, 1607, 1574, 1509, 1454, 1375, 1355, 
1300, 1252, 1198, 1178, 1162, 1103, 1013, 937. 1H NMR (CDCl3, 600 MHz) δ 7.87 (d, J = 8.4 
Hz, 2H), 7.57 (d, J = 7.8 Hz, 2H), 7.46-7.29 (m, 13H), 7.27 (dd, J = 10.2, 3.6 Hz, 1H), 7.06 (d, J 
= 9.0 Hz, 2H), 6.58 (d, J = 1.8 Hz, 1H), 6.47 (d, J = 1.8 Hz, 1H), 6.13 (d, J = 10.2 Hz, 1H), 5.92 
, J = 3.6 Hz, 1H), 5.27 (s, 2H), 5.15 (s, 2H), 5.08 (d, J = 12 Hz, 1H), 5.08 (d, J = 12 Hz, 1H), 
13
136.3, 136.2, 135.6, 130.4, 128.8, 128.7, 128.6, 
128.4, 128.2, 127.7, 127.6, 127.4, 126.6, 123.2, 114.7, 109. 9, 98.3, 94.3, 94.0, 71.5, 70.8, 70.5, 
70.1, 14.6; HRMS (CI): calcd. for [C42H34O8+Na]+: 689.2146, Found: 689.2153. 
 
3-((2S,5R,6S)-5,6-dihydro-5-hydroxy-6-methyl-2H-pyran-2-yloxy)-5,7 bis(benzyloxy)-2-(4-
(benzyloxy)phenyl)-4H-chromen-4-one (I-11) 
(d
4.02 (q, J = 6.0 Hz, 1H), 0.93 (d, J = 6.6Hz, 3H); C NMR (CDCl3, 150 MHz) δ 196.7, 173.3, 
163.0, 160.4, 159.8, 159.0, 154.9, 143.1, 137.6, 
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BnO
OBn
O
O
OBn
O
OHO
H  
A solution of 87 mg pyranone I-2 (0.13 mmol) in 3.5 mL CH2Cl2-MeOH (5:1) was cooled down 
to -78 °C, then 10 mg NaBH4 (0.26 mmol) was added in. The reaction mixture was kept stirring 
at -78 °C for 3 hours. The reaction was then quenched by 2 mL saturated aqueous NaHCO3, 
followed by extraction with Et2O (10 mL × 3). The organic layer was washed by 2 mL saturated 
aqueous NaCl, dried over Na2SO4, and concentrated under reduced pressure to give crude 
product. Crude 1H NMR showed a dr > 20:1. Chromatography on silica gel eluting with hexane-
EtOAc (2:1) gave allylic alcohol I-11 (63 mg, 73%): Amorphous yellow solid; Rf = 0.29 (1:1 
(v/v) hexane/EtOAc); [α] 25 -83 (c 0.85, CHCl3); IR (thin film, cm-1) 3361, 2927, 1604, 1509, 
1453, 1354, 1298, 
D
1251, 1176, 1098, 1013, 916; 1H NMR (CDCl3, 600 MHz) δ 7.95 (d, J = 8.4 
z, 2H), 7.55 (d, J = 7.8 Hz, 2H), 7.45-7.27 (m, 13H), 7.06 (d, J = 9.0 Hz, 2H), 6.56 (d, J = 2.4 
Hz, 1H), 6.44 (d, J = 2.4 Hz, 1H), 6.20 (ddd, J = 10.2, 2.4, 2.4 Hz, 1H), 5.97 (d, J = 10.2 Hz, 1H), 
dd, 
 Hz, 1H), 3.31 (dq, J = 8.4, 6.0 Hz, 1H), 0.71 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 
67.5 MHz) δ 173.8, 162.8, 160.3, 159.9, 159.0, 154.8, 138.3, 136.5, 136.4, 135.7, 133.9, 130.7, 
128.8, 128.7, 128.6, 128.5, 128.2, 127.8, 127.7, 127.5, 126.7, 126.6, 123.8, 114.6, 110.2, 98.3, 
95.7, 94.0, 70.8, 70.5, 70.1, 69.6, 69.4, 17.0; HRMS (CI): calcd. for [C42H36O8+Na]+: 691.2302, 
Found: 691.2296. 
 
H
5.60 (s, 1H), 5.26 (s, 2H), 5.15 (s, 2H), 5.07 (d, J = 12 Hz, 1H), 5.07 (d, J = 12 Hz, 1H), 3.74 (
J = 7.2, 6.6
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-(α-L-rhamnopyranosyloxy)-4H-chromen-4-
one (I-12) 
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BnO
OBn
O
O
OBn
O
OHO
HO
OH  
A solution of 80 mg allylic alcohol I-11 (0.12 mmol) in 2 mL acetone-t-BuOH (1:1) was cooled 
down to 0 °C. To the solution was added 0.5 mL NMO-H2O (w/w 1:1), and then catalytic 
amount of crystalline OsO4 was added into the mixture when stirring. The reaction mixture was 
kept stirring at 0 °C for 3 hours.  The reaction mixture was then quenched by 0.5 mL saturated 
aqueous Na2S2O3. After stirring for another 5 hours, all the staff was passed through a small pad 
of celite and silica gel, washed by EtOAc-MeOH (1:1) (10 mL×3). The organic effluent was 
dried by Na2SO4, and concentrated under reduced pressure to give crude prodcut. 
Chromatography on silica gel eluting with Et2O-MeOH (20:1) gave triol I-12 (80 mg, 96%): 
White solid, mp: 105-107 °C; Rf  = 0.56 (10:1 (v/v) Et2O/MeOH); [α]D25 -112 (c 1.3, MeOH); IR 
hin film, cm-1) 3418 (broad), 2924, 1606, 1506, 1453, 1354, 1299, 1255, 1177, 1141, 1102, 
1058, 998, 953; 1H NMR (acetone-d6, 600 MHz) δ 7.91 (d, J = 9.0 Hz, 2H), 7.68 (d, J = 7.8 Hz, 
6H), 7.38-7.29 (m, 3H), 7.19 (d, J = 8.4 Hz, 2H), 6.80 
(d, J = 1.8 Hz, 1H), 6.67 (d, J = 2.4 Hz, 1H), 5.57 (d, J = 1.8 Hz, 1H), 5.29 (d, J = 13.2 Hz, 1H), 
5.28 (d, J = 13.2 Hz, 1H), 5.24 (s, 2H), 5.23(s, 2H), 4.28 (dd, J = 3.6, 1.8 Hz, 1H), 3.70 (dd, J = 
9.0, 3.6 Hz, 1H), 3.33 (dd, J = 9.6, 9.6 Hz, 1H), 3.21 (dq, J = 9.6, 6.0 Hz, 1H), 2.91 (brs, 1H), 
0.87 (d, J = 6.0 Hz, 3H); 13C NMR (acetone-d6, 150 MHz) δ 173.5, 164.1, 161.5, 160.8, 159.8, 
154.8, 138.4, 138.1, 138.0, 137.4, 131.4, 129.5, 129.4, 129.3, 129.1, 128.9, 128.7, 128.5, 128.4, 
127.9, 124.4, 115.7, 110.6, 102.2, 98.9, 95.1, 73.2, 72.2, 71.5, 71.4, 71.3, 71.2, 70.8, 17.9; 
HRMS (ESI) calcd. for [C42H38O10+H]+: 703.2543, Found: 703.2537. 
(t
2H), 7.50 (d, J = 7.8 Hz, 4H) 7.43-39 (m, 
 
Kaempferol-3-α-L-rhamnoside (I-1b)62 
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HO
OH
O
O
OH
O
OHO
HO
OH  
A solution of 50 mg triol I-12 (0.07 mmol) in 2 mL THF-EtOH (1:1) was added 20 mg 
Pearlman’s catalyst (Pd-C, 10%). The solution was degassed using vacuum at -90 °C and 
filling with H2. This procedure was repeated three times, and then the bath was removed. The 
reaction was warmed up to room temperature and stirred under a H2 atmosphere for 3 hours. The 
e 
de (I-1b) (24mg, 80%): Pale yellow solid, mp: 140-142 °C; Rf = 0.71 
(5:1 (v/v) Et2O/MeOH); [α]D25 -96 (c 1.3, MeOH); IR (thin film, cm-1) 3259 (broad), 2924, 2855, 
1653, 1607, 1442, 1360, 1251, 1207, 1172, 1057, 996; 1H NMR (CD3OD, 600 MHz) δ 7.72 (d, J 
= 8.4 Hz, 2H), 6.89 (d, J = 9.0 Hz, 2H), 6.30 (d, J = 2.4 Hz, 1H), 6.13 (d, J = 1.8 Hz, 1H), 5.33 
(d, J = 1.8 Hz, 1H), 4.18 (dd, J = 3.0, 1.8 Hz, 1H), 3.67 (dd, J = 9.0, 2.4 Hz, 1H), 3.30-3.27 (m, 
4H), 0.88 (d, J = 6.0 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 179.5, 163.2, 161.6, 159.1, 158.7, 
136.1, 131.9, 122.7, 116.6, 105.5, 103.5, 100.4, 95.2, 73.2, 72.2, 72.2, 71.9, 17.6; HRMS (ESI) 
calcd. for [C21H20O10+Na]+: 455.0954, Found: 455.0949. 
re
reaction mixture was loaded onto silica gel and elution with Et2O-MeOH (20:1) gav
kaempferol-3-α-L-rhamnosi
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-(2,3,4-O-triacetyl-α-L-rhamnopyranoyloxy)-
4H-chromen-4-one (I-13) 
BnO
OBn
O
O
OBn
O
OAcO
AcO
OAc  
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mg, 86%): White solid, mp: 90-
92 °C; Rf = 0.58 (1:1 (v/v) hexane/EtOAc); [α]D25 -175 (c 1.3, CHCl3); IR (thin film, cm-1) 3035, 
z) δ 7.86 (d, J = 9.0 Hz, 2H), 7.56 
(d, J = 7.2 Hz, 2H), 7.46-7.27 (m, 13H), 7.14 (d, J = 9.0 Hz, 2H), 6.56 (d, J = 2.4 Hz, 1H), 6.45 
(d, J = 2.4 Hz, 1H), 5.73 (d, J = 1.8 Hz, 1H), 5.72 (dd, J = 3.6, 1.8 Hz, 1H), 5.32 (dd, J = 10.2, 
3.0 Hz, 1H), 5.26 (s, 2H), 5.15 (s, 2H), 5.08 (s, 2H), 4.92 (dd, J = 10.2, 9.6 Hz, 1H), 3.37 (dq, J = 
10.2, 6.6 Hz, 1H), 2.11 (s, 3H), 1.99 (s, 3H), 1.96 (s, 3H), 0.85 (d, J = 6.0 Hz, 3H); 13C NMR 
(CDCl3, 150 MHz) δ 172.9, 169.9, 169.8, 169.5, 162.9, 160.6, 159.9, 158.8, 154.2, 136.5, 136.4, 
136.3, 135.6, 130.4, 128.8, 128.7, 128.6, 128.4, 128.2, 127.7, 127.5, 127.4, 126.6, 123.1, 114.9, 
110.1, 98.4, 97.9, 94.0, 70.8, 70.7, 70.5, 70.2, 69.3, 69.1, 68.1, 20.9, 20.8, 20.7, 17.1; HRMS 
A solution of 63 mg triol I-12 (0.09 mmol) in 2.5 mL CH2Cl2 was cooled down to 0 °C, then 
sequentially 0.4 mL pyridine, catalytic amount of DMAP and 0.4 mL Ac2O were added. The 
reaction mixture was stirred at 0 °C overnight. The reaction mixture was diluted by 15 mL Et2O 
and then the reaction was quenched by 1.5 mL H2O, the organic layer was washed by 2 mL 
saturated aqueous NaHCO3, 2 mL saturated aqueous NaCl, dried over Na2SO4, and concentrated 
under reduced pressure to give a residue which was subjected to chromatography on silica gel. 
Elution with hexane-EtOAc (2:1) afforded triacetate I-13 (63 
2982, 2938, 1746, 1632, 1605, 1574, 1509, 1498, 1486, 1453, 1432, 1368, 1298, 1247, 1217, 
1174, 1136, 1101, 1044, 1019, 968; 1H NMR (CDCl3, 600 MH
(ESI) calcd. for [C48H44O13+Na]+: 851.2679, Found: 851.2678. 
 
Kaempferol-3-α-L-3’’,4’’,5’’-O-triacetylrhamnoside (I-1c)63 
HO
OH
O
O
OH
O
OAcO
AcO
OAc  
To a solution of 60 mg triacetate I-13 (0.07 mmol) in 3 mL THF-EtOH (1:1) was added 30 mg 
Pearlman’s catalyst (Pd-C, 10%). The reaction mixture was degassed using vacuum at -90 °C 
63 
 
 The reaction mixture was stirred under a H2 
atmosphere for 3 hours. The reaction mixture was loaded onto silica gel and elution with hexane-
α-L-3’’,4’’,5’’-O-triacetylrhamnoside (I-1c) (35 mg, 86%): 
); 
, 1749, 1654, 1609, 1504, 1364, 1207, 1174, 1085, 1043, 
971; 1H NMR (CDCl3, 600 MHz) δ 12.5 (s, 1H), 7.77 (d, J = 9.0 Hz, 2H), 6.98 (d, J = 8.4 Hz, 
2H), 6.35 (d, J = 1.8 Hz, 1H), 6.25 (d, J = 2.4 Hz, 1H), 5.62 (dd, J = 3.6, 1.8 Hz, 1H), 5.55 (d, J 
= 1.8 Hz, 1H), 5.32 (dd, J = 10.2, 3.6 Hz, 1H), 4.97 (dd, J = 10.2, 9.6 Hz, 1H), 3.54 (dq, J = 10.2, 
6.0 Hz, 1H), 2.13 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H), 0.94 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 
150 MHz) δ 177.9, 170.8, 170.3, 170.1, 162.5, 162.1, 158.6, 157.4, 156.9, 134.1, 130.7, 122.1, 
115.7, 105.7, 99.3, 98.2, 94.1, 70.4, 69.4, 69.2, 68.4, 20.9, 20.8, 20.7, 17.1; HRMS (ESI) calcd. 
for [C27H26O13+Na]+: 581.1271, Found: 581.1266. 
and refilling with H2. This procedure was repeated three times, then the bath was removed and 
the reaction was warmed up to room temperature.
EtOAc (1:1) gave kaempferol-3-
Yellow solid, mp: 152-154 °C; Rf = 0.42 (1:2 (v/v) hexane/EtOAc); [α]D25 -128 (c 1.4, CHCl3
IR (thin film, cm-1) 3372 (broad), 2982
 
6-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-yloxy)-3,6-dihydro-2-
methyl-2H-pyran-3-yl acetate (I-14) 
BnO
OBn
O
O
OBn
O
OAcO
H  
A solution of 210 mg pyranone I-2 (0.32 mmol) in 3.5 mL CH2Cl2-MeOH (5:1) was cooled 
down to -78 °C, then 25 mg NaBH4 (0.64 mmol) was added. The reaction mixture was stirred at 
-78 °C for 3 hours. Then the reaction was quenched by 3 mL saturated aqueous NaHCO3, 
followed by extraction with Et2O (15 mL × 3). The organic layer was washed by 3 mL saturated 
aqueous NaCl, dried over Na2SO4, and concentrated under reduced pressure to give a residue. 
All residual solvent was removed by applying a high vacuum produced by oil pump for half an 
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 gel 
eluting with hexane-EtOAc (5:1) gave pure acetate I-14 (156 mg, 70%): Amorphous yellow 
Rf = 0.52 (3:2 (v/v) hexane/EtOAc); [α]D25 -146 (c 1.1, CHCl3); IR (thin film, cm-1) 3052, 
MR 
96 (d, J = 9.0 Hz, 2H), 7.55 (d, J = 7.2 Hz, 2H), 7.47-7.27 (m, 13H), 7.09 
(d, J = 8.4 Hz, 2H), 6.56 (d, J = 2.4 Hz, 1H), 6.44 (d, J = 2.4 Hz, 1H), 6.20 (ddd, J = 10.2, 2.4, 
2.4 Hz, 1H), 5.90 (d, J = 10.2 Hz, 1H), 5.60 (brs, 1H), 5.27 (s, 2H), 5.17 (s, 2H), 5.08 (d, J = 
11.4 Hz, 1H), 5.07 (d, J = 11.4 Hz, 1H),  4.96 (ddd, J = 9.6, 1.8, 1.8 Hz, 1H), 3.60 (dq, J = 9.6, 
6.6 Hz, 1H), 2.08 (s, 3H), 0.61 (d, J = 6.0 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.5, 170.3, 
162.8, 160.2, 159.8, 154.5, 138.4, 136.5, 136.4, 135.7, 130.6, 130.3, 128.7, 128.6, 128.6, 128.5, 
128.4, 128.1, 127.6, 127.5, 127.3, 126.6, 123.8, 114.5, 110.0, 98.2, 95.8, 94.0, 70.8, 70.7, 70.4, 
70.1, 66.5, 21.1, 17.0; HRMS (CI): calcd. for [C44H38O9+Na]+: 733.2408, Found: 733.2405. 
hour. The dry residue was redissolved in CH2Cl2 and cooled down to 0 °C. To the solution was 
added 0.4 mL pyridine, catalytic amount of DMAP, and 0.3 mL Ac2O. After stirring for 1 hour, 
the mixture was diluted by 20 mL Et2O. The organic layer was sequentially washed with 2 mL 
H2O, 2 mL saturated aqueous NaHCO3, 2 mL saturated brine, dried over Na2SO4 and then 
concentrated under reduced pressure to afford crude product. Chromatography on silica
solid; 
2927, 1736, 1636, 1608, 1509, 1454, 1375, 1355, 1298, 1240, 1178, 1104, 1023, 936; 1H N
(CDCl3, 600 MHz) δ 7.
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-(4-O-acetyl-α-L-rhamnopyranoyloxy)-4H-
chromen-4-one (I-15) 
BnO
OBn
O
O
OBn
O
OAcO
HO
OH  
A solution of 142 mg acetate I-14 (0.20 mmol) in 3 mL acetone-t-BuOH (1:1) was cooled down 
to 0 °C. To the solution was added 1 mL NMO-H2O (w/w 1:1), and a catalytic amount (~ 5 mg) 
of crystalline OsO4 was added into the mixture. The reaction mixture was stirred at 0 °C for 24 
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 mp: 90.5-92.5 °C; Rf = 0.67 (10:1 
(v/v) Et2O/MeOH); [α]D25 -116 (c 0.8, CHCl3); IR (thin film, cm-1) 3424 (broad), 3066, 3035, 
z) δ 7.82 (d, J = 9.0 Hz, 2H), 7.53 (d, J = 
7.8 Hz, 2H), 7.46-7.27 (m, 13H), 7.09 (d, J = 9.0 Hz, 2H), 6.55 (d, J = 2.4 Hz, 1H), 6.45 (d, J = 
2.4 Hz, 1H), 5.51 (d, J = 1.8 Hz, 1H), 5.27 (s, 2H), 5.15 (s, 2H), 5.07 (s, 2H), 4.78 (dd, J = 9.6, 
9.0 Hz, 1H), 4.51 (ddd, J = 3.6, 3.6, 2.4 Hz, 1H), 3.93 (ddd, J = 8.4, 7.8, 3.0 Hz, 1H), 3.45 (d, J = 
4.2 Hz, 1H), 3.40 (dq, J = 9.6, 6.6 Hz, 1H), 2.91 (d, J = 7.8 Hz, 1H ), 2.05 (s, 3H), 0.81 (d, J = 
6.6 Hz, 3H); 13C NMR (acetone-d6, 150 MHz) δ 173.5, 171.2, 163.0, 160.5, 159.8, 158.9, 154.6, 
137.8, 136.4, 136.3, 135.6, 130.5, 128.8, 128.7, 128.6, 128.4, 128.2, 127.8, 127.6, 127.3, 126.8, 
123.3, 114.7, 109.9, 101.4, 98.4, 94.0, 74.7, 70.8, 70.7, 70.5, 70.2, 69.9, 67.8, 21.0, 17.1; HRMS 
hours.  The reaction was quenched with 1 mL saturated aqueous Na2S2O3 (aq.) and stirred 
overnight. Then the mixture was passed through a small pad of celite and silica gel, washed with 
EtOAc-MeOH (1:1) (15 mL × 3), the organic solution was dried over Na2SO4, and concentrated 
under reduced pressure to give a residue. Chromatography on silica gel eluting with hexane-
EtOAc (2:3) gave diol I-15 (115 mg, 77%): Pale yellow solid,
2928, 1741, 1605, 1574, 1509, 1498, 1486, 1454, 1375, 1354, 1299, 1251, 1199, 1177, 1144, 
1102, 1049, 1004, 955; 1H NMR (acetone-d6, 600 MH
(ESI) calcd. for [C44H40O11+H]+: 745.2649, Found: 745.2642. 
 
Kaempferol-3-α-L-4’’-O-acetylrhamnoside (1d)62c 
HO
OH
O
O
OH
O
OAcO
HO
OH  
To a solution of 54.8 mg diol I-15 (0.07 mmol) in 3 mL THF-EtOH (1:1) was added 30 mg 
Pearlman’s catalyst (Pd-C, 10%). The reaction mixture was degassed using vacuum at -90 °C 
and refilling with H2. This procedure was repeated three times, then the bath was removed and 
the reaction was warmed up to room temperature. The reaction mixture was stirred under a H2 
66 
 
ne-
pferol-3-α-L-4’’-O-acetylrhamnoside (I-1d) (30 mg, 87%): Yellow 
solid, mp: 150-152 °C; Rf = 0.18 (1:3 (v/v) hexane/EtOAc); [α]D25 -145 (c 1.3, MeOH); IR (thin 
film, cm-1) 3317 (broad), 2927, 1721, 1651, 1607, 1500, 1446, 1359, 1253, 1207, 1172, 1141, 
1085, 1047, 1004, 970, 952; 1H NMR (acetone-d6, 600 MHz) δ 7.84 (d, J = 9.0 Hz, 2H), 7.05 (d, 
J = 9.0 Hz, 2H), 6.47 (d, J = 1.8 Hz, 1H), 6.28 (d, J = 1.8 Hz, 1H), 5.53 (d, J = 1.2 Hz, 1H), 4.82 
(dd, J = 9.6, 9.6 Hz, 1H), 4.23 (dd, J = 3.6, 1.8 Hz, 1H), 3.85 (dd, J = 9.6, 3.6 Hz, 1H), 3.40 (dq, 
J = 9.6, 6.0 Hz, 1H), 2.87 (brs, 1H), 1.97 (s, 3H), 0.78 (d, J = 6.6 Hz, 3H); 13C NMR (acetone-d6, 
150 MHz) δ 179.3, 170.9, 165.1, 163.1, 161.1, 158.7, 158.2, 135.7, 131.8, 122.5, 116.4, 105.9, 
atmosphere for 3 hours. The reaction mixture was loaded onto silica gel and elution with hexa
EtOAc (1:2) to give kaem
102.4, 99.6, 94.7, 74.6, 71.5, 69.8, 69.1, 21.0, 17.6; HRMS (ESI) calcd. for [C23H22O11+Na]+: 
497.1060, Found: 497.1054. 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-(2,4-O-triacetyl-α-L-rhamnopyranoyloxy)-
4H-chromen-4-one (I-16) 
BnO
OBn
O
O
OBn
O
OAcO
HO
OAc  
To a solution of 75 mg diol I-15 (0.10 mmol) in 1.6 mL CH2Cl2 was added 0.6 mg (3 µmol) p-
TsOH·H2O, 38 µL trimethylorthoacetate (0.30 mmol) at 0 °C. After stirring at 0 °C for 15 min, 
0.5 mL 90% HOAc (aq.) was added and the reaction mixture was stirred for another 15 min. The 
reaction mixture was diluted with 25 mL EtOAc and washed at 0 °C by 3 mL saturated aqueous 
NaHCO3 two times, then it was washed by 3 mL saturated brine, and dried over Na2SO4. The 
organic layer was concentrated under reduced pressure to give crude product, which was then 
subjected to chromatography on silica gel. Elution with hexane-EtOAc (1:1) gave diacetate 12 
(78 mg, 99%): White solid, mp: 99.5-101.5 °C; Rf  = 0.58 (1:2 (v/v) hexane/EtOAc); [α]D25 -115 
1.1, CHCl3); IR (thin film, cm-1) 3430 (broad), 3032, 2927, 1741, 1628, 1604, 1575, 1509, 
1499, 1486, 1453, 1433, 1373, 1299, 1225, 1196, 1174, 1136, 1099, 1047, 1017, 963; 1H NMR 
(c 
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.2 Hz, 2H), 7.46-7.27 (m, 13H), 7.11 
(d, J = 9.0 Hz, 2H), 6.55 (d, J = 2.4 Hz, 1H), 6.45 (d, J = 2.4 Hz, 1H), 5.58 (d, J = 1.2 Hz, 1H), 
5.57 (dd, J = 3.6, 1.8 Hz, 1H), 5.26 (s, 2H), 5.16 (s, 2H), 5.07 (s, 2H), 4.76 (dd, J = 10.2, 9.6 Hz, 
1H), 4.11 (ddd, J = 9.6, 6.6, 3.0 Hz, 1H), 3.50 (dq, J = 10.2, 6.6 Hz, 1H), 2.28 (d, J = 6.6 Hz, 
1H ), 2.12 (s, 3H), 2.06 (s, 3H), 0.89 (d, J = 6.0 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.0, 
171.2, 170.5, 162.9, 160.6, 159.9, 158.8, 154.3, 136.9, 136.3, 135.6, 130.3, 128.8, 128.7, 128.6, 
128.4, 128.2, 127.7, 127.6, 127.3, 126.7, 123.1, 114.9, 110.0, 98.4, 98.3, 94.0, 74.1, 72.1, 70.8, 
70.5, 70.2, 68.8, 67.9, 21.0, 20.9, 17.1; HRMS (ESI) calcd. for [C46H42O12+Na]+: 809.2574, 
(CDCl3, 600 MHz) δ 7.81 (d, J = 9.0 Hz, 2H), 7.56 (d, J = 7
Found: 809.2567. 
 
Kaempferol-3-α-L-2’’,4’’-O-diacetylrhamnoside (I-1e)64 
HO
OH
O
O
OH
O
OAcO
HO
OAc  
To a solution of 66.8 mg diacetate I-16 (0.08 mmol) in 3 mL THF-EtOH (1:1) was added 30 mg 
Pearlman’s catalyst (Pd-C, 10%). The reaction mixture was degassed using vacuum at -90 °C 
and refilling with H2. This procedure was repeated three times, then the bath was removed and 
the reaction was warmed up to room temperature. The reaction mixture was stirred under a H2 
osphere for 3 hours. The reaction mixture was loaded onto silica gel and elution with hexane-
EtOAc (2:3) to give kaempferol-3-α-L-2’’,4’’-O-diacetylrhamnoside (I-1e) (38 mg, 88%): Yellow 
lid, mp: 127-129 °C; Rf  = 0.24 (1:2 (v/v) hexane/EtOAc); [α]D25 -93 (c 0.96, MeOH); IR (thin 
film, cm-1) 3311 (broad), 2925, 1721, 1653, 1608, 1502, 1445, 1362, 1205, 1171, 1144, 1129, 
1H NMR (acetone-d6, 600 MHz) δ 7.85 (d, J = 9.0 Hz, 2H), 7.06 (d, J = 
.4 Hz, 2H), 6.48 (d, J = 1.8 Hz, 1H), 6.28 (d, J = 1.8 Hz, 1H), 5.60 (s, 1H), 5.47 (dd, J = 3.6, 1.8 
Hz, 1H), 4.76 (dd, J = 10.2, 9.6 Hz, 1H), 4.04 (dd, J = 9.6, 3.6 Hz, 1H), 3.38 (dq, J = 10.2, 6.0 
atm
so
1085, 1047, 1007, 970; 
8
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) δ 
163.0, 161.2, 158.8, 158.1, 134.8, 131.8, 122.3, 116.5, 105.8, 99.7, 
99.3, 94.7, 74.4, 72.4, 69.2, 68.0, 21.0, 20.9, 17.7; HRMS (ESI) calcd. for [C25H24O12+Na]+: 
539.1166, Found: 539.1159. 
 
 
 
Hz, 1H), 2.06 (s, 3H), 1.99 (s, 3H), 0.81 (d, J = 6.0 Hz, 3H); 13C NMR (acetone-d6, 150 MHz
179.0, 170.8, 170.3, 165.2, 
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-(3,4-O-triacetyl-α-L-rhamnopyranoyloxy)-
4H-chromen-4-one (I-17) 
BnO
OBn
O
O
OBn
O
OAcO
AcO
OH  
To a solution of 50 mg diacetate I-16 (0.064 mmol) in 4 mL toluene was added a solution of 10 
µl DBU in 1 mL toluene at 0 °C. The reaction mixture was stirred at 0 °C for 1 hour, then diluted 
with 20 mL Et2O-EtOAc (1:1). The mixture was sequentially washed with 2 mL saturated 
aqueous NH4Cl, 2 mL saturated aqueous NaHCO3, dried over Na2SO4. The organic layer was 
concentrated under reduced pressure to give a residue. Crude 1H-NMR showed this residue 
contains 64% diacetate I-17 vs. 36% diacetate I-16. Chromatography on silica gel eluting with 
hexane-EtOAc (1.6:1) gave desired diacetate I-17 (31 mg, 62%) and further elution with hexane-
EtOAc (1.4:1) gave 17 mg (34%) starting material I-16 back. Diacetate I-17 : White solid, mp: 
93-95 °C; Rf  = 0.59 (2:3 (v/v) hexane/EtOAc); [α]D25 -151 (c 1.3, CHCl3); IR (thin film, cm-1) 
394 (broad), 3064, 2924, 1741, 1604, 1509, 1453, 1432, 1369, 1353, 1296, 1249, 1222, 1172, 3
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58; 1H NMR (CDCl3, 600 MHz) δ 7.86 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 7.8 
Hz, 2H), 7.46-7.27 (m, 13H), 7.12 (d, J = 9.0 Hz, 2H), 6.56 (d, J = 2.4 Hz, 1H), 6.46 (d, J = 2.4 
Hz, 1H), 5.53 (d, J = 2.4 Hz, 1H), 5.31 (dd, J = 9.0, 3.0 Hz, 1H), 5.26 (s, 2H), 5.15 (s, 2H), 5.08 
(s, 2H), 4.98 (dd, J = 9.6, 9.0 Hz, 1H), 4.57 (ddd, J = 6.6, 3.6 Hz, 1H), 3.46 (dq, J = 9.6, 6.6 Hz, 
1H), 2.87 (brs, 1H ), 2.07 (s, 3H), 1.99 (s, 3H), 0.82 (d, J = 6.0 Hz, 3H); 13C NMR (CDCl3, 150 
MHz) δ 173.3, 169.9, 169.8, 163.0, 160.5, 159.9, 158.9, 154.5, 137.6, 136.4, 136.3, 135.6, 130.5, 
128.8, 128.7, 128.6, 128.4, 128.2, 127.7, 127.6, 127.3, 126.7, 123.2, 114.8, 109.9, 101.9, 98.3, 
94.0, 74.7, 71.2, 70.8, 70.5, 70.1, 69.5, 67.9, 20.9, 20.8, 17.2; HRMS (ESI) calcd. for 
1100, 1043, 1004, 9
[C46H42O12+Na]+: 809.2574, Found: 809.2569. 
 
SL0101 (I-1a)3d,5  
HO
OH
O
O
OH
O
OAcO
AcO
OH  
To a solution of 46 mg diacetate I-17 (0.058 mmol) in 2.5 mL THF-EtOH (1:1) was added 25 
mg Pearlman’s catalyst (Pd-C, 10%). The reaction mixture was degassed using vacuum at -90 °C 
and refilling with H2. This procedure was repeated three times, then the bath was removed and 
ed up to room temperature. The reaction mixture was stirred under a H2 
atmosphere for 3 hours. The reaction mixture was loaded onto silica gel and elution with hexane-
tOAc (2:3) to give SL0101 (I-1a) (28 mg, 91%): Yellow solid, mp: 147-149 °C; Rf  = 0.26 (1:2 
(v/v) hexane/EtOAc); [α]D25 -163 (c 1.6, MeOH); IR (thin film, cm-1) 3211 (broad), 2980, 2930, 
1H NMR (acetone-d6, 600 
Hz) δ 7.86 (d, J = 9.0 Hz, 2H), 7.05 (d, J = 9.0 Hz, 2H), 6.48 (d, J = 1.8 Hz, 1H), 6.28 (d, J = 
1.8 Hz, 1H), 5.56 (d, J = 1.8 Hz, 1H), 5.17 (dd, J = 10.2, 3.0 Hz, 1H), 5.07 (dd, J = 10.2, 9.6 Hz, 
1H), 4.42 (dd, J = 3.0, 1.8 Hz, 1H), 3.49 (dq, J = 9.6, 6.0 Hz, 1H), 2.02 (s, 3H), 1.96 (s, 3H), 0.82 
the reaction was warm
E
1722, 1650, 1607, 1502, 1444, 1361, 1206, 1171, 1045, 1005, 970; 
M
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0, 161.1, 
.2, 99.7, 99.6, 94.7,  72.3, 71.2, 69.3, 69.2, 
21.0, 20.8, 17.6; HRMS (ESI) calcd. for [C25H24O12+Na]+: 539.1166, Found: 539.1161. 
 
 
 
(d, J = 6.0 Hz, 3H); 13C NMR (acetone-d6, 150 MHz) δ 179.2, 170.7, 170.4, 165.1, 163.
158.7, 158.2, 135.5, 131.8, 122.4, 116.5, 105.8, 102
 
3-((2R,6R)-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yloxy)-5,7-bis(benzyloxy)-2-(4-
(benzyloxy)phenyl)-4H-chromen-4-one ((ent)-I-2) 
 
To a solution of 44 mg (0.079 mmol) perbenzylated flavonol I-3 and 45 mg (0.197 mmol) α-D-
pyranone (ent)-I-4α in 1 mL CH2Cl2 was added a solution of 3 mg (0.0029 mmol)  
Pd2(DBA)3·CHCl3 and 3 mg PPh3 (0.011 mmol) in 0.3 mL CH2Cl2 at 0 ºC. The reaction mixture 
was stirred at 0 ºC for 3 hours and loaded directly onto silica gel column, eluting with hexane-
EtOAc (2.5:1) gave glycosylated pyranone (ent)-I-2 (37.4 mg, 71%): Light yellow solid, mp: 75-
77 °C; Rf = 0.34 (2:1 (v/v) hexane/EtOAc); [α]D20 +72 (c 2.22, CHCl3); IR (thin film, cm-1) υ 
064, 3032, 2985, 2918, 2871, 1698, 1634, 1604, 1573, 1509, 1452, 1374, 1353, 1299, 1250, 
196, 1175, 1161, 1100, 1002, 934. 1H NMR (CDCl3, 600 MHz) δ 7.86 (d, J = 9.0 Hz, 2H), 7.57 
(d, J = 7.8 Hz, 2H), 7.47-7.29 (m, 13H), 7.27 (dd, J = 10.2, 3.6 Hz, 1H), 7.06 (d, J = 9.0 Hz, 2H), 
.58 (d, J = 1.8 Hz, 1H), 6.47 (d, J = 2.4 Hz, 1H), 6.13 (d, J = 10.2 Hz, 1H), 5.91 (d, J = 3.6 Hz, 
J = 7.2 Hz, 1H), 0.92 (d, J = 6.6Hz, 3H); 
C NMR (CDCl3, 150 MHz) δ 196.7, 173.3, 163.0, 160.4, 159.9, 159.0, 154.9, 143.1, 137.6, 
3
1
6
1H), 5.28 (s, 2H), 5.15 (s, 2H), 5.09 (s, 2H), 4.01 (q, 
13
71 
 
, 126.7, 
MS (ESI): calcd. for 
[C42H34O8+Na]+: 689.2151, Found: 689.2149. 
 
 
 
136.3, 136.2, 135.6, 130.4, 128.8, 128.7, 128.6, 128.4, 128.2, 127.7, 127.6, 127.4, 127.4
123.2, 114.7, 110.0, 98.3, 94.3, 94.1, 71.5, 70.8, 70.5, 70.1, 14.6; HR
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-
methyltetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one ((ent)-I-12) 
 
A solution of 135.5 mg pyranone (ent)-I-2 (0.203 mmol) in 2.5 mL CH2Cl2-MeOH (5:1) was 
cooled down to -78 ºC, then 19 mg (0.50 mmol) NaBH4 was added in. The reaction mixture was 
stirred at -78 ºC for 3 hours. The reaction was then quenched by 2 mL saturated aqueous 
NaHCO3, followed by extraction with EtOAc (20 mL×3). The organic layer was washed by 2 
mL saturated aqueous NaCl, dried over Na2SO4, and concentrated under reduced pressure to give 
crude product.  The crude product was redissolved in a a mixture of 1 mL t-BuOH, 1 mL acetone 
and 1 mL NMO (50% w/w aqueous) at 0 ºC. Then catalytic amount of crystalline OsO4 was 
added into the mixture. The reaction mixture was stirred at 0 ºC overnight, then was quenched by 
addition of 0.5 mL saturated aqueous Na2S2O3. After stirring for another 0.5 hour at 0 ºC, all the 
staff was passed through a small pad of celite and silica gel, washed by EtOAc-MeOH (10:1) (10 
mL × 3). The organic effluent was dried by Na2SO4, and concentrated under reduced pressure to 
give crude prodcut. Chromatography on silica gel column, eluting with Et2O-MeOH (20:1), gave 
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1.0, MeOH); IR (thin film, cm-1) υ 3386 (broad), 3063, 2931, 1602, 
1509, 1453, 1352, 1299, 1252, 1198, 1174, 1102, 1098, 1055, 998, 993; 1H NMR (acetone-d6, 
00 MHz) δ 7.91 (d, J = 9.0 Hz, 2H), 7.69 (d, J = 7.8 Hz, 2H), 7.50 (d, J = 8.4 Hz, 4H) 7.43-7.39 
z, 2H), 6.80 (d, J = 1.8 Hz, 1H), 6.67 (d, J = 2.4 
Hz, 1H), 5.57 (d, J = 1.8 Hz, 1H), 5.29 (d, J = 13.2 Hz, 1H), 5.28 (d, J = 13.2 Hz, 1H), 5.24 (s, 
2H), 5.23(s, 2H), 4.28 (dd, J = 3.6, 1.8 Hz, 1H), 3.70 (dd, J = 9.0, 3.6 Hz, 1H), 3.33 (dd, J = 9.6, 
9.6 Hz, 1H), 3.21 (dq, J = 9.6, 6.0 Hz, 1H), 2.91 (brs, 1H), 0.87 (d, J = 6.0 Hz, 3H); 13C NMR 
(acetone-d6, 150 MHz) δ 173.5, 164.1, 161.5, 160.8, 159.8, 154.8, 138.4, 138.1, 138.0, 137.4, 
131.4, 129.5, 129.4, 129.3, 129.1, 128.8, 128.8, 128.5, 128.4, 127.9, 124.4, 115.7, 110.6, 102.2, 
98.9, 95.1, 73.2, 72.2, 71.5, 71.4, 71.3, 71.2, 70.8, 17.9; HRMS ESI) calcd. for [C42H38O10+H]+: 
703.2543, Found: 703.2541. 
triol (ent)-I-12 (85 mg, 60% over two steps): White solid, mp: 103-105 °C; Rf  = 0.27 (20:1 (v/v) 
Et2O/MeOH); [α]D20 +121 (c 
6
(m, 6H), 7.38-7.29 (m, 3H), 7.19 (d, J = 8.4 H
 (
 
Kaempferol-3-α-D-rhamnoside ((ent)-I-1b) 
 
A solution of 24 mg triol (ent)-I-12 (0.034 mmol) in 2 mL THF-EtOH (1:1) was added 14 mg 
Pd/C (10% w/w). The solution was degassed using vacuum at −50 to −40 ºC and refilling with 
H2. This procedure was repeated three times, and then the bath was removed. The reaction was 
warmed up to room temperature and stirred under a H2 atmosphere for 5 hours. The reaction 
mixture was loaded onto silica gel and elution with hexane-EtOAc (1:3) gave kaempferol-3-α-D-
rhamnoside ((ent)-I-1b) (14 mg, 93%): Pale yellow solid, mp: 148-150 ºC; Rf = 0.71 (5:1 (v/v) 
t2O/MeOH); [α]D20 +118 (c 1.0, MeOH); IR (thin film, cm-1) υ 3290 (broad), 2922, 2853, 1654, 
1607, 1500, 1448, 1359, 1261, 1207, 1173, 1056, 947; 1H NMR (acetone-d6, 600 MHz) δ 7.85 (d, 
E
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z, 2H), 6.47 (d, J = 1.8 Hz, 1H), 6.27 (d, J = 2.4 Hz, 1H), 5.53 
(d, J = 1.8 Hz, 1H), 4.21 (dd, J = 3.0, 1.8 Hz, 1H), 3.68 (dd, J = 9.0, 3.6 Hz, 1H), 3.33 (dd, J = 
6, 
63.0, 161.0, 158.5, 158.1, 135.9, 131.8, 122.6, 116.3, 105.8, 102.8, 
99.6, 94.6, 73.0, 72.2, 71.5, 71.4, 17.9; HRMS (ESI) calcd. for [C21H20O10+Na]+: 455.0954, 
Found: 455.0949. 
 
 
V.3. Chapter II Experimental  
(3aR,4aS,5aR,6aS)-hexahydro-2,2-dimethyl-3aH-bicyclo[4.1.0]hept-1(6)-eno[3,4-
d][1,3]dioxol-4a-ol (II-9a) 
J = 9.0 Hz, 2H), 7.01 (d, J = 8.4 H
9.6, 8.4 Hz, 1H), 3.30 (dd, J = 9.6, 6.0 Hz, 1H), 0.89 (d, J = 6.0 Hz, 3H); 13C NMR (acetone-d
150 MHz) δ 179.4, 165.1, 1
 
HO
O
O
H
 
(3aR,4aR,5aS,6aS)-hexahydro-2,2-dimethyl-3aH-bicyclo[4.1.0]hept-1(6)-eno[3,4-
d][1,3]dioxol-4a-ol (II-9b) 
O
O
HO
H
 
To a solution of 17.0 g enone II-4 (101.2 mmol) in 185 mL toluene was added 155 mg 
RhCl(PPh3)3 (0.34 mmol) and 17.0 mL phenyldimethylsilane (111.3 mmol), the mixture was 
stirred at 60 °C for 1 hour.  Then the reaction mixture was cooled down to 0 °C, into which a 
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d with 800 
mL hexane-ether (v/v 1:1) and quenched with 150 mL saturated aqueous NH Cl. The aqueous 
m
c
ganic layer was washed with saturated brine 300 mL and dried 
13C NMR (150 MHz, CDCl3) δ 107.1, 
74.0, 73.6, 52.0, 34.4, 29.9,  26.4, 23.4, 20.6, 14.8. HRMS (ESI): calcd. for [C10H16O3+Na]+: 
207.09917,  Found: 207.09916. 
II-9b: Colorless oil; Rf = 0.26 (1:1 (v/v) hexane/EtOAc); [α]D20 +11 (c 2.36, CHCl3); IR (thin 
film, cm-1) υ 3371, 2988, 2915, 1463, 1371; 1H NMR (600 MHz, CDCl3) δ 4.45 (ddd, J = 7.8, 
6.0, 6.0 Hz, 1H), 4.29 (ddd, J = 8.4, 6.0, 6.0 Hz, 1H), 2.35 (dd, J = 15.0, 6.0 Hz, 1H), 2.24 (ddd, 
J = 15.0, 5.4, 5.4, 1H), 2.05 (brs, 1H), 1.82 (dd, J = 15.0, 6.0 Hz, 1H),  δ 1.44 (s, 3H), 1.39 (ddd, 
z, 1H), 0.92 (dd, J = 
J = 6.0, 5.4 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 107.2, 72.0, 71.8, 
 (ESI): calcd. for [C10H16O3+H]+: 185.11722,  
ound: 185.11719.  1H-1H COSY and NOE as follow: 
solution of 18.7g ZnEt2 (151.8 mmol) was slowly added followed by addition of 18.4 ml CH2I2 
(228.0 mmol). The reaction mixture was stirred at 0 °C overnigtht.  Then it was dilute
4
layer was extracted with Et2O with hexane-ether (v/v 1:1) 500 L X 2.  The combined organic 
layer was washed wih 100 mL saturated aqueous Na2S2O3, 100 mL saturated brine and dried 
over Na2SO4. The solution was then concentrated to a residue, which was redissolved in 360 mL 
MeOH at 0 °C and 546 mg (2.87 mmol) p-TsOH was added in portions.  It was stirred at 0 °C for 
15 min, then quenched with 50 mL saturated aqueous NaHCO3.  The mixture was concentrated 
under reduced pressure to remove most of the MeOH, and then extracted with hexane-EtOA  
(v/v 1:5) 800 mL X 3.  The or
over Na2SO4.  Concentration of the solution gave a residue, which was subjected to 
chromatography on silica gel column. Elution with hexane-EtOAc (3:1) afforded cyclopropanol 
II-9a (9.3 g, 50 %) and elution with hexane-EtOAc (3:2) afforded II-9b (3.7 g, 20%). 
II-9a: Colorless oil; Rf = 0.44 (1:1 (v/v) hexane/EtOAc); [α]D20 +19 (c 2.50, CHCl3); IR (thin 
film, cm-1) υ 3433, 2987, 2933, 1453, 1371; 1H NMR (600 MHz, CDCl3) δ 4.48 (ddd, J = 7.8, 
3.0, 2.4 Hz, 1H), 4.32 (ddd, J = 7.8, 3.0, 2.4 Hz, 1H), 2.72 (s, 1H), 2.50 (dd, J = 15.6, 3.0 Hz, 
1H), 2.30 (dddd, J = 15.6, 4.8, 2.4, 1.8 Hz, 1H), δ 1.48 (s, 3H), 1.33 (s, 3H), 1.25 (dd, J = 15.6, 
2.4 Hz, 1H), 1.08 (m, 2H), 0.62 (m,1H); 0.18 (m, 1H); 
J = 15.0, 6.0, 6.0 Hz, 1H), 1.30 (s, 3H), 1.06 (dddd, J = 9.6, 6.0, 6.0, 5.4 H
9.6, 5.4 Hz, 1H), 0.88 (dd, 
53.4, 34.6, 27.6,  26.4, 23.1, 20.4, 17.1. HRMS
F
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H
HO
O
O
H
H H
H
H
H
4.29 ddd
1.38 ddd
2.24ddd
2.35 dd
1.82 dd
4.45 ddd
H
H
1.06 ddd
0.88 dd
0.92 dd
J = 9.6, 5.4 Hz
J = 8.4, 6.0, 6.0 Hz
J = 15.0, 6.0 Hz
J = 15.0, 5.4, 5.4 Hz
J = 15.0, 6.0 Hz
J = 7.8, 6.0, 6.0 Hz
J = 9.6, 6.0, 6.0, 5.4 Hz
J = 15.0, 6.0, 6.0 Hz
J = 6.0, 5.4 Hz
H
HO
O
O
H
H H
H
H
H
4.29 ddd
1.38 ddd
2.24ddd
2.35 dd
1.82 dd
4.45 ddd
H
H
1.06 ddd
0.88 dd
0.92 dd
J = 8.4, 6.0, 6.0 Hz
J = 15.0, 6.0 Hz
J = 15.0, 5.4, 5.4 Hz
J = 15.0, 6.0 Hz
J = 7.8, 6.0, 6.0 Hz
J = 9.6, 6.0, 6.0, 5.4 Hz
J = 15.0, 6.0, 6.0 Hz
J = 9.6, 5.4 Hz
J = 6.0, 5.4 Hz
                               
            1H-1H COSY of 13b                                                          NOE of 13b 
 
 
(3aR,7aS)-tetrahydro-2,2-dimethyl-6-methyleneben [d][1,3]dioxol-5(6H)-one (II-10a)  zo
 
 (3aR,7aS)-3a,4-dihydro-2,2,6-trimethylbenzo [d][1,3]dioxol-5(7aH)-one (II-10b) 
 
To a solution of 139 mg II-9a (0.76 mmol) in 6 mL toluene was added 128 µL pyridine (1.59 
mmol) and 178 mg Pd(OAc)2 (0.79 mmol). The reaction mixture was heated up to 80 °C and 
kept stirring for 3 h. Then it was cooled to RT, and was filtered through filter paper
Et O-hexane (1:1, v/v) 50 mL. The solution was washed with 1 mL 0.5 M NaHSO
, rinsing with 
2 4 at 0 °C, then 
as washed with 1 mL saturated aqueous NaHCO3, and 1 mL saturated aqueous NaCl, dried 
over Na2SO4. The solution was concentrated under reduced pressure to give a residue, which was 
w
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 pyridine (0.11 
mmol), 12 mg quinone (0.10 mmol) and 14 mg Pd(OAc)2 (0.06 mmol). The reaction mixture 
irred at RT for 24 h and the mixture was 
H), 2.77 (dd, J = 15.8, 3.0 Hz, 1H), 2.64 (dddd, J = 
J = 15.8, 3.5 Hz, 1H), 1.34 (s, 3H), 1.33 (s, 3H); 13C NMR 
(CDCl3, 67.5 MHz) δ 197.3, 138.9, 123.5, 108.0, 73.1, 72.4, 42.0, 34.9, 26.0, 24.1; HRMS (ESI) 
und: 183.1016. 
purified by silica gel column. Elution with hexane-EtOAc (7:1) afforded two pure compounds II-
10a (42 mg, 31%) and II-10b (75 mg, 55%). 
To a solution of 10 mg II-9a (0.05 mmol) in 0.5 mL toluene was added 8.7 µL
was heated up to 80 °C and kept stirring for 3 h. Then it was cooled to RT, and was filtered 
through filter paper, rinsing with Et2O-hexane (1:1, v/v) 5 mL. The solution concentrated under 
reduced pressure and directly loaded onto a silica gel column. Elution with hexane-EtOAc (5:1) 
afforded compounds II-10a (7 mg, ~70%) and II-9a (1 mg, ~10% recovery). 
 
To a solution of 1.6 mg II-9a (0.009 mmol) in 0.6 mL THF-EtOH (1:1 v/v) was added 11 mg 
10% Pd/C (0.01 mmol Pd). The reaction mixture was st
then filtered through filter paper. The solution was concentrated under reduced pressure to give a 
residue, which was shown by crude 1H NMR that it was exclusively II-10a. 
II-10a: White solid; mp: 58.3-60.3 °C; Rf = 0.45 (1:1 (v/v) hexane/EtOAc); [α]D20 +16 (c 0.33, 
CHCl3); IR (thin film, cm-1) υ 2991, 2917, 1709, 1671, 1627, 1431, 1384, 1363, 1286, 1274, 
1243, 1207, 1163, 1081, 1062, 1038, 950; 1H NMR (CDCl3, 270 MHz) δ 6.17 (dd, J = 2.0, 2.0 
Hz, 1H), 5.32 (dd, J = 2.2, 1.7 Hz, 1H), 4.69 (ddd, J = 6.7, 3.2, 3.2 Hz, 1H), 4.60 (ddd, J = 7.4, 
3.2, 3.2 Hz, 1H), 2.79 (dd, J = 15.3, 2.7 Hz, 1
15.3, 3.7, 2.2, 2.2 Hz, 1H), 2.58 (dd, 
calcd. for [C10H14O3+H]+: 183.1016, Fo
II-10b: Colorless oil; Rf = 0.55 (1:1 (v/v) hexane/EtOAc); [α]D20 +71 (c 1.89, CHCl3); IR (thin 
film, cm-1) υ 2986, 2926, 1679, 1450, 1380, 1368, 1243, 1223, 1155, 1063, 1038, 1012, 967; 1H 
NMR (CDCl3, 270 MHz) δ 6.39 (dq, J = 4.7, 1.5 Hz, 1H), 4.69 (dddd, J = 4.5, 3.0, 3.0, 1.5 Hz, 
1H), 4.63 (ddq, J = 4.9, 3.0, 2.0 Hz, 1H), 2.92 (dd, J = 17.3, 2.7 Hz, 1H), 2.65 (dd, J = 17.3, 3.9 
Hz, 1H), 1.80 (dd, J = 1.5, 1.5 Hz, 3H), 1.36 (s, 3H), 1.34 (s, 3H); 13C NMR (CDCl3, 67.5 MHz) 
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I-10b 
r II-10a (or 89% for II-10b).    
To a solution of 18 mg mixture of II-11a/II-11b (dr 3:1) (0.1 mmol) in 6 mL THF at 0 °C was 
added 5 drops of 0.5 M NaOH(aq.) and the mixture was stirred at 0 °C for 30 h. Then into the 
mixture was added 10 drops of saturated aqueous NH4Cl and diluted with 20 mL EtOAc. The 
organic layer was washed with 1 mL saturated aqueous NH4Cl, 1 mL saturated aqueous NaCl 
and dried over Na SO . The solution was concentrated under reduced pressure to give a residue 
δ 195.7, 140.6, 135.5, 109.6, 73.6, 71.6, 39.1, 27.8, 26.6, 15.8; HRMS (ESI) calcd. for 
[C10H14O3+H]+: 183.1016, Found: 183.1016. 
 
Hydrogenation of II-10a and I
To a solution of 40 mg enone II-10a (or II-10b) (0.22 mmol) in 3 mL THF-EtOH (1:1 v/v) was 
added 20 mg 10% Pd/C. The reaction mixture was degassed using vacuum and refilled with H2 
at ~ -30 °C for three times and then was stirred under balloon pressure of H2 at RT for 2 h. The 
mixture was filtered through filter paper and the solution was concentrated under reduced 
pressure to give a residue. A crude 1H NMR showed that it was a diastereomeric mixture of α-
methyl ketone II-11a/II-11b with dr(11a/11b) 3:1 for II-10a (or dr(11a/11b) 1:10 for II-10b). The two 
isomers II-11a and II-11b were inseparable on silica gel column and the mixture of isomers II-
11a/II-9b were obtained in 88% yield fo
 
β-elimination of II-11a/II-11b 
2 4
which by crude 1H NMR was shown that it was a mixture of II-12a/II-12b (dr(12a/12b) 2:3). The 
two isomers II-12a and II-12b were inseparable on silica gel column and the mixture of II-
12a/II-12b was obtained in 85% yield. 
 
 (3aR,6S,7aS)-tetrahydro-2,2,6-trimethylbenzo[d][1,3]dioxol-5(6H)-one (II-11a) 
O
O
O
 
To a solution of 660 mg cyclopropanol II-9a (3.6 mmol) in 30 mL THF-EtOH (v/v 1:1) was 
added 350 mg 10% Pd/C. The solution was degassed using vacuum and refilled with H2 three 
times at low temperature (~ -30 °C). Then at room temperature, the solution was stirred 
vernight under balloon pressure of H2.  It was filtered through a filter paper and rinse with ethyl 
acetate.  The solution was concentrated under reduced pressure to a small volume, which was 
exane-EtOAc (7:2) gave 
product II-11a (530 mg, 80%). 
II-11a: Colorless oil; Rf = 0.55 (1:1 (v/v) hexane/EtOAc); [α]D20 +105 (c 2.7, CHCl3); IR (thin 
film, cm-1) υ 2989, 2937, 1702, 1458, 1378, 1204, 1164, 1017; 1H NMR (CDCl3, 600 MHz) δ 
4.63 (ddd, J = 7.2, 4.2, 3.0 Hz, 1H)4.52 (ddd, J = 7.2, 3.0, 2.4 Hz, 1H),  2.67 (dd, J = 17.4, 3.0 
o
then subjected to chromatography on silica gel column. Elution with H
Hz, 1H), 2.53 (dqd, J = 13.8, 6.6, 4.2 Hz, 1H), 2.44 (dd, J = 16.8, 3.6 Hz, 1H), 2.06 (ddd, J = 
15.0, 4.2, 2.4 Hz, 1H), 1.65 (ddd, J = 16.2, 13.2, 3.0 Hz, 1H), 1.44 (s, 3H), 1.35 (s, 3H), 1.09 (d, 
J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 211.7, 107.6, 72.9, 71.9, 41.1, 37.4, 34.3, 26.0, 
23.8, 14.8; HRMS (ESI): calcd. for [C10H16O3+H]+: 185.11722,  Found: 185.11723. 
 
 (2S,4S,5R)-4,5-dihydroxy-2-methylcyclohexanone (II-13) 
O
HO
OH  
1.0 g acetonide II-11a (5.4 mmol) was placed in 250 mL flask at 0 °C, a pre-cooled 40 mL 
solution of THF-10%HCl (v/v 1:1) was added into the flask when stirring. Then the ice bath was 
removed and the mixture was allowed to warm up to room temperature over 1 hour when stirring.  
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he reaction. The mixture was extracted with EtOAc 200 mL X 3 
and the organic layer was washed with 40 mL saturated aqueous NaCl, dried over Na2SO4. The 
lution was concentrated under reduced pressure to a residue which was subjected to 
e-EtOAc (1:3) gave product diol II-13 
(600 mg, 77%).  
II-13: Colorless oil; Rf = 0.53 (10:1 (v/v) EtOAc/MeOH); [α]D20 +35 (c 1.32, CHCl3); IR (thin 
film, cm-1) υ 3391, 2969, 2932, 1701, 1455, 1430, 1376, 1355, 1243, 1215, 1105, 1066, 1031, 
963, 915; 1H NMR (CDCl3, 270 MHz) δ 4.15 (ddd, J = 2.7, 2.7, 2.7 Hz, 1H), 3.94 (ddd, J = 11.6, 
The mixture was cooled down to 0 °C and diluted with 120 mL EtOAc, into which 10 g NaHCO3 
(s) was slowly added to quench t
so
chromatography on silica gel column. Elution with hexan
5.4, 3.0 Hz, 1H),  2.78 (m, 2H), 2.55 (dd, J = 13.1, 5.2 Hz, 1H), 2.22 (ddd, J = 14.4, 5.9, 4.0 Hz, 
1H), 1.42 (ddd, J = 14.6, 13.1, 2.5 Hz, 1H), 1.01 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 150 
MHz) δ 210.1, 72.0, 68.3, 45.1, 37.6, 36.2, 13.6; HRMS (ESI): calcd. for [C7H12O3+Na]+: 
167.06787,  Found: 167.06781. 
 
(1S,3R,4S,6R)-bicyclo[4.1.0]heptane-1,3,4-triol (II-14) 
HO
OH
HO
H
 
A solution of 2.8 g of II-9a was dissolved in 10 mL THF-10%HCl (v/v, 1:1) and stirred at room 
temperature for 20 min. The mixture was cooled down to 0 °C, and diluted with 100 mL EtOAc, 
3 was slowly added to quench the reaction. The mixture was filtered through a 
esidue which was loaded to a silica gel column. 
Elution with EtOAc-MeOH (10:1 v/v) gave triol II-14 (1.8g, 82%).  
then ~7 g NaHCO
glass wool and the liquid was concentrated to a r
II-14: White solid; mp: 148-149 °C; Rf = 0.19 (10:1 (v/v) EtOAc/MeOH); [α]D20 +26 (c 4.99, 
MeOH); IR (thin film, cm-1) υ 3368, 3245, 2928, 2911, 1434, 1363, 1276, 1213, 1172; 1H NMR 
(CD3OD, 600 MHz) δ 3.56 (ddd, J = 6.6, 4.8, 1.8 Hz, 1H), 3.38 (ddd, J = 9.0, 4.8, 1.8 Hz, 1H), 
2.23 (ddd, J = 13.2, 13.2, 5.4 Hz, 1H), 2.19 (m, 2H), 1.56 (ddd, J = 15.0, 4.8, 1.8 Hz, 1H), 1.03 
(dddd, J = 10.2, 7.8, 6.0, 1.8 Hz, 1H), 0.84  (ddd, J = 10.2, 5.4, 1.2 Hz, 1H), 0.18 (dd, J = 6.0, 6.0 
Hz, 1H); 13C NMR (CD3OD, 150 MHz) δ 70.1, 69.7, 55.4, 36.2, 31.5, 20.0, 18.1; HRMS (ESI): 
calcd. for [C7H12O3+Na]+: 167.06787, Found: 167.06783. 
 
Alternatively preparation of II-13 from II-14 
80 
 
Into a solution of 300 mg (2.08 mmol) cyclopropanol II-14 in 13 mL THF-EtOH (1:1 v/v) was 
added 150 mg 10% Pd/C. The solution was degassed using vacuum and refilled with H2 three 
times at low temperature (~ −30 °C). Then at room temperature, the solution was stirred 4 hr 
under balloon pressure of H2.  It was filtered through a filter paper and rinsed with ethyl acetate.  
The solution was concentrated under reduced pressure to a small volume (some of the solution 
was taken out and concentrated to dry, then a crude NMR was taken to show that NO 
diastereomer was seen). The residue was subjected to chromatography on silica gel column. 
Elution with Hexane-EtOAc (1:3) gave product II-13 (246 mg, 82%). 
 
t-Butyl (1S,5S)-5-methyl-4-oxocyclohex-2-enyl carbonate (II-15) 
 
Diol II-13 (250 mg, 1.74 mmol) was dissolved in 15 mL CH2Cl2 at RT, into which 24 mg 
DMAP (0.2 mmol) was added, followed by addition of a solution of 1.2 g Boc2O (5.6 mmol) in 5 
mL CH2Cl2. The mixture was stirred at RT for 2 h, then it was cooled down to 0 °C, diluted with 
Et2O 30 mL and was then quenched with 10 mL saturated aqueous NaHCO3. The mixture was 
stirred at 0 °C for another 1 h and then was extracted with Hexane-Et2O (1:2 v/v) 50 mL x 2. The 
pooled organic layer was washed with 15 mL saturated aqueous NaCl and dried over Na2SO4. 
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ck to 0 °C, diluted with hexane-Et2O (1:1 v/v) 50 mL and it 
was then quenched by 30 mL 0.5 M NaHSO4 at 0 °C. The aqueous layer was extracted with 
2O (1:1 v/v) 100 mL x 2. The pooled organic layer was washed with 20 mL saturated 
. The solution was 
concentrated under reduced pressure to afford a residue, which was purified by silica gel column. 
Elution with hexane-EtOAc (10:1 v/v) gave enone II-15 (325 mg, 83% for two steps) as white 
solid; mp: 36.8-38.2 °C; Rf = 0.49 (4:1 (v/v) hexane/EtOAc); [α]D20 -175 (c 1.54, CHCl3); IR 
(thin film, cm-1) υ 2991, 2969, 2930, 2879, 1731, 1686, 1627, 1454, 1369, 1343, 1274, 1252, 
1195, 1156, 1121, 1079, 1067, 1046, 965; 1H NMR (CDCl3, 270 MHz) δ 6.86 (dd, J = 10.2, 4.2 
The solution was concentrated under reduced pressure to afford a residue. The residue was 
redissolved in 9 mL CH2Cl2 at 0 °C. Into the solution 1.8 mL Et3N (12.9 mmol) was slowly 
added. The mixture was then stirred at 0 °C overnight and continued to be stirred at RT for 
another 2 h. Then it was cooled ba
hexane-Et
aqueous NaHCO3, 20 mL saturated aqueous NaCl and dried over Na2SO4
Hz, 1H), 6.04 (dd, J = 9.9, 1.0 Hz, 1H), 5.29 (ddd, J = 4.5, 4.5, 4.2 Hz, 1H),  2.77 (dqd, J = 9.6, 
7.2, 4.9 Hz, 1H), 2.25 (dddd, J = 13.9, 4.9, 4.9, 1.0 Hz, 1H), 2.06 (ddd, J = 13.9, 9.4, 4.5 Hz, 1H), 
1.49 (s, 9H), 1.15 (d, J = 6.9 Hz, 3H); 13C NMR (CDCl3, 67.5 MHz) δ 201.0, 152.8, 143.3, 131.2, 
82.9, 68.1, 37.7, 35.4, 27.7, 14.9;  
 
t-Butyl (1S,4R,5S)-4-hydroxy-5-methylcyclohex-2-enyl carbonate (II-16) 
 
To a solution of 69 mg enone II-15 (0.30 mmol) in 6 mL THF at -78 °C was added 40 mg 
LiAlH4 (0.92 mmol) in several portions. The reaction mixture was stirred at -78 °C for 30 min, 
then 2 mL acetone was added dropwise at -78 °C and the mixture was stirred for another 20 min 
to quench the reaction. Then it was diluted with 30 mL EtOAc and 6 mL saturated aqueous 
NH4Cl was added. The mixture was warmed up and stirred at 0 °C for 15 min and then aqueous 
L x 2. The pooled organic layer was washed with 5 mL layer was extracted with EtOAc 30 m
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lution was 
concentrated under reduced pressure to give a residue, which was purified by chromatography on 
silica gel column. Elution with hexane-EtOAc (5:1) afforded allylic alcohol II-16 (60 mg, 90%) 
as white solid; mp: 81.6-83.6 °C; Rf = 0.27 (4:1 v/v hexane/EtOAc); [α]D20 -131 (c 1.05, CHCl3); 
IR (thin film, cm-1) υ 3354, 2974, 1732, 1455, 1397, 1370, 1340, 1281, 1256, 1155, 1058, 1035, 
945; 1H (CDCl3, 600 MHz) δ 5.95 (ddd, J = 9.6, 1.8 Hz, 1H), 5.85 (dddd, J = 10.2, 4.2, 1.8, 1.8 
saturated aqueous NH4Cl, 5 mL saturated brine, dried over Na2SO4. The so
Hz, 1H), 4.99 (m, 1H), 3.70 (ddd, J = 9.0, 3.6, 1.8 Hz, 1H), 1.91 (dddd, J = 14.4, 3.0, 3.0, 1.8 Hz, 
1H), 1.82 (ddqd, J = 12.0, 9.6, 6.6, 3.0 Hz, 1H), 1.57 (ddd, J = 15.0, 12.0, 4.8 Hz, 1H), 1.48 (s, 
9H), 1.07 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 153.2, 136.9, 125.4, 82.1, 73.2, 
69.1, 34.2, 32.8, 27.8, 18.0; HRMS (ESI) calcd. for [C12H20O4+Na]+: 251.1254, Found: 251.1254. 
 
t-Butyl (1S,2S,3S,4R,5S)-2,3,4-trihydroxy-5-methylcyclohexyl carbonate (II-17) 
 
To a solution of 37 mg olefin II-16 (0.16 mmol) in 1.5 mL t-BuOH-actone-50% NMO(aq.) (1:1:1 
/v/v) was added a small piece of crystalline OsO4 at 0 °C. The reaction mixture was stirred at 
0 °C for overnight, then 1.5 mL saturated aqueous Na2S2O4 was added and it was stirred at 0 °C 
 passed through a pad of sand-silica gel-celite, rinsing 
with EtOAc-MeOH (10:1, v/v). The effluent was dried over Na2SO4 and concentrated under 
reduced pressure to give a residue, which was purified by silica gel column. Elution with hexane-
EtOAc (1:2) gave triol II-17 (37 mg, 87%) as colorless oil: Rf  = 0.27 (1:3 (v/v) hexane/EtOAc); 
[α]D20 +10 (c 1.9, MeOH); IR (thin film, cm-1) υ 3388, 2933, 1740, 1457, 1369, 1277, 1255, 1157, 
1051, 960; 1H NMR (CD3OD, 600 MHz) δ 4.69 (ddd, J = 3.6, 3.0, 1.8 Hz, 1H), 3.92 (ddd, J = 
v
for another 2 h.  The reaction mixture was
3.6, 3.6, 1.2 Hz, 1H), 3.48 (dd, J = 9.6, 3.6 Hz, 1H), 3.29 (ddd, J = 9.0, 9.0, 1.8 Hz, 1H), 1.67 (m, 
3H), 1.46 (s, 9H), 1.02 (d, J = 5.4 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 154.4, 83.1, 76.4, 
76.3, 74.5, 72.2, 33.8, 33.2, 28.2, 18.4; HRMS (ESI) calcd. for [C12H22O6+Na]+: 285.1309, 
Found: 285.1309. 
 
5a-Carba-α-D-rhamnopyranose (II-17) 
OH
OH
CH3HO
HO
 
To a solution of 26 mg carbonate II-17 (0.10 mmol) in 2 mL THF at 0 °C was added 26 mg 
was 
 saturated aqueous NaHCO3 was added. It was stirred for 
another 20 min to quench the reaction and then the mixture was passed through a pad of sand-
silica gel-celite, eluting with EtOAc-MeOH (10:1 v/v). The effluent was dried over Na2SO4. The 
solution was concentrated under reduced pressure to give a residue, which was purified by silica 
gel column. Elution with EtOAc-MeOH (10:1) afforded cyclitol II-7 (13 mg, 83%) as colorless 
oil; Rf  = 0.24 (5:1 (v/v) EtOAc/MeOH); [α]D20 -17 (c 0.58, MeOH); IR (thin film, cm-1) υ 3315, 
2922, 1404, 1377, 1281, 1240, 1186, 1154, 1052, 1003, 964; 1H NMR (CD3OD, 600 MHz) δ 
LiAlH4 (0.68 mmol). The reaction mixture was warmed up and stirred at RT for 1 h, then it 
diluted with 10 mL EtOAc and 2 mL
3.87 (dd, J = 3.6, 3.0 Hz, 1H), 3.83 (ddd, J = 3.6, 3.0, 3.0 Hz, 1H), 3.61 (dd, J = 9.6, 3.0 Hz, 1H), 
3.26 (dd, J = 9.6, 9.6 Hz, 1H), 1.78 (ddqd, J = 10.2, 9.6, 6.6, 6.6 Hz, 1H), 1.59 (m, 2H), 1.01 (d, 
J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 76.9, 75.0, 74.3, 71.1, 35.9, 33.1, 18.6;  
 
(2S,3S,4aR,5aS,7aR)-octahydro-2,3-dimethoxy-2,3-dimethyl-2H-bicyclo[4.1.0]hept-1(6)-
eno[3,4-b][1,4]dioxin-5a-ol (II-18b) 
83 
 
OOH
O OMe
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MeO  
tOAc was added 
g 10% Pd/C. The solution was degassed using vacuum and refilled with H2 three times at 
low temperature (~-30 °C). Then at room temperature, the solution was stirred for 6 hr under 
alloon pressure of H2. It was then filtered through a filter paper and rinse with ethyl acetate.  
The solution was washed with 30 mL saturated aqueous NaHCO3, 30 mL saturated aqueous  
aCl, dried over Na2SO4 and then concentrated under reduced pressure to a small volume, which 
as subjected to chromatography on silica gel column. Elution with hexane-EtOAc (2.5:1) gave 
product diastereomeric mixture of II-19 (1.26g, 63%, dr(II-19a/II-19b) ~2:1) and elution with 
exane-EtOAc (1:1) gave pure cyclopropanol II-18b (420 mg, 21%). II-18b: Colorless oil; Rf = 
0.48 (1:2 (v/v) hexane/EtOAc); [α]D20 = +159 (c 1.0, CHCl3); IR (thin film, cm-1) υ 3405, 2992, 
To a solution of 5.2 g enone II-6 (21.5 mmol) in 74 mL toluene was added 30 mg RhCl(PPh3)3 
(0.065 mmol) and 4.1 mL phenyldimethylsilane (26.9 mmol), the mixture was stirred at 60 °C 
for 1 hour.  Then the reaction mixture was cooled down to 0 °C, into which a solution of 5.96 g 
ZnEt2 (48.3 mmol) was slowly added followed by addition of 4.9 mL CH2I2 (60.7 mmol). The 
reaction mixture was stirred at 0 °C overnight.  Then it was diluted with 300 mL hexane-ether 
(v/v 1:1) and quenched with 120 mL saturated aqueous NH4Cl. The aqueous layer was extracted 
with hexane-ether (v/v 1:1) 300 mL X 2.  The combined organic layer was washed with 10 mL 
saturated aqueous Na2S2O3, 100 mL saturated brine, dried over Na2SO4. The solution was then 
concentrated to a residue, which was redissolved in 215 mL MeOH at 0 °C and 326 mg (1.72 
mmol) p-TsOH was added in portions.  It was stirred at 0 °C for 15 min, and then quenched with 
10 mL saturated aqueous NaHCO3 and 1 g NaHCO3. The mixture was concentrated under 
reduced pressure to remove most of solvent, then 50 mL EtOAc was added and concentrated 
again to remove more solvent. The residue (~10 mL) was directly loaded onto a silica gel 
column. Elution with hexane-EtOAc (3:2, v/v) afforded cyclopropanol (4 g, 73 %) as 
diastereomeric mixture (dr ~1:1). 
To a solution of 2.0 g diastereomeric mixture (7.75 mmol, dr ~1:1) in 300 mL E
700 m
b
N
w
h
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dd, 
, 7.2 Hz, 1H), 3.25 (s, 3H), 3.23 (s, 3H), 3.22 (ddd, J = 11.4, 10.2, 5.4 Hz, 1H), 
2.51 (ddd, J = 12.6, 5.4, 0.6 Hz, 1H), 2.31 (ddd, J = 16.2, 9.6, 7.2 Hz, 1H), 2.03 (ddd, J = 12.0, 
10.8, 1.2 Hz, 1H), 1.36 (ddd, J = 13.8, 11.4, 2.4 Hz, 1H), 1.28 (s, 3H), 1.26 (s, 3H), 1.12 (dddd, J 
= 9.6, 9.6, 6.6, 1.2 Hz, 1H), 1.01 (ddd, J = 10.8, 6.0, 1.8 Hz, 1H), 0.38 (dd, J = 6.0, 5.4 Hz, 1H); 
13C NMR (150 MHz, CDCl3) δ 99.2, 99.0, 68.9, 67.1, 55.9, 47.9, 47.8, 36.0, 29.6, 20.9, 18.0, 
17.8. HRMS (ESI): calcd. for [C13H22O5+Na]+: 281.13594,  Found: 281.13599. 
 
 
 
,3-dimethoxy-2,3,7-trimethylbenzo[b][1,4]dioxin-6(7H)-
one (II-19a)  
2933, 2833, 1456, 1377, 1218, 1200, 1123, 1050, 1038; 1H NMR (600 MHz, CDCl3) δ 3.61 (d
J = 11.4, 10.8
 
 
(2S,3S,4aR,7R,8aR)-hexahydro-2
 
(2S,3S,4aR,7S,8aR)-hexahydro-2,3-dimethoxy-2,3,7-trimethylbenzo[b][1,4]dioxin-6(7H)-
) one (II-19b
O
O
O
OMe
MeO
H3C
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Diastereomeric mixture of II-19a/II-19b (6.5g, dr ~2:1) was recrystallized from hexane-ether 
n , 1731, 1461, 1430, 1364, 1277, 1204, 1108, 1073, 
1039, 1025, 971; H NMR (CDCl3, 600 MHz) δ 4.00 (ddd, J = 12.0, 9.6, 4.8 Hz, 1H), 3.74 (ddd, 
J = 13.2, 10.2, 5.4 Hz, 1H), 3.28 (s, 3H), 3.21 (s, 3H), 2.61 (dd, J = 15.0, 12.6 Hz, 1H), 2.58 (m, 
1H), 2.48 (ddd, J = 15.0, 5.4, 1.2 Hz, 1H), 1.84 (ddd, J = 13.2, 12.0, 6.6 Hz, 1H), 1.74 (ddd, J = 
13.8, 6.6, 3.0 Hz, 1H), 1.29 (s, 3H), 1.28 (s, 3H), 1.20 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 
MHz) δ 210.7, 99.7, 99.3, 68.8, 66.3, 48.0, 47.9, 43.3, 41.5, 32.2, 17.9, 17.7, 17.6; HRMS (ESI) 
calcd. for [C13H22O5+Na]+: 281.1359, Found: 281.1360. 
Separation of II-19a and II-19b 
multiple times, which resulted in diastereomerically enriched II-19a (~3.3g, dr(19a/19b) ~10:1) 
from the mother solutions and II-19b (~2.0g, dr(II-19b/II-19a) >20:1) from the crystal form, as well 
as other small amount of mixtures (dr ratio range from 4:1 to 1:4). The II-19a enriched part and 
the II-19b enriched part were further purified respectively by silica gel column chromatography, 
eluting with hexane-EtOAc (6:1) to give more enriched II-19a (2.6 g, dr ~18:1, 40% recovery 
from original mixture) and the pure II-19b (1.8g, 28% recovery from original mixture).  
II-19a (dr(II-19b/II-19a) 18:1): White solid; mp: 92.0-93.0 °C; Rf = 0.31 (4:1 (v/v) hexane/EtOAc); 
IR (thi  film, cm-1) υ 3016, 2949, 2911, 2840
1
II-19b: White crystal; mp: 174-175 °C; Rf = 0.33 (4:1 (v/v) hexane/EtOAc); [α]D20 = +145 (c 
0.37, CHCl3); IR (thin film, cm-1) υ 2987, 2951, 2913, 2884, 2833, 1703,1468, 1444, 1431, 
1377, 1277, 1231, 1220, 1202, 1156, 1112, 1081, 1054, 1037, 928; 1H NMR (600 MHz, CDCl3) 
δ 3.96 (ddd, J = 12.0, 9.6, 4.8 Hz, 1H), 3.71 (ddd, J =13.2, 9.6, 5.4 Hz, 1H), 3.32 (s, 3H), 3.23 (s, 
3H), 2.60 (dd, J = 13.8, 5.4 Hz, 1H), 2.53(ddd, J = 13.2, 13.2, 1.2 Hz, 1H), 2.41 (ddqd, J = 12.6, 
6.6, 6.6, 1.2 Hz, 1H), 2.08 (ddd, J = 12.6, 6.6, 4.2 Hz, 1H), 1.43 (ddd, J = 13.2, 12.6, 12.0 Hz, 
1H), 1.32 (s, 3H), 1.31 (s, 3H), 1.07 (d, J = 6.0 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 208.0, 
99.6, 99.4, 69.6, 69.4, 48.0, 47.9, 44.5, 43.0, 34.5, 17.7, 17.6, 14.0. HRMS (ESI): calcd. For 
[C13H22O5+H]+: 259.1540, Found: 259.1540. 
X-ray crystal data: Empirical formula C13H22O5; formula weight 258.31; 
Temperature 293(2) K; wavelength 0.71073Å; crystal system monoclinic; space group P21; uni 
cell dimensions a=6.934(1)Å, b=6.997(1)Å, c=14.613(2)Å, α=90º, β=99.312(2)º, γ=90º; volume 
699.66(17) Å3; Z=2; density (calculated) 1.226 g/cm3; absorption coefficient 0.93 cm-1; F(000) 
80; crystal size 0.08 X 0.18 X 0.26 mm; θ range for data collection 2.83 to 27.55º; index ranges 
-7≤h≤9, -9≤k≤9, -17≤l≤18; reflections collected 4849; independent reflections 3075 
od Full-matrix least-squares 
on F2; data/restraints/parameters 3075/1/168; goodness-of-fit on F2 1.040; final R indices 
[I>2σ(I)] R1=0.0497, wR2=0.1245; R indices (all data) R1=0.0649, wR2=0.1347; absolute 
structure parameter -0.3(12); largest diff. peak and hole 0.243 and -0.158 e/Å3. 
 
19b, resulting in a II-19b enriched mixture (dr(II-19b/II-19a)>13:1).  Chromatography on silica gel 
2
[R(int)=0.0325]; completeness to θ=27.55º 97.3%; refinement meth
 
Epimerization of II-19a to II-19b 
Ketone II-19a enriched diastereomeric mixture (dr(II-19a/II-19b) ~2:1) was treated in a THF-conc. 
HCl (aq.) (v/v 2:1) at 0 °C for 30 min at 0.1 M concentration . The solution was then neutralized 
with saturated aqueous NaHCO3 and extracted with EtOAc. The organic layer was washed with 
saturated aqueous NaCl, dried over Na2SO4. Concentration of the solution under reduced 
pressure gave a residue. Crude 1H NMR show that the reaction epimerized most of II-19a to II-
afforded pure II-19b (~90%). 
 
t-butyl (1R,5S)-5-methyl-4-oxocyclohex-2-enyl carbonate (II-20) 
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OOBoc  
hromatography on 
silica gel column. Elution with hexane-EtOAc (1:3) gave product diol (930 mg, 88%, dr ~15:1). 
L saturated aqueous NaCl and dried over 
Na2SO4. The solution was concentrated under reduced pressure to afford a residue. 
The residue was redissolved in 35 mL CH2Cl2 at 0 °C. Into the solution 5.5 mL Et3N was slowly 
 stirred at RT for 
another 2 hr. Then it was cooled down to 0 °C, diluted with hexane-Et2O (1:1 v/v) 130 mL and 
quenched by 50 mL 0.5 M NaHSO4.  The aqueous layer was then extracted with hexane-Et2O 
(1:1 v/v) 150 mL X 2. The pooled organic layer was washed with 20 mL 0.5 M NaHSO4, 20 mL 
saturated aqueous  NaHCO3, 20 mL saturated aqueous  NaCl and dried over Na2SO4. The 
solution was concentrated under reduced pressure to afford a residue, which was subjected to 
A 2.03 g sample of bisketal II-19b (7.86 mmol) was placed in 250 mL flask, a 5 mL solution of 
TFA/H2O (5:1 v/v) was added into the flask at RT when stirring. The mixture was continued to 
be stirred at RT for 15 min, then cooled down to 0 °C and diluted with 50 mL EtOAc, into which 
20 mL saturated aqueous  NaHCO3, as well as 10 g NaHCO3 (s) was slowly added to quench the 
reaction. The mixture was run through a pad of sand-silica gel-celite, rinsing with EtOAc-MeOH 
(10:1, v/v), and the effluent was dried over Na2SO4. The solution was concentrated under 
reduced pressure to give a residue. Crude 1H NMR showed that a little isomerization on the α-
methyl group happened with dr ratio 25:1. The residue was then subjected to c
930 mg diol (6.46 mmol, dr ~15:1) was dissolved in 32 mL THF-CH2Cl2 (v/v 1:1) at RT, into 
which 73 mg DMAP was added in, followed by addition of a solution of 5.0 g Boc2O (22.9 
mmol) in 5 mL CH2Cl2. The mixture was stirred at RT for 2 hr, then it was cooled down to 0 °C, 
diluted with Et2O 30 mL and quenched by 15 mL saturated aqueous  NaHCO3.  The mixture was 
stirred at 0 °C for another 2 hr and then was extracted with Hexane-Et2O (1:2 v/v) 150 mL X 2. 
The pooled organic layer was washed with 15 m
added in. The mixture was then stirred at 0 °C overnight and continued to be
chromatography on silica gel column. Elution with hexane-EtOAc (10:1 v/v) gave enone II-20 
(1.23g, 84% overall for two steps, 40% with dr >25:1 and 44% with dr ~8:1 ). 
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II-20: White solid; mp: 64.7-66.1 °C, Rf = 0.45 (4:1 (v/v) hexane/EtOAc); [α]D20 +42 (c 4.23, 
CHCl3); IR (thin film, cm-1) υ 2982, 2948, 1733, 1683, 1618, 1479, 1457, 1366, 1336, 1275, 
1252, 1153, 1098, 1082, 974; 1H NMR (CDCl3, 270 MHz) δ 6.81 (ddd, J = 10.2, 2.4, 1.8 Hz, 
1H), 5.99 (dd, J = 9.0, 2.4 Hz, 1H), 5.46 (dddd, J = 10.8, 5.4, 2.4, 2.4 Hz, 1H),  2.43 (m, 2H), 
1.84 (ddd, J = 14.4, 12.6, 10.4 Hz, 1H), 1.5 (s, 9H), 1.15 (d, J = 6.0 Hz, 3H), 13C NMR (CDCl3, 
67.5 MHz) δ 200.0, 152.7, 147.9, 130.0, 82.9, 71.7, 39.9, 37.5, 27.7, 14.8; HRMS (ESI) calcd. 
for [C12H18O4+H]+: 227.12779, Found: 227.12780. 
 
t-Butyl (1R,4R,5S)-4-hydroxy-5-methylcyclohex-2-enyl carbonate (II-20a) 
OBoc
OH
 
To a solution of 545 mg enone II-20 (2.41mmol, dr 10:1) in 35 mL THF at -78 °C was added 
200 mg LiAlH4 (5.26 mmol) in several portions. The reaction mixture was stirred at -78 °C for 
30 min, then 2 mL acetone was added dropwise in at -78 °C and the mixture was stirred for 
nother 20 min to quench the reaction. Then it was diluted with Et2O 150 mL and 50 mL 
saturated aqueous NH4Cl was added. The mixture was stirred at 0 °C for 15 min then aqueous 
nic layer was washed with 20 mL 
saturated aqueous NH4Cl, 20 mL saturated brine, dried over Na2SO4. The solution was 
concentrated under reduced pressure to give a residue. Crude 1H NMR showed that there was 
three isomers with diastereomeric ratio 11:1:1.1. The two minor isomers were easily removed by 
chromatography on silica gel column, elution with hexane-EtOAc (5:1) afforded allylic alcohol 
1H), 5.73 (ddd, J = 10.2, 3.6, 1.8 Hz, 1H), 5.04 (dddd, J = 9.6, 7.2, 2.4, 1.8 Hz, 1H), 3.85 (ddd, J 
a
layer was extracted with Et2O 200 mL X 2. The pooled orga
II-20a (450 mg, 82%). 
II-20a: White solid; mp: 100.2-101.7 °C; Rf = 0.15 (4:1 v/v hexane/EtOAc); [α]D20 +95 (c 1.90, 
CHCl3); IR (thin film, cm-1) υ 3515, 2977, 2941, 2878, 1713, 1458, 1396, 1351, 1366, 1334, 
1284, 1257, 1153, 1076, 1054, 956; 1H (CDCl3, 600 MHz) δ 5.80 (ddd, J = 10.2, 2.4, 1.8 Hz, 
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= 9.0, 4.8, 2.4 Hz, 1H), 2.13 (dddd, J = 12.6, 5.4, 2.4, 1.8 Hz, 1H), 1.65 (dddd, J = 12.0, 9.6, 6.6, 
3.0 Hz, 1H), 1.49 (s, 9H), 1.45 (ddd, J = 13.2, 13.2, 10.2 Hz, 1H), 1.12 (d, J = 6.6 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz) δ 153.1, 134.4, 128.4, 82.2, 73.3, 72.8, 37.3, 35.8, 27.8, 18.2; HRMS 
(ESI) calcd. for [C12H20O4+Na]+: 251.12538, Found: 251.12550. 
 
t-Butyl (1S,5S)-5-methylcyclohex-3-enyl carbonate (II-21) 
OBoc  
To a solution of 312 mg allylic diol II-20a (1.37 mmol) in 6 mL N-methylmorpholine at -25 °C 
was added 1.07 g (4.1 mmol) PPh3, followed by dropwise ad
 
dition of 0.81 mL DIAD, the 
mixture was stirred at -25 °C for 10 min, then 889 mg NBSH (4.1 mmol,  o-
itrobenzenesulfonylhydrazide) was added in.  It was stirred at -25 °C for 2 hr and then was 
warmed up and stirred at RT for another 2 hr. The reaction mixture was diluted with 120 mL 
2 4
t2O (1:1 v/v) 120 mL X 2. The pooled organic layer was washed with 30 
mL 0.5 M NaHSO4 again, then with 20 mL saturated aqueous NaHCO3, 20 mL saturated brine, 
dried over Na2SO4. The organic layer was concentrated under reduced pressure to give crude 
product, which was then subjected to chromatography on silica gel. Elution with hexane-EtOAc 
(20:1 v/v) gave olefin II-21 (260 mg, 89%). 
20
(ESI) calcd. for [C12H20O3+Na] : 235.13047, Found: 235.13049. 
n
hexane-Et O (1:1 v/v) and washed at 0 °C with 30 mL 0.5 M NaHSO . The aqueous layer was 
extracted with hexane-E
II-21: Colorless oil; Rf = 0.69 (4:1 v/v hexane/EtOAc); [α]D  -55 (c 0.89, CHCl3); IR (thin film, 
cm-1) υ 3024, 2958, 2934, 2873, 1736, 1476, 1457, 1393, 1368, 1313, 1300, 1275, 1249, 1159, 
1097, 1066, 983; 1H NMR (CDCl3, 600 M): 5.53 (dddd, J = 9.6, 4.8, 2.4, 2.4 Hz, 1H), 5.47 
(dddd, J = 10.2, 3.0, 3.0, 1.2 Hz, 2H), 4.77 (dddd, J = 12.0, 9.6, 6.0, 3.6 Hz, 1H), 2.41 (m, 2H), 
2.10 (m, 1H), 1.49 (s, 9H), 1.29 (ddd, J = 12.0, 12.0, 12.0 Hz, 1H), 1.02 (d, J = 7.2 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz) δ 153.1, 133.2, 122.7, 81.8, 73.4, 37.2, 31.0, 30.9, 27.8, 21.3; HRMS 
+
90 
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t-Butyl (3aR,4S,6R,7aS)-hexahydro-2,2,4-trimethylbenzo[d][1,3]dioxol-6-yl carbonate (II-
22) 
OBoc
O
O
 
To a solution of 138 mg olefin II-21 (0.65 mmol) in 3 mL t-BuOH-Actone-50% NMO (aq.) 
33 mmol) at 0 °C for 2hr.  It was diluted with 40 mL hexane-
t2O (1:1 v/v) and quenched with 3 mL saturated aqueous NaHCO3 at 0 °C.  The aqueous layer 
was extracted with hexane-Et2O (1:1 v/v) 40 mL X 2. The pooled organic layer was washed with 
. The solution was concentrated under reduced pressure 
to give a residue. The minor diastereomer was easily removed by chromatography on silica gel 
column, elution with hexane-EtOAc (25:1) afforded acetonide II-22 (155 mg, 83%). 
II-22: Colorless oil; Rf  = 0.51 (4:1 (v/v) hexane-EtOAc); [α]D20 +23 (c 1.74, CHCl3); IR (thin 
film, cm-1) υ 2982, 2933, 2874, 1736, 1459, 1368, 1276, 1242, 1218, 1156, 1101, 1065, 1042, 
(1:1:1 v/v/v) was added a small piece of crystalline OsO4 at 0 °C. The reaction mixture was 
stirred at 0 °C for overnight, then 3 mL saturated aqueous  Na2S2O4 was added and it was stirred 
at 0 °C for another 3 hr.  The reaction mixture was passed through a pad of sand-silica gel-celite, 
rinsing with EtOAc. The effluent was dried over Na2SO4 and concentrated under reduced 
pressure to give a residue. Crude 1H-NMR showed that the diastereoselectivity is 11:1. The 
residue was subjected to chromatography on silica gel column, eluting with hexane-EtOAc (1:1.5) 
gave inseparable mixture of diol (156 mg, 95%, dr 11:1). 
A 160 mg sample of diol (0.65 mmol, dr 11:1) was treated with 1 mL dimethoxypropane in the 
presence of 6.3 mg p-TsOH (0.0
E
3 mL saturated brine, dried over Na2SO4
975; 1H NMR (CDCl3, 600 MHz) δ 4.84 (dddd, J = 10.8, 10.8, 4.2, 4.2 Hz, 1H), 4.31 (ddd, J = 
4.8, 4.8, 2.4 Hz, 1H), 3.55 (dd, J = 9.0, 4.8 Hz, 1H), 2.44 (dddd, J = 14.4, 5.4, 3.0, 3.0 Hz, 1H), 
1.96 (ddd, J = 12.6, 6.6, 3.6 Hz, 1H), 1.78 (ddd, J = 15.0, 10.8, 4.8 Hz, 1H), 1.73 (ddqd, J = 10.2, 
10.2, 6.6, 3.6 Hz, 1H), 1.48 (s, 9H), 1.45 (s, 3H), 1.33 (s, 3H), 1.09 (ddd, J = 12.6, 12.6, 10.2 Hz, 
1H), 1.03 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 152.9, 108.4, 82.1, 80.4, 73.9, 
71.8, 36.5, 33.5, 32.6, 28.5, 27.8, 26.1, 18.7; HRMS (ESI) calcd. for [C15H26O5P+Na]+: 
309.16725,  Found: 309.16729. 
 
5a-Carba-β-D-digitoxopyranose (II-8) 
 
To a solution of 16 mg carbonate II-22 (0.06 mmol) in 2 mL THF at 0 °C was added 16 mg 
LiAlH4 (0.42 mmol). The reaction mixture was warmed up and stirred at RT for 1 h, then it was 
diluted with 5 mL EtOAc and 1.5 mL saturated aqueous NaHCO3 was added. It was stirred for 
another 20 min to quench the reaction and then the mixture was passed through a pad of sand-
lica gel-celite, eluting with EtOAc. The effluent was dried over Na2SO4. The solution was 
residue was redissolved in 1.5 mL 
THF-10%HCl (1:1 v/v) and the mixture was stirred at room temperature for 30 min. It was then 
cooled down to 0 °C, and diluted with 5 mL EtOAc, then 1 mL saturated aqueous NaHCO3 and 
250 mg NaHCO3 (s) was slowly added to quench the reaction. The mixture was concentrated to a 
residue, which was directly loaded to a silica gel column. Elution with EtOAc-MeOH (20:1) 
gave cyclitol II-8 (7 mg, 85%) as colorless oil; Rf  = 0.44 (5:1 (v/v) EtOAc-MeOH); [α]D20 +33 (c 
si
concentrated under reduced pressure to give a residue. The 
0.64, CHCl3); IR (thin film, cm-1) υ 3353, 2975, 2950, 2930, 1454, 1417, 1370, 1307, 1184, 1141, 
1094, 1047, 980; 1H NMR (CD3OD, 600 MHz) δ 3.95 (ddd, J = 3.0, 3.0, 2.4 Hz, 1H), 3.94 (dddd, 
J = 11.4, 11.4, 4.2, 4.2 Hz, 1H), 3.06 (dd, J = 10.2, 3.0 Hz, 1H), 2.11 (dddd, J = 13.2, 3.6, 3.6, 
3.0 Hz, 1H), 1.88 (dddd, J = 12.0, 3.6, 3.6, 2.4 Hz, 1H), 1.83 (ddqd, J = 10.2, 10.2, 6.6, 3.6 Hz, 
1H), 1.39 (ddd, J = 13.2, 11.4, 2.4 Hz, 1H), 1.01 (ddd, J = 12.6, 12.6, 11.4 Hz, 1H), 1.00 (d, J = 
6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 78.3, 71.7, 66.1, 43.4, 41.5, 32.4, 19.2; HRMS 
(ESI) calcd. for [C7H14O3–H]–: 145.0870, Found: 145.0871. 
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)-4,5-dihydroxy-2-methylcyclohexanone (II-23) 
 
(2R,4R,5R
OH
O
CH3
HO
 
A 500 mg sample of bisketal II-19a (1.94 mmol, dr ~10:1) was placed in 250 mL flask at 0 °C, 
and 3.7 mL solution of TFA/H2O (5:1 v/v) was added into the flask at 0 °C when stirring. The 
mixture was stirred at 0 °C for 20 min, then was diluted with 30 mL EtOAc, into which 10 mL 
saturated aqueous NaHCO3, as well as 6 g NaHCO3 (s) was slowly added to quench the reaction. 
The mixture was run through a pad of sand-silica gel-celite, rinsing with EtOAc-MeOH (10:1, 
/v), and the effluent was dried over Na2SO4. The solution was concentrated under reduced 
1 ation on the α-methyl 
group happened, which lower the dr to ~8:1. The residue was then purified by silica gel column. 
Elution with hexane-EtOAc (1:3) gave pure diol II-23 (195 mg, 70%) with the minor isomer 
removed. 
II-23: White solid; mp: 67.9-69.2 °C; Rf = 0.50 (10:1 (v/v) EtOAc/MeOH); [α]D20 -13 (c 2.6, 
CHCl ); IR (thin film, cm-1) υ 3373, 3280, 2969, 2924, 1694, 1437, 1421, 1399, 1380, 1276, 
v
pressure to give a residue. Crude H NMR showed that a little isomeriz
3
1229, 1165, 1123, 1094, 1071, 1032, 967; 1H NMR (CDCl3, 600 MHz) δ 4.19 (dddd, J = 4.8, 4.2, 
3.6, 3.2 Hz, 1H), 4.02 (dddd, J = 4.2, 3.6, 3.6, 3.6 Hz, 1H), 2.91 (ddd, J = 14.4, 3.6, 0.6 Hz, 1H), 
2.78 (ddq, J = 7.8, 7.2, 6.6 1H), 2.42 (dd, J = 14.4, 4.8 Hz, 1H), 2.14 (d, J = 3.0 Hz, 1H), 2.07 (d, 
J = 3.6 Hz, 1H), 2.00 (dd, J = 8.4, 4.2 1H), 1.99 (dd, J = 8.4, 3.6 1H), 1.08 (d, J = 6.6 Hz, 1H); 
13C NMR (CDCl3, 150 MHz) δ 211.9, 74.0, 69.0, 44.5, 40.1, 36.9, 14.7; HRMS (ESI) calcd. for 
[C7H12O3+H]+: 145.0859, Found: 145.0859. 
 
t-Butyl (1R,5R)-5-methyl-4-oxocyclohex-2-enyl carbonate ((ent)-II-15) 
OBoc
O
CH3
 
142 mg diol II-23 (1.0 mmol) was dissolved in 7.5 mL THF-CH2Cl2 (1:2 v/v) at RT, into which 
12 mg DMAP (0.1 mmol) was added in, followed by addition of a solution of 870 mg Boc2O (4 
mmol) in 2.5 mL CH2Cl2. The mixture was stirred at RT for 2 h, then it was cooled down to 0 °C, 
diluted with Et2O 30 mL and was then quenched with 7 mL saturated aqueous NaHCO3.  The 
mixture was stirred at 0 °C for another 2 h and then was extracted with Hexane-Et2O (1:2 v/v) 30 
mL x 2. The pooled organic layer was washed with 7 mL saturated aqueous NaCl and dried over 
Na2SO4. The solution was concentrated under reduced pressure to afford a residue. The residue 
was redissolved in 6.5 mL CH2Cl2 at 0 °C. Into the solution 1.0 mL Et3N (5 mmol) was slowly 
dded in. The mixture was then stirred at 0 °C overnight and continued to be stirred at RT for 
another 2 h. Then it was cooled back to 0 °C, diluted with hexane-Et2O (1:1 v/v) 40 mL and it 
The aqueous layer was extracted with 
hexane-Et2O (1:1 v/v) 40 mL x 2. The pooled organic layer was washed with 10 mL 0.5 M 
NaHSO4 at 0 °C, then was washed with 10 mL saturated aqueous NaHCO3, 10 mL saturated 
aqueous NaCl and dried over Na2SO4. The solution was concentrated under reduced pressure to 
afford a residue, which was purified by silica gel colum . Elution with hexane-EtOAc (10:1 v/v) 
gave enone (ent)-II-15 (200 mg, 90%) as white solid; mp: 37.5-38.9 °C; Rf = 0.44 (4:1 (v/v) 
9, 152.9, 
E +
a
was then quenched by 10 mL 0.5 M NaHSO4 at 0 °C. 
n
hexane/EtOAc); [α]D20 +168 (c 1.0, CHCl3); IR (thin film, cm-1) υ 2980, 2935, 2875, 1735, 1684, 
1459, 1369, 1341, 1272, 1252, 1155, 1080, 1044, 965; 1H NMR (CDCl3, 600 MHz) δ 6.86 (dd, J 
= 10.2, 4.2 Hz, 1H), 6.03 (d, J = 10.2 Hz, 1H), 5.29 (ddd, J = 4.8, 4.8, 4.2 Hz, 1H), 2.76 (dqd, J = 
10.2, 7.2, 5.4 Hz, 1H), 2.25 (dddd, J = 14.4, 4.8, 4.8, 0.6 Hz, 1H), 2.06 (ddd, J = 14.4, 9.6, 4.8 
Hz, 1H), 1.49 (s, 9H), 1.15 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 200.
143.3, 131.2, 82.9, 68.1, 37.7, 35.4, 27.7, 14.9; HRMS ( SI) calcd. for [C12H18O4+Na] : 
249.1097, Found: 249.1097. 
 
(1R,3R,4S,6S)-bicyclo[4.1.0]heptane-1,3,4-triol (II-24) 
94 
 
HO
95 
 
HO
OH
H
 
L THF-10%HCl (1:1 v/v) and 
stirred at room temperature for 15 min. The mixture was cooled down to 0 °C, and diluted with 
70 mL EtOAc, then ~5 g NaHCO3 (s) was slowly added to quench the reaction. The mixture was 
filtered through a glass wool and the liquid was concentrated to a residue which was loaded to a 
silica gel column. Elution with EtOAc-MeOH (10:1 v/v) gave triol II-24 (1.0 g, 82%).  
A solution of 1.39 g (7.5 mmol) of II-9b was dissolved in 6 m
II-24: Colorless oil; Rf = 0.38 (5:1 (v/v) EtOAc/MeOH); [α]D20 0.71 (c 7.03, MeOH); IR (thin 
film, cm-1) υ 3304, 3009, 2924, 1432, 1362, 1276, 1218, 1183, 1093, 1045, 914; 1H NMR 
(CD3OD, 600 MHz) δ 3.82 (ddd, J = 5.4, 5.4, 2.4 Hz, 1H), 3.70 (ddd, J = 7.8, 5.4, 1.8 Hz, 1H), 
2.36 (ddd, J = 14.4, 6.0 Hz, 1H), 2.11 (dd, J = 14.4, 5.4 Hz, 1H), 2.09 (ddd, J = 13.8, 8.4, 6.0 Hz, 
1H), 1.64 (ddd, J = 14.4, 8.4, 1.8 Hz, 1H), 0.97 (dddd, J = 10.2, 8.4, 8.4, 2.4 Hz, 1H), 0.80 (m, 
2H); 13C NMR (CD3OD, 150 MHz) δ 70.5, 70.3, 53.5, 38.3, 29.7, 21.9, 18.9; HRMS (ESI): calcd. 
for [C7H12O3+Na]+: 167.06787, Found: 167.06785. 
 
(2R,4S,5R)-4,5-dihydroxy-2-methylcyclohexanone (II-25) 
HO
OH
O
 
Into a solution of 200 mg (1.39 mmol) cyclopropanol II-24 in 4.5 mL THF-EtOH (1:1 v/v) was 
added 80 mg 10% Pd/C. The solution was degassed using vacuum and refilled with H2 three 
times at low temperature (~-30 °C). Then at room temperature, the solution was stirred 5 hr 
under balloon pressure of H2.  It was filtered through a filter paper and rinsed with ethyl acetate.  
The solution was concentrated under reduced pressure to a small volume (some of the solution 
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was taken out and concentrated to dry, then a crude NMR was taken to show that NO 
diastereomer was seen). The residue was subjected to chromatography on silica gel column. 
Elution with hexane-EtOAc (1:4) gave product II-25 (160 mg, 80%).  
II-25: White solid; mp: 76-78 °C; Rf = 0.55 (5:1 (v/v) EtOAc/MeOH); [α]D20 -19 (c 1.47, MeOH); 
IR (thin film, cm-1) υ 3366, 2940, 2918, 2863, 1696, 1447, 1405, 1380, 1315, 1244, 1213, 1160, 
1097, 1036, 1008, 973, 937; 1H NMR (CDCl3, 600 MHz) δ 4.26 (ddd, J = 5.4, 3.0, 3.0 Hz, 1H), 
4.13 (ddd, J = 11.4, 4.2, 2.4 Hz, 1H),  3.83 (brs, 1H), 3.66 (brs, 1H), 2.55 (ddd, J = 14.4, 3.0, 0.6 
Hz, 1H), 2.51 (dd, J = 15.0, 3.6 Hz, 1H), 2.43 (dqd, J = 12.6, 6.6, 6.0 Hz, 1H), 2.03 (dddd, J = 
12.0, 6.0, 4.8, 1.8 Hz, 1H), 1.82 (ddd, J = 12.6, 12.6, 12.0 Hz, 1H), 0.99 (d, J = 6.0 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz) δ 211.3, 72.1, 70.0, 45.8, 41.8, 36.3, 14.2; HRMS (ESI): calcd. for 
[C7H12O3+H]+: 145.08592,  Found: 145.08589. 
X-Ray Crystal data: Empirical formula C7H12O3; formula weight 144.17; 
Temperature 293(2) K; wavelength 0.71073Å; crystal system monoclinic; space group P21; uni 
cell dimensions a=5.7707(9)Å, b=8.6125(13)Å, c=7.7163(12)Å, α=90º, β=105.997(3)º, γ=90º; 
volume 368.6(1) Å3; Z=2; density (calculated) 1.299 g/cm3; absorption coefficient 1.01cm-1; 
F(000) 156; crystal size 0.16 X 0.18 X 0.50 mm; θ range for data collection 3.63 to 27.50º; index 
ranges -7≤ h≤ 7, -11≤k≤10, -9≤l≤10; reflections collected 2356; independent reflections 1230 
[R(int)=0.0318]; completeness to θ=27.50º 96.7%; refinement method Full-matrix least-squares 
on F2; data/restraints/parameters 1230/1/94; goodness-of-fit on F2 1.022; final R indices [I>2σ(I)] 
R1=0.0460, wR2=0.1213; R indices (all data) R1=0.0494, wR2=0.1253; absolute structure 
parameter -0.3(15); largest diff. peak and hole 0.364 and -0.178 e/Å3. 
 
(4S,6R)-4-hydroxy-6-methylcyclohex-2-enone (II-12b) 
OH
O
 
A solution of 1.88 g diol II-25 (13.1 mmol) in 70 mL CH2Cl2 was added 159 mg (1.31 mmol) 
DMAP at 0 °C, then 7.9 mL (9.80 mmol) pyridine was injected in. Then a solution of 3.8 g (13.1 
mmol) triphosgene in 20 mL CH2Cl2 was slowly injected in at 0 °C. The reaction mixture was 
stirred at 0 °C for 1 hr. The solution was then diluted with 150 mL hexane-EtOAc (1:2 v/v), and 
r another 1 hour.  Then the mixture was diluted 
with hexane-EtOAc (1:1 v/v) 200 mL and cooled down to 0 °C, then was quenched with 25 mL 
.5 M NaHSO4 at 0 °C.  The aqueous layer was then extracted with hexane-EtOAc (1:1 v/v) 150 
4 at 0 °C again, then it 
was washed with 25 mL saturated aqueous NaHCO3, 25 mL saturated aqueous NaCl, dried over 
Na2SO4. Concentration of the solution under reduced pressure gave a residue, which was purified 
by silica gel column. Elution with hexane-EtOAc (2:3, v/v) gave product allylic alcohol II-12b 
(1.2 g, 73%). 
II-12b: Colorless oil; Rf = 0.40 (1:2 (v/v) hexane/EtOAc); [α]D20 -65 (c 2.38, CHCl3); IR (thin 
film, cm-1) υ 3406, 3036, 2968, 2934, 2870, 1668, 1457, 1376, 1252, 1214, 1182, 1100, 1067, 
added 25 mL 0.5 M NaHSO4, it was stirred for ~10 min at 0 °C. The aqueous layer was then 
extracted with hexane-EtOAc (1:2 v/v) 150 mL X 2. The pooled organic layer was washed with 
25 mL 0.5 M NaHSO4 at 0 °C, then washed with 20 mL saturated aqueous NaHCO3, 20 mL 
saturated aqueous NaCl, dried over Na2SO4. Concentration of the solution under reduced 
pressure gave a residue. Then the residue was redissolved in 50 mL CH2Cl2 at 0 °C, into which 
7.2 mL (52.2 mmol) Et3N was added slowly. The mixture was stirred overnight at 0 °C and 
continued to be stirred at room temperature fo
0
mL X 2. The pooled organic layer was washed with 25 mL 0.5 M NaHSO
1027, 952; 1H NMR (CDCl3, 270 MHz) δ 6.87 (ddd, J = 10.2, 1.8, 1.8 Hz, 1H), 5.96 (dd, J = 
10.2, 2.4 Hz, 1H), 4.64 (d, J = 8.4 Hz, 1H),  2.40 (dqd, J = 13.2, 6.6, 4.8 Hz, 1H), 2.37 (dddd, J = 
12.0, 5.4, 4.8, 2.4 Hz 1H), 1.73 (ddd, J = 13.8, 13.2, 10.8 Hz 1H), 1.16 (d, J = 6.6 Hz, 3H), 13C 
NMR (CDCl3, 150 MHz) δ 201.2, 152.9, 128.7, 67.4, 41.4, 40.1, 14.9; HRMS (ESI) calcd. for 
[C7H10O2+H]+: 127.07536, Found: 127.07535. 
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 (1R,5R)-5-methyl-4-oxocyclohex-2-enyl 4-nitrobenzoate (II-26) 
O
O
O
NO2
 
To a solution of 710 mg allylic diol II-12b (5.6 mmol) in 40 mL THF at 0 °C was injected a 
solution of 1.14 g (6.8 mmol) p-nitrobenzoic acid in 10 mL THF, followed by a injection of a 
solution of 1.79 g PPh3 (6.8 mmol) in 10 mL THF. Then at 0 °C 1.65 mL (7.1 mmol) DIAD was 
added dropwise. The mixture was stirred at 0 °C for 1 hr. The mixture was diluted with 150 mL 
hexane-Et2O (1:2 v/v) and was washed with 15 mL 0.5 M NaHSO4 at 0 °C. The aqueous layer 
as extracted with hexane-Et2O (1:2 v/v) 120 mL X 2 at 0 °C. The pooled organic layer was 
ed over Na2SO4. The 
organic layer was concentrated under reduced pressure to give crude product, which was then 
subjected to chromatography on silica gel column. Elution with hexane-EtOAc (7:1 v/v) gave 
ester II-26 (1.28g, 95%). 
II-26: Pale yellow solid; mp: 119-120.5 °C; Rf = 0.42 (3:1 (v/v) hexane/EtOAc); [α]D20 +265 (c 
6.24, CHCl3); IR (thin film, cm-1) υ 3112, 3086, 2992, 2970, 2933, 2874, 1718, 1676, 1607, 1523, 
1343, 1321, 1274, 1222, 1205, 1099, 1063, 1045, 1009, 931; 1H NMR (CDCl , 600 MHz) δ 8.31 
(1R,4S,5R)-4-hydroxy-5-methylcyclohex-2-enyl 4-nitrobenzoate (II-27) 
w
washed with 20 mL saturated aqueous NaHCO3, 20 mL saturated brine, dri
3
(d, J = 9.0 Hz, 1H), 8.22 (d, J = 8.4 Hz, 1H), 6.95 (dd, J = 10.2, 4.2 Hz, 1H), 6.16 (d, J = 10.2 Hz, 
1H), 5.78 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.85 (dqd, J = 12.0, 7.2, 2.4 Hz, 1H), 2.37 (ddd, J = 
13.8, 4.8, 4.8 Hz 1H), 1.73 (ddd, J = 14.4, 10.2, 4.2 Hz 1H), 1.25 (d, J = 7.2 Hz, 3H), 13C NMR 
(CDCl3, 150 MHz) δ 200.6, 164.1, 150.8, 142.6, 135.1, 132.0, 130.9, 123.7, 67.3, 37.9, 35.5, 
15.0; HRMS (ESI) calcd. for [C14H13NO5+Na]+: 298.06859, Found: 298.06865. 
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OH
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O
NO2
O  
To a solution of 1.28 g ester II-26 (4.64 mmol) in 60 mL THF at -78 °C was slowly added 330 
mg (8.68 mmol) LiAlH4 in portions. The reaction mixture was stirred at -78 °C for 30 min, then 
6 mL acetone was added dropwise in at -78 °C to quench the reaction, which was stirred at -
78 °C for 30 min. It was then diluted with 360 mL hexane-EtOAc (1:5 v/v) and slowly 30 mL 
saturated aqueous NH4Cl was added in. It was then allowed to stir at 0 °C for 20 min. The 
organic layer was washed again with 30 mL saturated aqueous NH4Cl, then washed with 30 mL 
saturated brine, dried over Na2SO4. The solution was concentrated under reduced pressure to 
ive a residue. A crude 1H NMR showed that the diastereoselectivity is 11:1. The residue was 
allylic alcohol II-27 (1.16 g, 91%). 
II-27: White solid; mp: 77.2-78.5 °C; Rf = 0.55 (1:1 (v/v) hexane/EtOAc); [α]D20 +197 (c 3.52, 
CHCl3); IR (thin film, cm-1) υ 3272, 3113, 3039, 2959, 2909, 2889, 1717, 1607, 1521, 1460, 
1338, 1270, 1116, 1101, 1056, 1038, 1009, 958, 903; 1H NMR (CDCl3, 600 MHz) δ 8.30 (d, J = 
9.0 Hz, 1H), 8.20 (d, J = 9.6 Hz, 1H), 6.05 (dd, J = 10.2, 2.4 Hz, 1H), 5.92 (dddd, J = 10.2, 4.2, 
g
subjected to chromatography on silica gel column and elution with hexane-EtOAc (4:1) afforded 
1.8, 1.8 Hz, 1H), 5.47 (ddd, J = 6.0, 4.2, 1.8 Hz, 1H), 3.81 (ddd, J = 9.0, 3.6, 2.4 Hz, 1H), 2.01 
(dddd, J = 15.0, 3.0, 1.8, 1.8 Hz 1H), 1.92 (ddqd, J = 12.0, 9.0, 6.6, 3.0 Hz 1H), 1.71 (ddd, J 
=14.4, 12.0, 4.2 Hz 1H), 1.14 (d, J = 6.6 Hz, 3H), 13C NMR (CDCl3, 150 MHz) δ 164.2, 150.5, 
137.5, 135.8, 130.7, 125.0, 123.5, 73.1, 68.2, 34.3, 32.9, 18.1; HRMS (ESI) calcd. for 
[C14H15NO5+Na]+: 300.08424, Found: 300.08421. 
 
(1R,2R,3R,4S,5R)-2,3,4-trihydroxy-5-methylcyclohexyl-4-nitrobenzoate (II-28) 
OPNBz
OH
CH3HO
HO
 
To a solution of 30 mg olefin II-27 (0.11 mmol) in 1.5 mL t-BuOH-actone-50% NMO(aq.) (1:1:1 
sO4 at 0 °C. The reaction mixture was stirred at 
0 °C for overnight, then 1.5 mL saturated aqueous Na2S2O3 was added and it was stirred at 0 °C 
for another 2 h.  The reaction mixture was passed through a pad of sand-silica gel-celite, rinsing 
with EtOAc-MeOH (10:1, v/v). The effluent was dried over Na2SO4 and concentrated under 
reduced pressure to give a residue, which was purified by silica gel column. Elution with EtOAc-
MeOH (20:1) gave triol II-28 (32 mg, 94%) as white solid; mp: 203-204 °C; Rf = 0.20 (1:2 (v/v) 
14
v/v/v) was added a small piece of crystalline O
hexane/EtOAc); [α]D20 -33 (c 0.54, MeOH); IR (thin film, cm-1) υ 3351, 2925, 1715, 1608, 1525, 
1408, 1346, 1314, 1275, 1159, 1122, 1102, 1078, 1052, 1009, 952; 1H NMR (CD3OD, 600 MHz) 
δ 8.33 (d, J = 9.0 Hz, 2H); 8.22 (d, J = 9.0 Hz, 2H); 5.20 (ddd, J = 4.2, 2.4, 2.4 Hz, 1H), 4.05 (dd, 
J = 3.0, 3.0 Hz, 1H), 3.65(dd, J = 9.6, 3.6 Hz, 1H), 3.39 (dd, J = 9.6, 9.6 Hz, 1H), 1.82 (m, 3H), 
1.07 (d, J = 6.0 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 165.2, 152.3, 137.0, 131.9, 124.9, 76.3, 
75.4, 74.8, 72.0, 34.1, 33.1, 18.5; HRMS (ESI) calcd. for [C H17O7+Na]+:334.0897, Found: 
334.0896. 
 
5a-Carba-α-L-rhamnopyranose ((ent)-II-7) 
OH
OH
CH3HO
HO
 
To a solution of 25 mg ester II-28 (0.08 mmol) in 1.5 mL MeOH was added 3.0 mg LiOH (0.12 
mmol) at RT. The reaction mixture was stirred at RT for 4 h. Then 0.5 mL saturated aqueous 
NH4Cl was added. This small amount of mixture was directly loaded onto a silica gel column. 
Elution with EtOAc-MeOH (10:1) afforded cyclitol (ent)-II-7 (11mg, 85%) as colorless oil; Rf = 
100 
 
0.28 (5:1 (v/v) EtOAc/MeOH); [α]D20 +11 (c 0.65, MeOH); IR (thin film, cm-1) υ 3297, 2922, 
1455, 1406, 1377, 1296, 1239, 1186, 1153, 1050, 1002, 964; 1H NMR (CD3OD, 600 MHz) δ 
3.87 (dd, J = 3.6, 3.6 Hz, 1H), 3.83 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 3.62 (dd, J = 9.6, 3.0 Hz, 1H), 
3.26 (dd, J = 10.2, 9.6 Hz, 1H), 1.78 (ddqd, J = 9.6, 9.6, 6.6, 6.6 Hz, 1H), 1.59 (m, 2H), 1.01 (d, 
J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 76.9, 75.0, 74.3, 71.1, 35.9, 33.1, 18.6; HRMS 
(ESI) calcd. for [C7H14O4+Na]+:185.0784,  Found: 185.0784.  
 
(4S,6S)-4-hydroxy-6-methylcyclohex-2-enone (II-38) 
OH
O
 
A solution of 234 mg diol II-13 (1.63 mmol) in 8.5 mL CH2Cl2 was added 19 mg (0.16 mmol) 
DMAP at 0 °C, then 0.46 mL (5.69 mmol) pyridine was slowly added via syringe. Then a 
solution of 250 mg (0.81 mmol) triphosgene in 2 mL CH Cl  was slowly injected in at 0 °C. The 
2 2
3 rnight at 0 °C and continued to 
e stirred at room temperature for another 1 hour.  Then the mixture was diluted with EtOAc 120 
mL EtOAc, and cooled down to 0 °C then was quenched with 20 mL 0.5 M NaHSO4 at 0 °C. 
pooled organic layer was 
washed with 15 mL saturated aqueous NaHCO3, 15 mL saturated aqueous NaCl, dried over 
Na2SO4. Concentration of the solution under reduced pressure gave a residue, which was purified 
by silica gel column. Elution with hexane-EtOAc (3:2, v/v) gave product allylic alcohol II-38 
(150 mg, 73%) 
2 2
reaction mixture was stirred at 0 °C for 2 hr. The solution was then diluted with 80 mL EtOAc, 
and quenched with 8 mL 0.5 M NaHSO4. The aqueous layer was then extracted with EtOAc 50 
mL X 2. The pooled organic layer was washed with 10 mL saturated aqueous NaHCO3, 10 mL 
saturated aqueous NaCl, dried over Na2SO4. Concentration of the solution under reduced 
pressure gave a residue. Then the residue was redissolved in 6.5 mL CH Cl  at 0 °C, into which 
0.8 mL (5.8 mmol) Et N was added. The mixture was stirred ove
b
The aqueous layer was then extracted with EtOAc 50 mL X 2. The 
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II-38: Colorless oil; Rf = 0.40 (1:2 (v/v) hexane/EtOAc); [α]D20 -145 (c 1.72, CHCl3); IR (thin 
film, cm-1) υ 3412, 3036, 2967, 2934, 2875, 1664, 1454, 1380, 1252, 1056; 1H NMR (CDCl3, 
270 MHz) δ 6.86 (dd, J = 10.1, 3.9 Hz, 1H), 5.96 (dd, J = 10.1, 1.0 Hz, 1H), 4.55 (ddd, J = 4.7, 
4.7, 4.5 Hz, 1H),  2.76 (ddd, J = 7.4, 7.4, 5.2 Hz, 1H), 2.11 (m, 2H), 1.17 (d, J = 7.2 Hz, 3H), 13C 
NMR (CDCl3, 67.5 MHz) δ 201.9, 148.3, 129.2, 63.5, 38.8, 37.8, 15.3; HRMS (ESI) calcd. for 
[C7H10O2+H]+: 127.07536, Found: 127.07535. 
 
Dibenzyl (1S,5S)-5-methyl-4-oxocyclohex-2-enyl phosphate (II-39) 
O
OP(O)(OBn)2  
Into a solution of 54 mg allylic alcohol II-38 (0.43 mmol) in 1.8 mL CH2Cl2 was added a 
solution of 0.36 mL 85% N,N-diethyl dibenzylphosphoramidite (1.1 mmol) in 1.5 mL CH2Cl2 at 
room temperature followed by addition of 2.5 mL 0.45 M 1H-tetrazole in acetonitrile (1.1 mmol). 
The mixture ws stirred at RT for 1 hr. Then it was cooled down to 0 °C, and added 1.5 mL 30% 
H2 2. It was stirred at to 0 °C for 15 min. Into the m
 
O ixture 2 mL saturated aqueous Na2S2O3 was 
added and it was then stirred 0 °C for 2 hr. The mixture was extracted with EtOAc 30 mL X 2. 
he organic layer was washed with 4 mL saturated aqueous NaHCO3, 4 mL saturated aqueous 
NaCl, dried over Na SO , and concentrated under reduced pressure to give a residue which was 
lution with hexane-EtOAc (1:1) afforded 
phosphate II-39 (126 mg, 76%). 
II-39: Colorless oil; Rf = 0.48 (1:2 (v/v) hexane/EtOAc); [α]D20 -43 (c 3.09, CHCl3); IR (thin film, 
cm-1) υ 3035, 2965, 1683, 1498, 1456, 1381, 1269, 1215, 981; 1H NMR (CDCl3, 600 MHz) δ 
7.36 (m, 10H), 6.69 (ddd, J = 10.2, 4.8, 1.2 Hz, 1H), 5.96 (d, J = 10.2 Hz, 1H), 5.09 (ddd, J = 
T
2 4
subjected to chromatography on silica gel column. E
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11.4, 8.4, 5.4Hz, 2H), 5.04 (ddd, J = 12.0, 9.0, 3.6 Hz, 2H), 4.99 (dddd, J = 7.8, 4.2, 4.2, 4.2 Hz, 
1H), 2.64 (dqd, J = 9.6, 7.2, 4.8 Hz, 1H), 2.18 (dddd, J = 14.4, 4.8, 4.8, 1.2 Hz, 1H), 1.94 (dddd, 
J = 14.4, 10.2, 4.2, 1.2 Hz, 1H), 1.08 (d, J = 6.6 Hz, 1H); 13C NMR (CDCl3, 150 MHz) δ 200.7, 
143.2 (d, J = 4.6 Hz), 135.6 (d, J = 5.2 Hz), 131.0, 128.7, 128.6, 128.0 (d, J = 5.2 Hz), 69.6 (d, J 
= 5.7 Hz), 69.5 (d, J = 5.2 Hz), 37.3, 36.7 (d, J = 4.5 Hz), 14.7; HRMS (ESI) calcd. for 
[C21H23O5P+Na]+: 409.11753, Found: 409.11727. 
 
(2S,4R)-4-hydroxy-2-methylcyclohexanone (II-40) 
O
OH  
 MeOH was added 30 mg 10% 
Pd/C. The reaction mixture was degassed using vacuum and refilled with H2 at ~-30 °C three 
times. The reaction was stirred under balloon pressure of H2 at room temperature for 3 hr. The 
reaction mixture was filtered and rinsed with EtOAc and concentrated under reduced pressure to 
give a residue, which was loaded onto silica gel column. Elution with hexane-EtOAc (3:2) gave 
saturated alcohol II-40 (43 mg, 72%). II-40: Colorless oil; Rf = 0.43 (1:1 (v/v) hexane/EtOAc); 
To a solution of 52 mg allylic alcohol II-38 (0.41 mmol) in 4 mL
[α]D20 +6 (c 1.7, CHCl3); IR (thin film, cm-1) υ 3407, 2966, 2931, 1697, 1436, 1349, 1318, 1257, 
1138, 1111, 1011, 950; 1H NMR (CDCl3, 600 MHz) δ 4.25 (dddd, J = 3.6, 3.0, 2.4, 2.4 Hz, 1H), 
2.90 (m, 1H), 2.76 (ddd, J = 13.2, 13.2, 6.0 Hz, 1H), 2.27 (ddd, J = 13.8, 4.8, 2.4 Hz, 1H), 2.15 
(m, 2H), 1.92 (dddd, J = 13.8, 13.8, 5.4, 3.0 Hz, 1H), 1.63 (ddd, J = 12.6, 12.6, 2.4 Hz, 1H), 1.03 
(d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 213.1, 65.3, 42.5, 39.2, 36.2, 34.3, 14.3; 
HRMS (ESI) calcd. for [C7H12O2+H]+: 129.09101, Found: 129.09102. 
 
Dibenzyl (1R,3S)-3-methyl-4-oxocyclohexyl phosphate (II-41) 
O
OP(O)(OBn)2  
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 °C for 2 hr. The mixture was extracted with 
EtOAc 30 mL X 2. The organic layer was washed with 4 mL saturated aqueous NaHCO3, 4 mL 
2SO4, and concentrated under reduced pressure to give a 
umn. Elution with hexane-
EtOAc (1:1) afforded phosphate II-41 (42 mg, 70%). 
II-41: Colorless oil; Rf = 0.36 (1:2 (v/v) hexane/EtOAc); [α]D20 -3 (c 2.2, MeOH); IR (thin film, 
cm-1) υ 3035, 2934, 1712, 1497, 1455, 1270, 990; 1H NMR (CD3OD, 600 MHz) δ 7.38 (m, 10H), 
5.13 (dd, J = 12.0, 9.6 Hz, 2H), 5.09 (dd, J = 12.0, 10.2 Hz, 2H), 4.73 (m, 1H), 2.58 (ddd, J = 
19.8, 12.6, 6.6 Hz, 1H), 2.52 (ddd, J = 14.4, 14.4, 5.4 Hz, 1H), 2.19 (m, 1H), 2.13 (ddd, J = 14.4, 
 
(1R,3S)-3-methyl-4-oxocyclohexyl dihydrogen phosphate (II-31) 
Into a solution of 20 mg alcohol II-40 (0.16 mmol) in 0.5 mL CH2Cl2 was added a solution of 
0.14 mL 85% N,N-diethyl dibenzylphosphoramidite (0.43 mmol) in 0.5 mL CH2Cl2 at room 
temperature followed by addition of 0.95 mL 0.45 M 1H-tetrazole in acetonitrile (0.43 mmol). 
The mixture ws stirred at RT for 1 hr. Then it was cooled down to 0 °C, and slowly added 0.75 
mL 30% H2O2. It was stirred at to 0 °C for 15 min. Into the mixture, 2 mL saturated aqueous 
Na2S2O3 was added and it was then stirred at 0
saturated aqueous NaCl, dried over Na
residue which was subjected to chromatography on silica gel col
4.8, 2.4 Hz, 1H), 1.87 (ddddd, J = 11.8, 11.8, 4.8, 2.4, 2.4 Hz, 1H), 1.58 (dddd, J = 11.8, 11.8, 
2.4, 2.4 Hz, 1H), 0.89 (d, J = 6.6 Hz, 1H); 13C NMR (CD3OD, 150 MHz) δ 213.6, 137.5 (d, J = 
5.7 Hz), 137.4 (d, J = 5.7 Hz), 130.0, 129.9, 129.4 (d, J = 2.2 Hz), 75.6 (d, J = 5.7 Hz), 71.1 (d, J
= 5.7 Hz), 41.4 (d, J = 1.6 Hz), 40.3, 37.0, 33.5 (d, J = 4.6 Hz), 14.4; HRMS (ESI) calcd. for 
[C21H25O5P+H]+: 389.15124, Found: 389.15117. 
 
O
OP(O)(OH)2  
38 mg 10% Pd/C was first washed with HPLC grade MeOH 2 mL X 2, then it was transferred 
with another 2 mL HPLC grade MeOH to 25 mL flask which contained 22 mg dibenzyl 
phosphate II-41 (0.06 mmol). The mixture was degassed us g vacuum and refilled with H  at ~-in 2
30 °C three times. The reaction was stirred under balloon pressure of H2 at room temperature for 
3 hr. The reaction mixture was filtered and rinsed with HPLC grade MeOH and concentrated 
under reduced pressure to give a residue, which was then treated under vacuum at RT overnight 
to afford phosphate II-31 (8.5 mg, 73%). 1H  and 31P NMR show it is a mixture of two epimers 
105 
 
on the α-methyl group (dr α:β 2:1).  
II-31 (dr α:β 2:1): Colorless oil; [α] 20 -4 (c 0.74, MeOH); IR (thin film, cm-1) υ 3500-2500 
7H13O5P-H]-: 
207.04278, Found: 207.04273. 
II-31α: (α isomer) 1H NMR (D2O, 600 MHz) δ 3.01 (ddd, J = 18.6, 12.6, 6.0 Hz, 1H), 2.85 (ddd, 
J = 13.8, 13.8, 6.0 Hz, 1H), 2.36 (m, 3H), 2.02 (dd, J = 14.4, 13.8 Hz, 1H), 1.77 (dd, J = 13.8, 
13.2 Hz, 1H), 1.03 (d, J = 6.6 Hz, 1H); 13C NMR (D2O, 150 MHz) δ 220.0, 71.1 (d, J = 5.1 Hz), 
Dibenzyl (1S,4R,5S)-4-hydroxy-5-methylcyclohex-2-enyl phosphate (II-42) 
D
(broad), 2936, 1702, 1456, 1378, 1150, 1013, 990; HRMS (ESI) calcd. for [C
40.6 (d, J = 3.8 Hz), 39.6, 36.2, 32.7 (d, J = 4.5 Hz), 13.6; 31P NMR (D2O, 242 MHz) δ 0.66; 
II-31β: (β epimer) 1H NMR (D2O, 600 MHz) δ 2.75 (ddd, J = 19.8, 13.2, 6.6 Hz, 1H), 2.63 (ddd, 
J = 14.4, 14.4, 7.8 Hz, 1H), 2.36 (m, 3H), 1.89 (dd, J = 15.0, 15.0, 4.8 Hz, 1H), 1.68 (dd, J = 
13.8, 13.2 Hz, 1H), 1.05 (d, J = 6.6 Hz, 1H); 13C NMR (D2O, 150 MHz) δ 218.4, 72.8 (d, J = 5.7 
Hz), 41.7, 40.8 (d, J = 4.5 Hz), 37.8, 33.0 (d, J = 3.9 Hz), 13.9; 31P NMR (D2O, 242 MHz) δ 0.46; 
 
OP(O)(OBn)2
OH
 
To a solution of 89 mg phosphate II-39 (0.23 mmol) in 3.5 mL THF at -78 °C was added 20 mg 
LiAlH4 (0.50 mmol). The reaction mixture was stirred at -78 °C for 30 min, then 1 mL acetone 
was added at -78 °C to quench the reaction. Then 6 mL saturated aqueous NH4Cl was added and 
the reaction was stirred at 0 °C for 15 min. The mixture was passed through a pad of sand-silica 
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ed over Na2SO4. The 
solution was concentrated under reduced pressure to give a residue. Crude 1H NMR showed that 
the diastereoselectivity is 11:1. The residue was subjected to silica gel chromatography and 
elution with hexane-EtOAc (2:3) afforded allylic alcohol II-42 (67 mg, 87%). 
II-42: colorless oil; Rf = 0.71 (10:1 v/v EtOAc/MeOH); [α]D20 -6 (c 2.50, CHCl3); IR (thin film, 
-1 1
gel-celite, eluting with EtOAc-MeOH (10:1) and the effluent was dri
cm ) υ 3412, 3034, 2954, 1498, 1456, 1380, 1252, 1215, 1034, 982; H (CDCl3, 600 MHz) δ 
7.34 (m, 10H), 5.90 (dd, J = 10.2, 1.8 Hz, 1H), 5.76 (dddd, J = 10.2, 4.2, 1.8, 1.8 Hz, 1H), 5.04 
(ddd, J = 12.0, 8.4, 3.0 Hz, 2H), 5.01 (ddd, J = 11.4, 8.4, 3.0 Hz, 2H), 4.78 (dddd, J = 7.2, 4.2, 
3.6, 3.0 Hz, 1H), 3.66 (ddd, J = 9.0, 3.0, 1.8 Hz, 1H), 1.90 (dddd, J = 14.4, 2.4, 2.4, 1.2 Hz, 1H), 
1.77 (ddqd, J = 12.6, 12.6, 6.6, 3.0 Hz, 1H), 1.48 (dddd, J = 14.4, 12.0, 3.6, 1.8 Hz, 1H), 1.02 (d, 
J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 136.9, 135.9 (d, J = 7.0 Hz), 128.5, 128.4 (d, J = 
1.2 Hz), 127.9 (d, J = 4.4 Hz), 125.8 (d, J = 4.4 Hz),  73.0, 70.9 (d, J = 6.0 Hz), 69.1 (d, J = 5.4 
Hz), 35.6 (d, J = 4.8 Hz), 32.2,  17.9; HRMS (ESI) calcd. for [C21H25O5P+Na]+: 411.13318, 
Found: 411.13294. 
Dibenzyl (1R,3S,4S)-4-hydroxy-3-methylcyclohexyl phosphate (II-43) 
OP(O)(OBn)2
OH
 
To a solution of 30 mg allylic alcohol II-42 (0.077 mmol) in 0.35 mL N-methylmorpholine was 
added 167 mg (0.77 mmol) o-nitrobenzenesulfonylhydrazide and 128 µl Et3N. It was stirred at 
RT for 18 hr, then the reaction mixture was diluted with 30 mL EtOAc and washed at 0 °C by 8 
mL 0.5 M NaHSO4. The aqueous layer was extracted with EtOAc 30 mL X 2. The organic layer 
was washed with 5 mL saturated aqueous NaHCO3, 5 mL saturated brine, and dried over Na2SO4. 
he organic layer was concentrated under reduced pressure to give crude product, which was 
then subjected to chromatography on silica gel column. Elution with hexane-EtOAc (1:1.5-1:2) 
II-43 (18 mg, 60%) and recovered starting material II-42 (6 mg, 20% 
ecovery). 
T
gave saturated alcohol 
r
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HCl3); IR (thin film, 
cm-1) υ 3420, 3064, 2977, 2934, 1498, 1456, 1256, 1213, 997; 1H NMR (CDCl3, 600 MHz) δ 
7.35 (m, 10H), 5.06 (dd, J = 12.0, 8.4 Hz, 2H), 5.02 (ddd, J = 12.0, 8.4, 1.2 Hz, 2H), 4.61 (ddddd, 
J =6.0, 3.6, 3.0, 3.0, 2.4 Hz, 1H), 3.13 (ddd, J = 10.2, 10.2, 4.2 Hz, 1H), 1.97 (dddd, J = 13.8, 6.6, 
3.6, 3.0 Hz, 1H), 1.91 (ddd, J = 14.4, 7.2, 3,6 Hz, 1H), 1.74 (ddd, J = 12.0, 7.2, 3.6 Hz, 1H), 1.67 
(ddqd, J = 13.2, 12.6, 6.6, 3.0 Hz, 1H), 1.53 (m, 2H), 1.18 (dddd, J = 14.4, 12.0, 2.4, 1.8 Hz, 1H), 
II-43: Colorless oil; Rf = 0.19 (1:3 v/v hexane/EtOAc); [α]D20 +0.3 (c 0.76, C
0.95 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 136.0 (d, J = 5.4 Hz), 128.5, 128.4, 
127.8, 75.1, 74.2 (d, J = 6.0 Hz), 69.1 (d, J = 5.4 Hz), 38.1 (d, J = 4.4 Hz), 34.0, 30.2 (d, J = 4.4 
Hz), 20.1, 17.8; 31P NMR (CD3OD, 242 MHz) δ -0.419; HRMS (ESI) calcd. for [C21H27O5P+H]+: 
391.16687, Found: 391.16685. 
 
 
 
(1R,3S,4S)-4-hydroxy-3-methylcyclohexyl dihydrogen phosphate (II-32) 
OH
OP(O)(OH)2  
erred 
with another 2 mL HPLC grade MeOH to 25 mL flask which contained 21 mg dibenzyl 
phosphate II-43 (0.05 mmol). The mixture was degassed using vacuum and refilled with H2 at ~-
30 °C three times. The reaction was stirred under balloon pressure of H2 at room temperature for 
3 hr. The reaction mixture was filtered and rinsed with HPLC grade MeOH and concentrated 
under reduced pressure to give a residue, which was then treated under vacuum at RT overnight 
38 mg 10% Pd/C was first washed with HPLC grade MeOH 2 mL X 2, then it was transf
to afford phosphate II-32 (9.5 mg, 85%).  
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 4.4 Hz), 28.3, 17.6; 31P NMR 
(D O, 242 MHz) δ -0.492; HRMS (ESI) calcd. for [C H O P-H]-
II-32: Colorless oil; [α]D20 +14 (c 0.95, MeOH); IR (thin film, cm-1) υ 3500-2500 (broad), 3254, 
2935, 2872, 1654, 1446, 1377, 1162, 1001, 980; 1H NMR (D2O, 600 MHz) δ 4.50 (m, 1H), 3.29 
(ddd, J = 10.2, 10.2, 4.2 Hz, 1H), 2.00 (m, 1H), 1.97 (m, 2H), 1.79 (m, 2H), 1.65 (m, 2H), 1.35 
(dddd, J = 13.8, 12.6, 1.2, 1.2 Hz, 1H), 1.00 (d, J = 6.6 Hz, 3H); 13C NMR (D2O, 150 MHz) δ 
75.2, 72.8 (d, J = 5.6 Hz), 38.0 (d, J = 4.4 Hz), 33.4, 29.9 (d, J =
2 7 15 5 : 209.05843, Found: 209.05843. 
 
Dibenzyl (1S,2S,3S,4R,5S)-2,3,4-trihydroxy-5-methylcyclohexyl phosphate (II-44) 
OP(O)(OBn)2
OH
HO
HO
 
To a solution of 60 mg allylic alcohol II-42 (0.154 mmol) in 1.5 mL t-BuOH-Actone-50% NMO 
q.) (1:1:1 v/v/v) was added a small piece of crystalline OsO4 at 0 °C. The reaction mixture was 
stirred at 0 °C for overnight, then 1.5 mL saturated aqueous Na S O  was added and it was 
-silica 
gel-celite, washing with EtOAc-MeOH (1:1, v/v). The solution was dried over Na2SO4 and 
concentrated under reduced pressure to give a residue. Crude 1H-NMR showed only one single 
diastereomer was formed. The residue was subjected to chromatography on silica gel column, 
eluting with EtOAc-MeOH (20:1) gave triol II-44 (50 mg, 77%). 
 6.3 Hz), 76.2, 74.0, 72.8 (d, J = 5.8 Hz), 71.1 (d, J = 6.4 
(a
2 2 3
stirred at 0 °C for another 2 hr.  The reaction mixture was passed through a pad of sand
II-44: Colorless oil: Rf  = 0.77 (10:1 (v/v) EtOAc/MeOH); [α]D20 +6 (c 1.84, MeOH); IR (thin 
film, cm-1) 3378, 3066, 3035, 2952, 2926, 1498, 1456, 1378, 1247, 1215, 995, 970; 1H NMR 
(CD3OD, 600 MHz) δ 7.37 (m, 10H), 5.06 (ddd, J = 11.4, 8.4, 1.2 Hz, 2H), 5.03 (ddd, J = 11.4, 
9.0, 4.2 Hz, 2H), 4.46 (dddd, J =6.6, 4.2, 3.0, 2.4 Hz, 1H), 3.95 (dd, J = 3.6, 3.6 Hz, 1H), 3.49 
(dd, J = 9.6, 3.6 Hz, 1H), 3.25 (dd, J = 9.6, 9.6 Hz, 1H), 1.64 (m, 3H), 0.96 (d, J = 6.6 Hz, 3H); 
13C NMR (CD3OD, 150 MHz) δ 137.3 (d, J = 5.8 Hz), 129.9 (d, J = 2.8 Hz), 129.8 (d, J = 1.2 
Hz), 129.3 (d, J = 7.5 Hz), 78.9 (d, J =
Hz), 71.0 (d, J = 6.4 Hz), 34.2 (d, J = 4.0 Hz), 33.2, 18.2; 31P NMR (CD3OD, 242 MHz) δ -1.003; 
HRMS (ESI) calcd. for [C21H27O7P+H]+: 423.15672, Found: 423.15630. 
 
(1S,2S,3S,4R,5S)-2,3,4-trihydroxy-5-methylcyclohexyl dihydrogen phosphate (II-33) 
OP(O)(OH)2
OH
HO
HO
 
39 mg 10% Pd/C was first washed with HPLC grade MeOH 2 mL X 2, then it was transferred 
with another 2 mL HPLC grade MeOH to 25 mL flask which contained 24 mg dibenzyl 
phosphate II-44 (0.06 mmol). The mixture was degassed using vacuum and refilled with H2 at ~-
30 °C three times. The reaction was stirred under balloon pressure of H2 at room temperature for 
4 hr. The reaction mixture was filtered and rinsed with HPLC grade MeOH and concentrated 
Hz), 32.8 (d, J = 3.4 Hz), 31.6, 17.1; 31P NMR (D2O, 242 MHz) δ -0.612; HRMS 
-
under reduced pressure to give a residue, which was then treated with vacuum at RT overnight to 
afford phosphate II-33 (12 mg, 87%).  
II-33: Colorless oil; [α]D20 +4 (c 1.13, MeOH); IR (thin film, cm-1) υ 3283, 2918, 1376, 1011, 
972; 1H NMR (D2O, 600 MHz) δ 4.37 (ddd, J = 9.0, 6.0, 3.0, 1H), 4.12 (ddd, J = 3.6, 3.6, 1.2 Hz, 
1H), 3.73 (dd, J = 9.6, 3.0 Hz, 1H), 3.35 (dd, J = 10.2, 10.2 Hz, 1H), 1.89 (dddd, J = 14.4, 3.0, 
2.4, 1.8 Hz, 1H), 1.83 (ddqd, J = 13.2, 10.8, 6.6, 4.2 Hz, 1H), 1.63 (dddd, J = 13.2, 13.2, 2.4, 1.2 
Hz, 1H), 1.05 (d, J = 6.0 Hz, 3H); 13C NMR (D2O, 150 MHz) δ 75.1, 74.5 (d, J = 5.6 Hz), 72.2, 
71.9 (d, J = 5.4 
(ESI) calcd. for [C7H15O7P-H] : 241.04826, Found: 241.04805. 
 
(3aS,5R,7S,7aR)-hexahydro-2,2,7-trimethylbenzo[d][1,3]dioxol-5-ol (II-45) 
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OH
O
O
 
H4 (1.26 mmol). The reaction mixture was warmed up and stirred at RT for 2 hr, then it was 
diluted with 30 mL EtOAc and cooled down to 0 °C, and 4 mL saturated aqueous NaHCO3 was 
added and it was stirred for another 20 min to quench the reaction. The mixture was passed 
through a pad of sand-silica gel-celite, rinsing with EtOAc. The effluent was dried over Na2SO4. 
The solution was concentrated under reduced pressure to give a residue, which was subjected to 
chromatography on silica gel column, elution with hexane-EtOAc (5:1) afforded alcohol II-45 
(78 mg, 93%). 
d: 187.13288.  
To a solution of 130 mg carbonate II-22 (0.45 mmol) in 5 mL THF at 0 °C was added 48 mg 
LiAl
II-45: White solid; mp: 61.5-62.0 °C; Rf  = 0.28 (1:2 (v/v) hexane-EtOAc); [α]D20 +54 (c 0.66, 
CHCl3); IR (thin film, cm-1) υ 3257, 2990, 2940, 2923, 2884, 1458, 1433, 1378, 1364, 1242, 
1214, 1197, 1151, 1130, 1064, 1042, 1024, 960; 1H NMR (CDCl3, 600 MHz) δ 4.28 (ddd, J = 
4.8, 4.8, 2.4 Hz, 1H), 3.96 (ddd, J = 10.8, 10.8, 4.2, 4.2 Hz, 1H), 3.51 (dd, J = 9.6, 5.4 Hz, 1H), 
2.39 (dddd, J = 14.4, 4.8, 2.4, 2.4 Hz, 1H), 1.85 (s, OH), 1.77 (ddd, J = 12.6, 6.6, 3.6 Hz, 1H), 
1.65 (ddqd, J = 10.2, 10.2, 6.6, 3.6 Hz, 1H), 1.59 (ddd, J = 15.0, 10.8, 6.4 Hz, 1H), 1.43 (s, 3H), 
1.32 (s, 3H), 1.01 (d, J = 6.6 Hz, 3H), 1.00 (ddd, J = 13.2, 13.2, 10.8 Hz, 1H); 13C NMR (CDCl3, 
150 MHz) δ 108.2, 80.7, 74.5, 66.0, 40.5, 36.2, 33.7, 28.5, 26.1, 18.7; HRMS (ESI) calcd. for 
[C10H18O3+H]+: 187.13287,  Foun
 
Dibenzyl (3aR,4S,6R,7aS)-hexahydro-2,2,4-trimethylbenzo[d][1,3]dioxol-6-yl phosphate (II-
46) 
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OP(O)(OBn)2
O
O
 
d a solution of 
0.39 mL 85% N,N-diethyl dibenzylphosphoramidite (1.2 mmol) in 1.8 mL CH2Cl2 at room 
temperature followed by addition of 2.6 mL 0.45 M 1H-tetrazole in acetonitrile (1.2 mmol). The 
mixture was stirred at RT for 1 hr. Then it was cooled down to 0 °C, and added 1.8 mL 30% 
H2O2. It was stirred at to 0 °C for 30 min. To the mixture was added 3 mL saturated aqueous 
Na2S2O3 and it was then stirred 0 °C for 2 hr. The mixture was extracted with EtOAc 30 mL X 3. 
3 (m, 4H), 4.60 (ddddd, J = 10.8, 10.8, 7.2, 4.2, 4.2 Hz, 
Into a solution of 74 mg alcohol II-45 (0.40 mmol) in 1.8 mL CH2Cl2 was adde
The organic layer was washed with 5 mL saturated aqueous NaHCO3, 5 mL saturated aqueous 
NaCl, dried over Na2SO4, and concentrated under reduced pressure to give a residue which was 
subjected to chromatography on silica gel column. Elution with hexane-EtOAc (3:1) afforded 
phosphate II-46 (131 mg, 74%). 
II-46: Colorless oil: Rf  = 0.38 (1:1 (v/v) hexane/EtOAc); [α]D20 +14 (c 2.95, CHCl3); IR (thin 
film, cm-1) υ 3034, 2955, 2934, 1497, 1456, 1370, 1264, 1243, 1216, 1065, 993; 1H NMR 
(CDCl3, 600 MHz) δ 7.35 (m, 10H), 5.0
1H), 4.24 (ddd, J = 4.8, 4.8, 2.4 Hz, 1H), 3.49 (dd, J = 9.6, 5.4 Hz, 1H),  2.45 (dddd, J = 14.4, 
4.8, 2.4, 2.4 Hz, 1H), 1.90 (ddd, J = 13.2, 6.6, 3.6 1H); 1.76 (ddd, J = 14.4, 10.2, 4.2 Hz, 1H), 
1.60 (ddqd, J = 10.2, 10.2, 6.6, 3.6 Hz, 1H), 1.43 (s, 3H), 1.31 (s, 3H), 1.12 (ddd, J = 12.6, 12.6, 
10.8 Hz, 1H); 0.98 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 135.9 (d, J = 7.0 Hz), 
128.5 (d, J = 2.7 Hz), 128.4 (d, J = 1.6 Hz), 127.9, 80.1, 73.9, 73.7 (d, J = 6.0 Hz), 69.2 (d, J = 
5.6 Hz), 37.9 (d, J = 3.9 Hz), 34.1 (d, J = 6.0 Hz), 33.3, 28.4, 26.1, 18.5; HRMS (ESI) calcd. for 
[C24H31O6P+H]+: 447.19310, Found: 447.19283. 
 
Dibenzyl (1R,3S,4R,5S)-3,4-dihydroxy-5-methylcyclohexyl phosphate (II-47) 
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OH
OP(O)(OBn)2
OH
 
A solution of 100 mg (0.22 mmol) of acetonide II-46 was dissolved in 1.4 mL THF-10%HCl 
(v/v, 1:1) and stirred at room temperature for 30 min. The mixture was cooled down to 0 °C, and 
/v) hexane/EtOAc); [α]D20 +4 (c 0.91, 
MeOH); IR (thin film, cm-1) υ 3454, 3394, 3038, 2956, 2926, 2869, 1605, 1497, 1456, 1377, 
1
3 21H27O6P+H]+: 407.1618, 
ound: 407.1617. 
diluted with 50 mL EtOAc, then 2 mL saturated aqueous NaHCO3 and 400 mg NaHCO3 (s) was 
slowly added to quench the reaction. The mixture was filtered through a pad of sand-silica gel-
celite, rinsing with EtOAc-MeOH (10:1 v/v). The effluent was dried over Na2SO4 and 
concentrated to a residue, which was loaded to a silica gel column. Elution with hexane-EtOAc 
(1:7 v/v) gave diol II-47 (93mg, 95%).  
II-47: White solid; mp: 122-123 °C; Rf  = 0.13 (1:2 (v
1251, 1215, 1057, 1007; H NMR (CD3OD, 600 MHz) δ 7.36 (m, 10H), 5.03 (dd, J = 12.6, 8.0 
Hz, 1H), 5.01 (ddd, J = 12.0, 8.4, 1.8 Hz, 1H), 4.60 (ddddd, J = 11.4, 11.4, 7.2, 4.8, 4.8 Hz, 1H), 
3.93 (ddd, J = 3.6, 3.0, 3.0 Hz, 1H), 3.06 (dd, J = 10.8, 3.0 Hz, 1H),  2.24 (dddd, J = 13.2, 4.2, 
3.0, 3.0 Hz, 1H), 1.92 (dddd, J = 12.6, 4.2, 3.6, 3.6 Hz, 1H); 1.82 (ddqd, J = 13.2, 10.2, 6.6, 3.6 
Hz, 1H), 1.59 (ddd, J = 13.8, 11.4, 3.0 Hz, 1H), 1.17 (ddd, J = 12.6, 12.6, 12.6 Hz, 1H); 0.97 (d, 
J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 137.4 (d, J = 6.0 Hz), 129.8, 129.7, 129.3, 77.5, 
75.9 (d, J = 6.6 Hz), 71.1, 70.8 (d, J = 5.4 Hz), 41.0 (d, J = 4.5 Hz), 39.9 (d, J = 4.8 Hz), 33.2, 
18.9; 31P NMR (CD OD, 242 MHz) δ -1.003; HRMS (ESI) calcd. for [C
F
(1R,3S,4R,5S)-3,4-dihydroxy-5-methylcyclohexyl dihydrogen phosphate (II-34) 
OP(O)(OH)2
HO
OH
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H NMR (D2O, 600 MHz) δ 4.49 (ddddd, J = 11.4, 11.4, 
9.0, 4.8, 4.8 Hz, 1H), 4.12 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 3.32 (dd, J = 10.8, 3.0 Hz, 1H),  2.29 
A 37 mg sample of 10% Pd/C was first washed with HPLC grade MeOH 2 mL X 2, then it was 
transferred with another 2 mL HPLC grade MeOH to 25 mL flask which contained 21 mg 
dibenzyl phosphate II-47 (0.05 mmol). The mixture was degassed using vacuum and refilled 
with H2 at ~-30 °C three times. The reaction was stirred under balloon pressure of H2 at room 
temperature for 3 hr. The reaction mixture was filtered and rinsed with HPLC grade MeOH and 
concentrated under reduced pressure to give a residue, which was then treated with vacuum at 
RT overnight to afford phosphate II-34 (9.0 mg, 78%).  
II-34: Colorless oil; [α]D20 +14 (c 0.85, MeOH); IR (thin film, cm-1) υ 3311, 2933, 1653, 1459, 
1379, 1158, 1124, 1088, 1005, 960, 917; 1
(dddd, J = 13.2, 4.2, 3.6, 3.6 Hz, 1H), 2.12 (dddd, J = 12.6, 4.2, 3.6, 3.6 Hz, 1H); 1.90 (ddqd, J = 
13.2, 10.2, 6.6, 3.6 Hz, 1H), 1.71 (ddd, J = 13.8, 12.0, 2.4 Hz, 1H), 1.30 (ddd, J = 12.0, 12.0, 
12.0 Hz, 1H); 1.05 (d, J = 6.6 Hz, 3H); 13C NMR (D2O, 150 MHz) δ 76.2, 71.7 (d, J = 5.4 Hz), 
70.0, 39.4 (d, J = 4.1 Hz), 38.2 (d, J = 4.4 Hz), 30.6, 17.8; 31P NMR (D2O, 242 MHz) δ -0.413; 
HRMS (ESI) calcd. for [C7H15O6P-H]-: 225.05335, Found: 225.05335. 
 
(1R,4S,5R)-4-t-butyldimethylsilyloxy-5-methylcyclohex-2-enyl 4-nitrobenzoate (II-27a) 
OTBS
O
NO2
O  
A solution of 1.15 g allylic alcohol II-27 (4.18 mmol) in 42 mL CH2Cl2 was added 1.14 g (16.7 
mmol) imidazole when stirring, followed by addition of 1.30 g TBSCl (16.7 mmol) in portions. 
It was stirred at RT overnight, then it was diluted with 200 mL hexane-Et2O (1:3 v/v) and cooled 
down to 0 °C, and 25 mL saturated aqueous NaHCO3 was added. It was stirred at 0 °C for 30 
min, and then the aqueous layer was extracted with Et2O 60 mL x 2. The pooled organic layer 
was washed with 50 mL saturated aqueous NaCl, dried over Na2SO4. Concentration of the 
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4.2, -4.6; HRMS (ESI) calcd. for [C20H29NO5Si+Na] : 414.17072, Found: 414.17035. 
 
t-Butyldimethylsilyl (1S,4R,6R)-4-hydroxy-6-methylcyclohex-2-enyl ether (II-48) 
solution under reduced pressure gave crude product which will be used directly for next step 
reaction. For characterization, small amount of the crude product was subjected to 
chromatography on silica gel column, eluting with hexane-EtOAc (20:1, v/v) gave product 
silylether II-27a. 
II-27a: White solid; mp: 77.3-78.3 °C; Rf = 0.51 (6:1 (v/v) hexane/EtOAc); [α]D20+97 (c 4.12, 
CHCl3); IR (thin film, cm-1) υ 3039, 2953, 2929, 2898, 2857, 1713, 1609, 1600, 1522, 1462, 
1390, 1338, 1271, 1249, 1101, 1081, 1008, 932; 1H NMR (CDCl3, 600 MHz) δ 8.27 (d, J = 8.4 
Hz, 1H), 8.21 (d, J = 9.0 Hz, 1H), 5.95 (dd, J = 10.2, 1.8 Hz, 1H), 5.84 (dddd, J = 10.2, 3.6, 1.8, 
1.2 Hz, 1H), 5.45 (ddd, J = 6.0, 3.0, 1.2 Hz, 1H), 3.80 (ddd, J = 8.4, 3.6, 1.8 Hz, 1H), 1.98 (ddd, 
J = 14.4, 4.2, 3.2 Hz 1H), 1.94 (ddqd, J = 12.0, 9.6, 6.6, 3.0 Hz 1H), 1.68 (ddd, J =16.2, 12.0, 4.8 
Hz 1H), 1.05 (d, J = 6.6 Hz, 3H), 0.93 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H); 13C NMR (CDCl3, 150 
MHz) δ 164.2, 150.5, 138.7, 136.0, 130.8, 124.0, 123.4, 73.8, 68.4, 34.5, 32.8, 25.8, 18.5, 18.1, -
+
OH
OTBS
 
The crude product of II-27a obtained from last step was redissolved in 45 mL MeOH at 0 °C. 
Then 115.4 mg LiOH (4.81 mmol) was slowly added into the solution. The reaction mixture was 
stirred at 0 °C for 2 hr. It was then diluted with 450 mL hexane-EtOAc (1:2 v/v) and 35 mL 
saturated aqueous NH4Cl was added in. The aqueous layer was extracted with hexane-EtOAc 
(1:2 v/v) 100 mL X 2. The pooled organic layer was washed with 50 mL saturated aqueous NaCl, 
dried over Na2SO4. Concentration of the solution under reduced pressure gave a residue, then 
washed with 30 mL saturated brine, dried over Na2SO4. The solution was concentrated under 
reduced pressure to give ~5 mL residue, which was subjected to chromatography on silica gel 
column. Elution with hexane-EtOAc (8:1) afforded allylic alcohol II-48 (873 mg, 85% for two 
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58, 1472, 1462, 1388, 1251, 1098, 1078, 
1061, 989; 1H NMR (CDCl , 600 MHz) δ 5.75 (dddd, J = 10.2, 3.0, 1.2, 1.2 Hz, 1H), 5.71 (dd, J 
steps). II-48: Colorless oil; Rf = 0.49 (2:1 (v/v) hexane/EtOAc); [α]D20 -21 (c 1.74, CHCl3); IR 
(thin film, cm-1) υ 3335, 3032, 2953, 2929, 2896, 28
3
= 10.2, 1.8 Hz, 1H), 4.10 (ddd, J = 6.6, 3.0 Hz, 1H), 3.70 (ddd, J = 7.8, 3.0, 1.8 Hz, 1H), 1.80 (m, 
2H), 1.50 (ddd, J =16.8, 12.6, 4.8 Hz 1H), 0.99 (d, J = 6.6 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 
0.07 (s, 3H); 13C NMR (CDCl3, 150 MHz) δ 135.5, 128.7, 74.0, 64.0, 37.4, 32.0, 25.8, 18.5, 18.1, 
-4.2, -4.7; HRMS (ESI) calcd. for [C13H26O2Si+H]+: 243.17748, Found: 243.17744. 
 
Dibenzyl (1S,4R,5S)-4-t-butyldimethylsiloxy-5-methylcyclohex-2-enyl phosphate (II-49) 
OTBS
OP(O)(OBn)2  
Into a solution of 36.7 mg allylic alcohol II-48 (0.15 mmol) in 0.5 mL CH2Cl2 was added a 
solution of 0.15 mL 85% N,N-diethyl dibenzylphosphoramidite (0.46 mmol) in 0.5 mL CH2Cl2 
at room temperature, followed by addition of 1.0 mL 0.45 M 1H-tetrazole in acetonitrile (0.45 
mmol). The mixture was stirred at RT for 1 hr. Then it was cooled down to 0 °C, and added 0.75 
mL 30% H2O2. It was stirred at to 0 °C for 30 min. Into the mixture 1 mL saturated aqueous 
Na S O  was added and it was then stirred 0 °C for 20 min. The mixture was extracted with 
 (dddd, J = 10.2, 4.2, 1.8, 1.8 Hz, 1H), 5.04 
(ddd, J = 11.4, 7.8, 2.4 Hz, 2H), 5.02 (ddd, J = 11.4, 7.8, 3.0 Hz, 2H), 4.79 (m, 1H), 3.66 (ddd, J 
= 8.4, 2.4, 1.8 Hz, 1H), 1.91 (dddd, J = 14.4, 4.2, 2.4 Hz, 1H), 1.85 (ddqd, J = 13.2, 9.0, 6.6, 2.4 
2 2 3
EtOAc 15 mL X 3. The organic layer was washed with 4 mL saturated aqueous NaHCO3, 4 mL 
saturated aqueous NaCl, dried over Na2SO4, and concentrated under reduced pressure to give a 
residue which was subjected to chromatography on silica gel column. Elution with hexane-
EtOAc (4:1) afforded phosphate II-49 (49 mg, 66%). 
II-49: Colorless oil; Rf = 0.30 (2:1 v/v EtOAc/MeOH); [α]D20 +18 (c 2.0, CHCl3); IR (thin film, 
cm-1) υ 3035, 2955, 2929, 2857, 1498, 1456, 1394, 1252, 1214, 1082, 985; 1H (CDCl3, 600 MHz) 
δ 7.34 (m, 10H), 5.82 (dd, J = 10.2, 1.8 Hz, 1H), 5.76
Hz, 1H), 1.48 (dddd, J = 14.4, 12.6, 4.2, 1.8 Hz, 1H), 0.95 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 
150 MHz) δ 138.0, 136.0 (d, J = 6.9 Hz), 128.5, 128.4, 127.8 (d, J = 8.7 Hz), 124.9 (d, J = 4.0 
Hz),  73.7, 71.1 (d, J = 5.8 Hz), 69.1 (d, J = 5.8 Hz), 35.7 (d, J = 5.2 Hz), 32.0, 25.8, 18.3, 18.1, -
4.3, -4.7; HRMS (ESI) calcd. for [C27H39O5PSi+H]+: 503.23771, Found: 503.23769. 
 
Dibenzyl (1S,2S,3S,4R,5S)-4-t-butyldimethylsilyloxy-2,3-dihydroxy-5-methylcyclohexyl 
phosphate (II-49a) 
OP(O)(OBn)2
OTBS
HO
HO
 
To a solution of 72 mg olefin II-49 (0.146 mmol) in 1.5 mL t-BuOH-Actone-50% NMO (aq.) 
(1:1:1 v/v/v) was added a small piece of crystalline OsO4 at 0 °C. The reaction mixture was 
stirred at 0 °C for overnight, then 1 mL saturated aqueous Na2S2O3 was added and it was stirred 
at 0 °C for another 2 hr.  The reaction mixture was passed through a pad of sand-silica gel-celite, 
washing with EtOAc-MeOH (1:1, v/v). The solution was dried over Na2SO4 and concentrated 
 (thin 
film, cm ) υ 3380, 3066, 3036, 2953, 2928, 2893, 2856, 1498, 1457, 1386, 1361, 1247, 1215, 
under reduced pressure to give a residue. Crude 1H-NMR showed only one single diastereomer 
was formed. The residue was subjected to chromatography on silica gel column, eluting with 
hexane-EtOAc (1:1) gave diol II-49a (62 mg, 81%). 
II-49a: Colorless oil: Rf  = 0.36 (1:2 (v/v) hexane-EtOAc); [α]D20 -8 (c 2.43, CHCl3); IR
-1
1096, 997; 1H NMR (CDCl3, 600 MHz) δ 7.34 (m, 10H), 5.04 (m, 2H), 5.01 (m, 2H), 4.52 (dddd, 
J =8.4, 5.4, 5.4, 3.0 Hz, 1H), 3.95 (dd, J = 4.2, 4.2 Hz, 1H), 3.60 (dd, J = 7.2, 5.0 Hz, 1H), 3.45 
(dd, J = 7.8, 7.2 Hz, 1H), 3.2 (brs, 1H), 2.34 (brs, 1H), 1.72 (m, 2H), 1.58 (d, J = 10.8, 10.8, 3.6, 
3.0 Hz, 1H), 0.93 (d, J = 7.2 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H); 13C NMR (CDCl3, 
150 MHz) δ 135.7 (d, J = 6.3 Hz), 128.6, 128.0, 127.9, 76.3 (d, J = 5.8 Hz), 76.0, 73.7, 71.9 (d, J 
= 5.1 Hz), 69.5 (d, J = 4.6 Hz), 71.0 (d, J = 6.4 Hz), 33.0 (d, J = 4.6 Hz), 32.9, 25.9, 18.2, 18.0, -
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4.1, -4.4; 31P NMR (CD3OD, 242 MHz) δ -1.003; HRMS (ESI) calcd. for [C27H41O7PSi+H]+: 
537.24319, Found: 537.24241. 
 
Dibenzyl (1R,2R,3R,4S,5R)-2,3,4-trihydroxy-5-methylcyclohexyl phosphate (II-50) 
 
A 60 mg sample of diol II-49a (0.114 mmol) was dissolved in 1.2 mL MeOH at 0 °C and 4.4 mg 
(0.023 mmol) p-TsOH•H2O was added.  It was stirred at 0 °C for 24 hr, then was diluted with 10 
mL EtOAc and quenched with 0.4 mL saturated aqueous NaHCO3. The mixture was 
concentrated under reduced pressure to give a residue, which was subjected to chromatography 
on silica gel column. Elution with EtOAc-MeOH (20:1) afforded triol II-50 (46 mg, 98%). 
II-50: Colorless oil: Rf  = 0.31 (10:1 (v/v) EtOAc-MeOH); [ 20
-1
α]D  -6 (c 1.57, MeOH); IR (thin 
film, cm ) υ 3376, 3065, 3036, 2953, 2926, 1498, 1456, 1379, 1247, 1215, 995, 970; 1H NMR 
R,2R,3R,4S,5R)-2,3,4-trihydroxy-5-methylcyclohexyl dihydrogen phosphate ((ent)-II-33) 
(CD3OD, 600 MHz) δ 7.37 (m, 10H), 5.06 (ddd, J = 12.0, 9.0, 1.2 Hz, 2H), 5.03 (ddd, J = 11.4, 
9.0, 4.2 Hz, 1H), 4.46 (dddd, J =6.6, 4.2, 3.6, 3.0 Hz, 1H), 3.96 (dd, J = 3.0, 3.0 Hz, 1H), 3.50 
(dd, J = 9.6, 3.0 Hz, 1H), 3.26 (dd, J = 9.6, 9.0 Hz, 1H), 1.64 (m, 3H), 0.96 (d, J = 6.6 Hz, 3H); 
13C NMR (CD3OD, 150 MHz) δ 137.3 (d, J = 6.3 Hz), 129.9 (d, J = 2.2 Hz), 129.8 (d, J = 1.2 
Hz), 129.3 (d, J = 6.9 Hz), 78.9 (d, J = 6.3 Hz), 76.2, 73.9, 72.8 (d, J = 5.8 Hz), 71.1 (d, J = 5.8 
Hz), 71.0 (d, J = 5.8 Hz), 34.1 (d, J = 4.0 Hz), 33.2, 18.2; HRMS (ESI) calcd. for 
[C21H27O7P+H]+: 423.15672, Found: 423.15655. 
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OP(O)(OH)2
OH
HO
HO
 
A 37 mg sample of 10% Pd/C was first washed with HPLC grade MeOH 2 mL x 2, then it was 
transferred with another 2 mL HPLC grade MeOH to 25 mL flask which contained 22 mg 
dibenzyl phosphate II-50 (0.05 mmol). The mixture was degassed using vacuum and refilled 
 
 
V.4. Chapter III Experimental 
with H2 at ~ -30 °C three times. The reaction was stirred under balloon pressure of H2 at room 
temperature for 4 hr. The reaction mixture was filtered and rinsed with HPLC grade MeOH and 
concentrated under reduced pressure to give a residue, which was then treated with vacuum at 
RT overnight to afford phosphate (ent)-II-33 (10 mg, 81%).  
(ent)-II-33: Colorless oil; [α]D20 -6 (c 0.73, MeOH); IR (thin film, cm-1) υ 3278, 2933, 1440, 
1376, 1137, 1010, 972; 1H NMR (D2O, 600 MHz) δ 4.37 (ddd, J = 9.0, 6.6, 3.0, 1H), 4.12 (ddd, 
J = 3.0, 3.0, 1.2 Hz, 1H), 3.74 (dd, J = 9.6, 3.0 Hz, 1H), 3.35 (dd, J = 10.2, 9.6 Hz, 1H), 1.89 
(dddd, J = 14.4, 3.0, 2.4, 1.8 Hz, 1H), 1.83 (ddqd, J = 13.2, 10.2, 6.6, 3.0 Hz, 1H), 1.63 (dddd, J 
= 13.2, 13.2, 2.4, 1.2 Hz, 1H), 1.05 (d, J = 6.6 Hz, 3H); 13C NMR (D2O, 150 MHz) δ 75.1, 74.4 
(d, J = 5.6 Hz), 72.2, 71.9 (d, J = 5.4 Hz), 32.8 (d, J = 3.9 Hz), 31.6,  17.1; 31P NMR (D2O, 242 
MHz) δ -0.594; HRMS (ESI) calcd. for [C7H15O7P-H]-: 241.04826, Found: 241.04805. 
 
(4S,6S)-4-(benzyloxy)-6-methylcyclohex-2-enone (III-7) 
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 A solution of 832 mg (3.68 mmol) α-D-Boc-enone (ent)-III-4 and 0.70 mL (6.77 mmol) BnOH 
in 3 mL CH2Cl2 at 0 ºC was added a solution of 95 mg (0.092 mmol) Pd2(dba)3•CHCl3 and 96 
mg (0.368 mmol) PPh3 in 2 mL CH2Cl2. It was stirred at 0 ºC for 2 h and another solution of 95 
mg (0.092 mmol) Pd2(dba)3•CHCl3 and 96 mg (0.368 mmol) PPh3 in 2 mL CH2Cl2 was added. 
The reaction mixture was stirred at 0 ºC for another 3 h. The mixture was directly loaded onto 
silica gel column. Elution with hexane-EtOAc (15:1, v/v) afforded glycosylated enone III-7 (475 
mg 60%) as colorless oil. Rf = 0.35 (4:1 (v/v) hexane/EtOAc); [α]D20 -146 (c 2.56, CHCl3); IR 
(thin film, cm-1) υ 3033, 2964, 2931, 2872, 1678, 1497, 1454, 1377, 1331, 1250, 1205, 1220, 
087, 1068, 1027, 946; 1H NMR (CDCl3, 600 MHz) δ 7.38-7.35 (m, 4H), 7.31 (m, 1H), 6.89 (dd, 
1H), 4.62 (d, J = 12.0 Hz, 
1H), 4.20 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.80 (dqd, J = 9.0, 7.2, 4.8 Hz, 1H), 2.55 (dddd, J = 
13.8, 6.0, 4.8, 1.2 Hz, 1H), 1.98 (ddd, J = 13.8, 9.0, 4.2 Hz, 1H), 1.15 (d, J = 7.2 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz) δ 201.9, 146.2, 138.0, 129.9, 128.5, 127.9, 127.7, 71.3, 69.8, 37.8, 35.6, 
15.2; HRMS (ESI): calcd. for [C14H16O2+H]+: 217.1223, Found: 217.1223. 
then 
the mixture was directly subjected to silica gel column chromatography to afford the 
orresponding glycosylated product. 
S,6S)-6-methyl-4-phenoxycyclohex-2-enone (III-21) 
1
J = 10.2, 3.6 Hz, 1H), 5.99 (d, J = 9.6 Hz, 1H), 4.67 (d, J = 12.0 Hz, 
 
General procedure of palladium(0)-catalyzed cyclitolization for phenols 
A solution of 0.1 mmol phenol and 27 mg (0.12 mmol) α-D-Boc-enone (ent)-III-4 in 1.5 mL 
CH2Cl2 at 0 ºC was added a solution of 2.6 mg (0.0025 mmol Pd2(dba)3•CHCl3 and 2.6 mg 
(0.010 mmol) PPh3 in 0.5 mL CH2Cl2. The reaction mixture was stirred at 0 ºC for 0.5-2 h, 
c
(4
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 Colorles oil, Rf = 0.43 (4:1 (v/v) hexane/EtOAc); [α]D20 -150 (c 1.2, CHCl3); IR (thin film, cm-1) 
υ 3039, 2932, 1683, 1596, 1492, 1455, 1384, 1290, 1227, 1054, 980; 1H NMR (CDCl3, 600 MHz) 
δ 7.32 (dd, J = 7.2, 7.2 Hz, 2H), 7.01 (t, J = 7.2 Hz, 1H), 6.96 (m, 3H), 6.08 (d, J = 10.2 Hz, 1H), 
5.04 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.87 (dqd, J = 9.6, 7.2, 4.8 Hz, 1H), 2.39 (ddd, J = 13.8, 4.8, 
4.8 Hz, 1H), 2.11 (ddd, J = 13.8, 9.6, 4.8 Hz, 1H), 1.20 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 
150 MHz) δ 201.5, 157.3, 144.6, 130.7, 129.8, 121.7, 115.9, 68.6, 37.7, 35.5, 15.1; HRMS (ESI): 
calcd. for [C13H14O2+H]+: 203.1066, Found: 203.1066. 
 
(4S,6S)-4-(4-methoxyphenoxy)-6-methylcyclohex-2-enone (III-22) 
 
Colorles oil, Rf = 0.31 (4:1 (v/v) hexane/EtOAc); [α]D20 -233 (c 0.07, CHCl3); IR (thin film, cm-1) 
212, 1033, 980; 1H NMR (CDCl3, 
600 MHz) δ 6.95 (dd, J = 10.2, 3.6 Hz, 1H), 6.91 (d, J = 9.0 Hz, 2H), 6.86 (d, J = 9.0 Hz, 2H), 
6.06 (d, J = 10.2 Hz, 1H), 4.90 (ddd, J = 4.8, 4.8, 4.2 Hz, 1H), 2.86 (dqd, J = 9.0, 7.2, 4.8 Hz, 
1H), 2.36 (ddd, J = 13.8, 5.4, 4.8 Hz, 1H), 2.07 (ddd, J = 13.8, 9.0, 4.2 Hz, 1H), 1.19 (d, J = 7.2 
Hz, 3H); 13C NMR (CDCl , 150 MHz) δ 201.6, 154.7, 151.3, 144.9, 130.5, 117.6, 114.9, 70.0, 
O
ethoxynaphthalen-1-yloxy)-6-methylcyclohex-2-enone (III-23) 
υ 3042, 2933, 1680, 1591, 1504, 1463, 1441, 1383, 1289, 1
3
55.7, 37.7, 35.6, 15.1; HRMS (ESI): calcd. for [C14H16 3+H]+: 233.1172, Found: 233.1173. 
 
 
 
(4S,6S)-4-(7-bromo-5,8-dim
120 
 
 Brown solid, mp: 85.0-86.5 ºC; Rf = 0.36 (4:1 (v/v) hexane/EtOAc); [α]D20 -138 (c 1.51, CHCl3); 
IR (thin film, cm-1) υ 3074, 2963, 2931, 2834, 1680, 1576, 1505, 1453, 1441, 1430, 1408, 1329, 
1259, 1209, 1178, 1057, 1041, 975; 1H NMR (CDCl3, 600 MHz) δ 7.94 (dd, J = 8.4, 1.2 Hz, 1H), 
7.40 (dd, J = 8.4, 7.2 Hz, 1H), 7.06 (ddd, J = 9.6, 4.2, 0.6 Hz, 1H), 7.06 (d, J = 7.2 Hz, 1H), 6.96 
(s, 1H), 6.12 (dd, J = 9.6, 0.6 Hz, 1H), 5.09 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 3.97 (s, 3H), 3.82 (s, 
3H), 3.01 (dqd, J = 9.6, 7.2, 5.4 Hz, 1H), 2.50 (dddd, J = 14.4, 5.4, 4.8, 0.6 Hz, 1H), 2.11 (ddd, J 
= 13.8, 9.6, 4.2 Hz, 1H), 1.21 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 201.7, 152.5, 
152.0, 146.3, 144.6, 130.8, 128.6, 125.8, 122.3, 117.1, 114.7, 114.0, 109.1, 71.1, 61.8, 56.0, 37.8, 
35.4, 15.1; HRMS (ESI): calcd. for [C19H19BrO4+Na]+: 413.0359, Found: 413.0361. 
 
(4S,6S)-6-methyl-4-(o-tolyloxy)cyclohex-2-enone (III-24) 
 
Colorles oil, Rf = 0.42 (4:1 (v/v) hexane/EtOAc); [α]D20 -190 (c 1.0, CHCl3); IR (thin film, cm-1) 
υ 3024, 2966, 2931, 2874, 1681, 1601, 1589, 1490, 1460, 1438, 1380, 1232, 1188, 1117, 1048, 
980; 1H NMR (CDCl3, 600 MHz) δ 7.17 (m, 2H), 6.97 (dd, J = 10.2, 3.6 Hz, 1H), 6.92 (m, 2H), 
6.08 (d, J = 10.2 Hz, 1H), 5.03 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.89 (dqd, J = 9.0, 7.2, 4.8 Hz, 
1H), 2.41 (ddd, J = 13.8, 5.4, 4.8 Hz, 1H), 2.23 (s, 3H), 2.12 (ddd, J = 13.8, 9.0, 4.2 Hz, 1H), 
1.21 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 201.5, 155.5, 144.9, 131.3, 130.5, 128.1, 
126.8, 121.4, 112.9, 68.9, 37.8, 35.8, 16.3, 15.1; HRMS (ESI): calcd. for [C14H16O2+H]+: 
217.1223, Found: 217.1223. 
(4S,6S)-4-(2-t-butylphenoxy)-6-methylcyclohex-2-enone (III-25) 
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 Colorless oil; Rf = 0.42 (4:1 (v/v) hexane/EtOAc); [α]D20 -218 (c 1.85, CHCl3); IR (thin film, cm-
1) υ 3005, 2985, 2960, 2950, 2940, 2895, 1689, 1593, 1484, 1441, 1378, 1290, 1249, 1222, 1200, 
22
S,6S)-4-(4-bromophenoxy)-6-methylcyclohex-2-enone (III-26)  
1125, 1091, 1051, 985; 1H NMR (CDCl3, 600 MHz) δ 7.34 (dd, J = 7.8, 1.8 Hz, 1H), 7.20 (ddd, 
J = 9.0, 7.2, 1.8 Hz, 1H), 7.01 (dd, J = 10.2, 4.2 Hz, 1H), 6.93 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H), 
6.91 (ddd, J = 7.8, 1.2, 0.6 Hz, 1H), 6.10 (dd, J = 10.2, 1.2 Hz, 1H), 5.18 (ddd, J = 4.8, 4.8, 4.2 
Hz, 1H), 2.87 (dqd, J = 9.0, 7.2, 4.8 Hz, 1H), 2.48 (dddd, J = 13.8, 5.4, 4.8, 1.2 Hz, 1H), 2.19 
(ddd, J = 13.8, 9.0, 4.2 Hz, 1H), 1.24 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 201.4, 
155.7, 144.6, 138.6, 130.6, 127.3, 127.0, 120.8, 111.7, 67.5, 38.1, 35.6, 34.9, 29.9, 15.2; HRMS 
(ESI): calcd. for [C17H O2+H]+: 259.1692, Found: 259.1693. 
 
(4
 
Colorles oil, Rf = 0.54 (2:1 (v/v) hexane/EtOAc); [α]D20 -148 (c 1.78, CHCl3); IR (thin film, cm-1) 
υ 3040, 2970, 2931, 2875, 1680, 1578, 1384, 1280, 1230, 1173, 1148, 978; 1H NMR (CDCl3, 
 
-enyloxy)benzoate (III-27) 
600 MHz) δ 7.41 (d, J = 9.0 Hz, 2H), 6.92 (dd, J = 10.2, 4.2 Hz, 1H), 6.84 (d, J = 9.0 Hz, 2H),
6.08 (dd, J = 10.2, 1.2 Hz, 1H), 4.98 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.85 (dqd, J = 9.0, 7.2, 4.8 
Hz, 1H), 2.36 (dddd, J = 14.4, 5.4, 4.8, 1.2 Hz, 1H), 2.09 (ddd, J = 13.2, 9.0, 4.2 Hz, 1H), 1.20 (d, 
J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 201.2, 156.4, 143.9, 132.6, 131.0, 117.7, 113.9, 
69.0, 37.6, 35.4, 15.1. 
 
Methyl 2-((1S,5S)-5-methyl-4-oxocyclohex-2
122 
 
 Colorles oil, Rf = 0.33 (2:1 (v/v) hexane/EtOAc); [α]D20 -194 ( 1.42, CHCl3); IR (thin film, cm-1) 
υ 3040, 2951, 2875, 1725, 1680, 1599, 1485, 1450, 1299, 1240, 1126, 1081, 1045; 1H NMR 
 
S,6S)- 4-(4-acetylphenoxy)-6-methylcyclohex-2-enone (III-28) 
c 
(CDCl3, 600 MHz) δ 7.82 (ddd, J = 8.4, 2.4, 0.6 Hz, 1H), 7.48 (ddd, J = 7.8, 7.8, 1.8, 0.6 Hz, 1H),
7.07 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H), 7.06 (d, J = 7.8 Hz, 1H), 6.98 (dd, J = 10.2, 4.2 Hz, 1H), 
6.09 (d, J = 10.2 Hz, 1H), 5.04 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 3.86 (s, 3H), 2.97 (dqd, J = 9.6, 
7.2, 4.8 Hz, 1H), 2.44 (ddd, J = 13.8, 4.8, 4.8 Hz, 1H), 2.10 (ddd, J = 13.8, 9.6, 4.2 Hz, 1H), 1.20 
(d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 201.5, 166.4, 156.9, 144.0, 133.3, 132.0, 
131.0, 122.5, 121.9, 116.6, 70.9, 52.0, 37.6, 35.8, 15.0; HRMS (ESI): calcd. for [C15H16O4+Na]+: 
283.0941, Found: 283.0942. 
 
(4
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Colorless oil; Rf = 0.27 (2:1 (v/v) hexane/EtOAc); [α]D20 -194 (c 1.79, CHCl3); IR (thin film, cm-
1) υ 3075, 3040, 2975, 2965, 2935, 2870, 1677, 1597, 1576, 1506, 1359, 1271, 1242, 1174, 954; 
1H NMR (CDCl3, 600 MHz) δ 7.96 (d, J = 9.0 Hz, 2H), 6.98 (dd, J = 9.0 Hz, 2H), 6.94 (dd, J = 
7-((1S,5S)-5-methyl-4-oxocyclohex-2-enyloxy)-2H-chromen-2-one (III-29) 
10.2, 4.2 Hz, 1H), 6.11 (dd, J = 10.2, 0.6 Hz, 1H), 5.14 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.85 (dqd, 
J = 9.6, 7.2, 4.8 Hz, 1H), 2.56 (s, 3H), 2.40 (dddd, J = 13.8, 4.8, 4.8, 0.6 Hz, 1H), 2.14 (ddd, J = 
14.4, 9.6, 4.8 Hz, 1H), 1.21 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 200.9, 196.5, 
161.1, 143.3, 131.3, 131.0, 130.8, 115.1, 68.6, 37.6, 35.4, 26.3, 15.0; HRMS (ESI): calcd. for 
[C15H16O3+H]+: 245.1172, Found: 245.1173. 
 
 White solid, mp: 137.2-137.8 ºC; Rf = 0.36 (1:1 (v/v) hex
-1
ane/EtOAc); [α]D20 -104 (c 1.97, 
CHCl3); IR (thin film, cm ) υ 3075, 3055, 2980, 2970, 2920, 2890, 1703, 1683, 1608, 1501, 
1403, 1352, 1403, 1276, 1232, 1211, 1196, 1124, 1079, 1031, 1005, 985; 1H NMR (CDCl3, 600 
MHz) δ 7.64 (d, J = 9.6 Hz, 1H), 7.41 (d, J = 9.0 Hz, 1H), 6.94 (dd, J = 10.2, 4.2 Hz, 1H), 6.88 
(m, 2H), 6.28 (d, J = 9.6 Hz, 1H), 6.12 (d, J = 10.2 Hz, 1H), 5.11 (ddd, J = 4.8, 4.8, 4.2 Hz, 1H), 
2.86 (dqd, J = 9.6, 7.2, 5.4 Hz, 1H), 2.40 (ddd, J = 13.8, 4.8, 4.8 Hz 1H), 2.16 (ddd, J = 13.8, 9.6, 
4.8 Hz, 1H), 1.21 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 200.8, 160.8, 160.4, 155.8, 
143.1, 142.9, 131.4, 129.1, 113.7, 113.5, 113.1, 102.4, 69.1, 37.6, 35.2, 15.0; HRMS (ESI): calcd. 
for [C16H14O4+H]+: 271.0965, Found: 271.0966. 
 
2-((1S,5S)-5-methyl-4-oxocyclohex-2-enyloxy)naphthalene-1,4-dione (III-30) 
O
O
O
O
 
Red brown solid, mp: 60-62 ºC; Rf = 0.58 (10:1 (v/v) CH2Cl2/MeOH); [α]D20 -97 (c 0.55, CHCl3); 
IR (thin film, cm-1) υ 3280, 2975, 2925, 2870, 1740, 1720, 1664, 1642, 1595, 1460, 1368, 1340, 
1273, 1246, 1214, 1153; 1H NMR (CDCl3, 600 MHz) δ 8.15 (d, J = 7.8 Hz, 1H), 8.12 (d, J = 7.8 
Hz, 1H), 7.80 (ddd, J = 7.8, 7.2, 1.2 Hz, 1H), 7.73 (ddd, J = 7.8, 7.2, 1.2 Hz, 1H), 7.54 (s, 1H), 
6.87 (ddd, J = 10.2, 1.8, 1.2 Hz, 1H), 6.07 (dd, J = 10.2, 2.4 Hz, 1H), 4.32 (dddd, J = 10.2, 5.4, 
.4, 2.4 Hz, 1H), 2.68 (dqd, J = 12.0, 7.2, 4.8 Hz, 1H), 2.45 (ddd, J = 13.8, 9.6, 4.8 Hz 1H), 1.94 
ddd, J = 13.2, 4.8, 4.8, 1.2 Hz, 1H), 1.29 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 
34.2, 29.4, 15.6; HRMS (ESI): calcd. for [C17H14O4+H]+: 283.0965, Found: 283.0966. 
2
(d
202.2, 183.7, 181.2, 153.7, 151.0, 135.4, 133.3, 132.7, 129.2, 127.7, 127.1, 126.4, 123.4, 40.2, 
124 
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(1R,4S,6S)-4-(benzyloxy)-6-methylcyclohex-2-enol (III-31) 
 
A solution of 528 mg (2.44 mmol) enone III-7 in 10 mL THF at -78 ºC was added 93 mg (2.44 
mmol) LiAlH4 in one portion. It was stirred at -78 ºC for 1 h and then diluted with 50 mL EtOAc 
and quenched with 16 mL saturated aqueous NaHCO3. The mixture was stirred at 0 ºC for 15 
min. The organic layer was separated and the aqueous layer was extracted with EtOAc. The 
pooled organic layer was washed with saturated brine and dried over Na2SO4. After removal of 
the solvent under reduced pressure, the residue was subjected to silica gel column 
chromatography. Elution with hexane-EtOAc (4:1, v/v) afforded allylic alcohol III-31 (454 mg 
85%). Rf = 0.48 (1:1 (v/v) hexane/EtOAc); [α]D20 -90 (c 1.33, CHCl3);  IR (thin film, cm-1) υ 
3357 (broad), 3064, 3029, 2952, 2928, 2908, 2869, 1497, 1454, 1390, 1375, 1326, 1305, 1196, 
1067, 1037, 1026, 971; 1H NMR (CDCl3, 600 MHz) δ 7.37-7.32 (m, 4H), 7.30-7.26 (m, 1H), 
5.88 (m, 2H), 4.60 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 3.87 (m, 1H), 3.68 (d, J = 9.0 
Hz, 1H), 1.94 (dddd, J = 14.4, 3.6, 3.0, 1.2 Hz, 1H), 1.68 (ddqd, J = 11.4, 8.4, 6.6, 3.0 Hz, 1H), 
1.43 (dddd, J = 13.8, 11.4, 4.2 Hz, 1H), 1.08 (d, 13J = 7.2 Hz, 3H); C NMR (CDCl3, 150 MHz) δ 
138.8, 134.9, 128.4, 127.7, 127.6, 127.5, 73.6, 70.8, 70.3, 38.9, 32.8, 18.2; HRMS (ESI): calcd. 
r [C14H18O2+Na]+: 241.1199, Found: 241.1199. 
 
 
 
(1R,2S,3S,4S,6S)-4-(benzyloxy)-6-methylcyclohexane-1,2,3-triol (III-33) 
fo
 
OH
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OBn
HO
HO
 
To a solution of 22 mg olefin III-31 (0.10 mmol) in 0.9 mL t-BuOH-actone-50% NMO(aq.) (1:1:1 
v/v/v) was added a small piece of crystalline OsO4 at 0 °C. The reaction mixture was stirred at 
0 °C for 2h, and then it was diluted with EtOAc 20 mL and 1.5 mL saturated aqueous Na2S2O3 
was added at 0 °C. It was stirred at 0 °C for 30 min.  The mixture was passed through a pad of 
sand-silica gel-celite, eluting with EtOAc-MeOH (3:1, v/v). The effluent was dried over Na2SO4 
,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-((1R,5R)-5-methyl-4-oxocyclohex-2-enyloxy)-
4H-chromen-4-one (III-9) 
and concentrated under reduced pressure to give a residue, which was purified by silica gel 
column. Elution with EtOAc-MeOH (20:1) gave triol III-33 (25 mg, 98%) as viscous colorless 
oil: Rf  = 0.46 (10:1 (v/v) EtOAc/MeOH); [α]D20 +14 (c 2.58, MeOH); IR (thin film, cm-1) υ 3357 
(broad), 3060, 3025, 2920, 2870, 1497, 1453, 1055, 1027, 976; 1H NMR (CD3OD, 600 MHz) δ 
7.35-7.30 (m, 4H), 7.28-7.23 (m, 1H), 4.57 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 12.0 Hz, 1H), 4.01 
(dd, J = 3.0, 3.0 Hz, 1H), 3.61 (m, 1H), 3.60 (dd, J = 9.6, 3.6 Hz, 1H), 3.27 (dd, J = 9.6, 9.6 Hz, 
1H), 1.77 (m, 1H), 1.73 (ddqd, J = 13.2, 10.2, 6.6, 3.6 Hz, 1H), 1.52 (ddd, J = 14.4, 12.6, 1.8 Hz 
1H), 1.01 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 140.3, 129.5, 128.8, 128.7, 78.6, 
76.8, 74.7, 72.9, 71.9, 33.4, 33.0, 18.6; HRMS (ESI): calcd. for [C14H20O4+Na]+: 275.1254, 
Found: 275.1255.  
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133 mg (0.24 mmol) perbenzylated flavonol III-8 and 65 mg (0.29 mmol) α-L-Boc-enone (III-4) 
was suspended in 2.5 mL CH2Cl2 at 0 ºC. A solution of 6.2 mg (0.006 mmol) Pd2(dba)3•CHCl3 
and 6.3 mg PPh  (0.024 mmol) in 1 mL CH Cl  wad added via a syringe at 0 ºC. The reaction 
7
3 2 2
mixture was stirred at 0 ºC for 30 min and then directly loaded onto a silica gel column, elution 
with hexane-EtOAc (3:1) gave glycosylated enone III-9 (133 mg, 84%): yellow solid, mp: 59-61 
ºC;  Rf = 0.60 (1:1 (v/v) hexane/EtOAc); [α]D20 + 57 (c 3.1, CHCl3); IR (thin film, cm-1) υ 3063, 
3034, 2931, 2872, 1734, 1681, 1626, 1602, 1572, 1508, 1452, 1436, 1375, 1355, 1296, 1248, 
1195, 1173, 1100, 1043, 1003, 972. 1H NMR (CDCl3, 600 MHz) δ 7.96 (d, J = 9.0 Hz, 2H), 7.58 
(d, J = 7.8 Hz, 2H), 7.46-7.29 (m, 13H), 7.04 (d, J = 9.0 Hz, 2H), 7.04 (dd, J = 10.2, 4.2 Hz, 1H), 
6.59 (d, J = 1.8 Hz, 1H), 6.48(d, J = 2.4 Hz, 1H), 5.92 (dd, J = 9.6, 1.2 Hz, 1H), 5.29 (s, 2H), 
5.14 (s, 2H), 5.09 (s, 2H), 5.07 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.60 (dqd, J = 10.2, 6.6, 4.8 Hz, 
1H), 2.11 (ddd, J = 13.8, 4.8, 4.2 Hz, 1H), 1.86 (ddd, J = 14.4, 10.2, 4.8 Hz, 1H), 0.94 (d, J = .2 
Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 201.9, 173.7, 162.9, 160.4, 159.8, 158.8, 154.1, 145.6, 
138.7, 136.3, 135.6, 130.4, 130.0, 128.7, 128.6, 128.6, 128.4, 128.2, 127.7, 127.5, 127.4, 126.6, 
123.3, 114.6, 109.9, 98.3, 94.0, 72.8, 70.8, 70.5, 70.1, 37.8, 35.8, 14.7; HRMS (ESI): calcd. for 
[C43H36O7+H]+: 665.2534, Found: 665.2530. 
 
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-((1R,4S,5R)-4-hydroxy-5-methylcyclohex-2-
enyloxy)-4H-chromen-4-one (III-34) 
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A solution of 115 mg (0.17 mmol) enone III-9 in 14 mL THF at -78 ºC was added 13 mg (0.35 
mmol) LiAlH4 in two portions. It was stirred at -78 ºC for 1 h and then 3 mL acetone was slowly 
added via syringe into the reaction mixture at -78 ºC. The mixture was stirred at -78 ºC for 20 
(1S,4R,6R)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-yloxy)-6-
ethylcyclohex-2-enyl acetate (III-35) 
min  and  diluted with 20 mL hexane-EtOAc (1:1, v/v) and quenched with 6 mL saturated 
aqueous NaHCO3. The mixture was stirred at 0 ºC for 20 min. The organic layer was separated 
and the aqueous layer was extracted with EtOAc. The pooled organic layer was washed with 
saturated brine and dried over Na2SO4. After removal of the solvent under reduced pressure, the 
residue was subjected to silica gel column chromatography. Elution with hexane-EtOAc (1.5:1, 
v/v) afforded allylic alcohol III-34 (97 mg, 89%). Rf = 0.38 (1:1 (v/v) hexane/EtOAc); [α]D20 + 
10 (c 3.7, CHCl3); IR (thin film, cm-1) υ 3507, 3035, 2949, 2900, 2862, 1626, 1597, 1507, 1447, 
1379, 1361, 1303, 1245, 1179, 1103, 1038, 947; 1H NMR (CDCl3, 600 MHz) δ 7.99 (d, J = 9.0 
Hz, 2H), 7.58 (d, J = 7.2 Hz, 2H), 7.46-7.27 (m, 13H), 7.05 (d, J = 9.0 Hz, 2H), 6.57 (d, J = 2.4 
Hz, 1H), 6.45 (d, J = 1.8 Hz, 1H), 6.03 (dddd, J = 9.6, 4.2, 1.8, 1.8 Hz, 1H), 5.80 (dd, J = 9.6, 1.8 
Hz, 1H), 5.28 (s, 2H), 5.15 (s, 2H), 5.08 (s, 2H), 4.73 (m, 1H), 3.59 (d, J = 8.4 Hz, 1H), 1.73 
(ddd, J = 14.4, 4.2, 2.4 Hz, 1H), 1.63 (ddqd, J = 13.2, 9.6, 6.6, 3.0 Hz, 1H), 1.29 (ddd, J = 15.0, 
12.6, 4.8 Hz, 1H), 0.79 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 174.0, 162.6, 160.2, 
159.8, 158.8, 154.0, 139.3, 136.5, 136.4, 135.7, 135.4, 130.6, 128.7, 128.7, 128.6, 128.4, 128.1, 
127.7, 127.6, 127.5, 127.4, 126.7, 123.8, 114.4, 110.1, 98.2, 94.0, 73.7, 73.5, 70.8, 70.4, 70.1, 
34.5, 33.0, 17.8; HRMS (ESI): calcd. for [C43H38O7+H]+: 667.2696, Found: 667.2678. 
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A solution of 95 mg (0.14 mmol) enone III-34 and 1.7 mg (0.014 mmol) DMAP in 2.5 mL 
CH2Cl2 at 0 ºC was added 250 µL (3.09 mmol) pyridine and 150 µL (1.59 mmol) Ac2O via 
syringe. It was stirred at 0 ºC for 2 h and diluted with 20 mL hexane-EtOAc (1:1, v/v) and 
(1S,2S,3R,4R,6R)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-
loxy)-2,3-dihydroxy-6-methylcyclohexyl acetate (III-36) 
washed with 6 mL 0.5 M aqueous NaHSO4. The organic layer was separated and the aqueous 
layer was extracted with EtOAc. The pooled organic layer was washed with saturated aqueous 
NaHCO3 and saturated brine subsequently and then dried over Na2SO4. After removal of the 
solvent under reduced pressure, the residue was subjected to silica gel column chromatography. 
Elution with hexane-EtOAc (3:1, v/v) afforded allylic acetate III-35 (94 mg, 93%). Pale yellow 
solid, mp: 68-70 ºC; Rf = 0.30 (hexane/EtOAc 2:1, v/v); [α]D20 -33 (c 3.15, CHCl3); IR (thin film, 
cm-1) υ 3063, 3033, 2930, 1729, 1625, 1602, 1508, 1453, 1434, 1372, 1356, 1295, 1243, 1172, 
1100, 1021, 920; 1H NMR (CDCl3, 600 MHz) δ 8.02 (d, J = 9.0 Hz, 2H), 7.58 (d, J = 7.2 Hz, 
2H), 7.47-7.27 (m, 13H), 7.06 (d, J = 9.6 Hz, 2H), 6.58 (d, J = 1.8 Hz, 1H), 6.45 (d, J = 2.4 Hz, 
1H), 6.13 (dddd, J = 10.2, 4.2, 1.8, 1.2 Hz, 1H), 5.71 (dd, J = 10.2, 1.8 Hz, 1H), 5.28 (s, 2H), 
5.15 (s, 2H), 5.08 (s, 2H), 4.88 (dddd, J = 9.0, 2.4, 1.8, 1.2 Hz, 1H), 4.74 (m, 1H), 2.09 (s, 3H), 
1.94 (ddqd, J = 13.2, 9.6, 6.6, 3.0 Hz, 1H), 1.77 (m, 1H), 1.40 (ddd, J = 14.4, 12.6, 4.8 Hz, 1H), 
0.70 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.9, 171.0, 162.7, 160.2, 159.8, 158.8, 
153.8, 139.4, 136.5, 136.4, 135.7, 131.1, 130.5, 129.2, 128.7, 128.7, 128.6, 128.4, 128.1, 127.6, 
127.5, 127.4, 126.6, 123.8, 114.4, 110.1, 98.2, 94.0, 75.2, 73.5, 70.8, 70.4, 70.1, 34.3, 29.5, 21.2, 
17.6 ; HRMS (ESI): calcd. for [C45H40O8+H]+: 709.2796, Found: 709.2782. 
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A solution of 92 mg (0.13 mmol) allylic acetate (III-35) in1 mL acetone-t-BuOH (1:1) was 
cooled down to 0 °C. To the solution was added 0.5 mL NMO-H2O (w/w 1:1), and a small piece 
of crystalline OsO  was added into the mixture. The reaction mixture was stirred at 0 °C for 20 
.1, 21.1, 17.3; HRMS (ESI) calcd. for 
45H42O10+H]+: 743.2851, Found: 743.2835. 
S,2S,3R,4R,6R)-4-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-2,3-
dihydroxy-6-methylcyclohexyl acetate (III-1) 
4
hours.  The reaction was diluted with 20 mL EtOAc and then quenched with 1 mL saturated 
Na2S2O3 (aq.) and stirred for 1 h at 0 °C. Then the mixture was passed through a small pad of 
celite/silica gel/sand and washed with EtOAc-MeOH (3:1). The effluent was dried over Na2SO4, 
and concentrated under reduced pressure to give a residue. Chromatography on silica gel eluting 
with hexane-EtOAc (1.5:1) gave diol III-36 (70 mg, 73%): White solid, mp: 97-99 ºC; Rf = 0.24 
(1:2 (v/v), hexane/EtOAc); [α]D20 -47 (c 2.7, CHCl3); IR (thin film, cm-1) υ 3404, 3064, 2932, 
1727, 1601, 1508, 1453, 1433, 1373, 1297, 1247, 1196, 1172, 1099, 1036, 959; 1H NMR (CDCl3, 
600 MHz) δ 7.90 (d, J = 9.0 Hz, 2H), 7.55 (d, J = 7.2 Hz, 2H), 7.47-7.27 (m, 13H), 7.08 (d, J = 
9.0 Hz, 2H), 6.56 (d, J = 2.4 Hz, 1H), 6.46 (d, J = 2.4 Hz, 1H), 5.26 (s, 2H), 5.15 (s, 2H), 5.07 (s, 
2H), 4.79 (dd, J = 7.8, 7.2 Hz, 1H), 4.28 (ddd, J = 5.4, 5.4, 3.0 Hz, 1H), 4.17 (dd, J = 3.6, 4.8 Hz, 
1H), 3.85 (dd, J = 7.2, 3.0 Hz, 1H), 2.85 (brs, 1H), 2.08 (s, 3H), 1.80 (m, 1H), 1.69 (ddd, J = 
14.4, 5.4, 4.8 Hz, 1H ), 1.41 (ddd, J = 13.8, 9.6, 3.6 Hz, 1H), 0.81 (d, J = 6.6 Hz, 3H); 13C NMR 
(CDCl3, 150 MHz) δ 174.2, 171.3, 163.0, 160.5, 159.8, 158.8, 154.4, 139.3, 136.4, 136.3, 135.6, 
130.6, 128.7, 128.7, 128.6, 128.4, 128.2, 127.7, 127.5, 127.4, 126.7, 123.4, 114.6, 109.8, 98.4, 
94.0, 80.6, 76.9, 72.0, 71.9, 70.9, 70.5, 70.1, 32.7, 31
[C
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To a solution of 17 mg (0.023 mmol) diol III-36 in 2.5 mL THF-EtOH (1:1) was added 21 mg 
Pd/C (10%). The reaction mixture was degassed at -50 to -40 °C using vacuum and refilled with 
H . This procedure was repeated three times, then the bath was removed and the reaction was 
2
h hexane-EtOAc (1.5:1) to 
give product (III-1) (7.3 mg, 68%): Yellow solid, mp: 161-163 ºC; Rf = 0.24 (1:4 (v/v) 
hexane/EtOAc); [α]D20 -31 (c 0.49, MeOH); IR (thin film, cm-1) υ 3283, 2923, 1710, 1649, 1607, 
1499, 1436, 1360, 1259, 1208, 1170, 1085, 1039, 971; 1H NMR (CD3OD, 600 MHz) δ 7.78 (d, J 
= 9.0 Hz, 2H), 6.94 (d, J = 8.4 Hz, 2H), 6.38 (d, J = 1.8 Hz, 1H), 6.21 (d, J = 1.8 Hz, 1H), 4.76 
(dd, J = 10.2, 10.2 Hz, 1H), 4.31 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 4.08 (dd, J = 3.0, 3.0 Hz, 1H), 
3.72 (dd, J = 9.6, 3.0 Hz, 1H), 2.07 (s, 3H), 1.70 (ddqd, J = 12.6, 10.2, 6.0, 3.0 Hz, 1H), 1.64 
(dddd, J = 15.0, 4.2, 3.0, 1.2 Hz, 1H ), 1.50 (ddd, J = 15.0, 12.6, 2.4 Hz, 1H), 0.70 (d, J = 5.4 Hz, 
2
warmed up to room temperature. The reaction mixture was stirred under a H  atmosphere for 12 
hours. The reaction mixture was loaded onto silica gel and elution wit
3H); 13C NMR (CD3OD, 150 MHz) δ 180.2, 173.5, 166.0, 163.4, 161.8, 159.4, 158.7, 137.7, 
132.2, 123.0, 116.6, 106.2, 99.9, 94.9, 82.1, 79.0, 72.9, 72.3, 33.3, 32.1, 21.2, 18.0; HRMS (ESI) 
calcd. for [C24H24O10+H]+: 473.1442, Found: 473.1441. 
 
 
 
(1S,2R,3R,4R,6R)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-
yloxy)-2-hydroxy-6-methylcyclohexane-1,3-diyl diacetate (III-37) 
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(1S,2S,3S,4R,6R)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-
yloxy)-3-hydroxy-6-methylcyclohexane-1,2-diyl diacetate (III-38) 
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To a solution of 46 mg (0.062 mmol)  diol III-36 in 1.3 mL CH2Cl2 at 0 °C was added 1.0 mg 
(5.5 µmol) p-TsOH•H2O, 48 µL trimethylorthoacetate (0.36 mmol). After stirring at 0 °C for 20 
min, 0.5 mL 90% HOAc (aq.) was added at 0 °C, and the reaction mixture was stirred for another 
15 min at 0 °C. The reaction mixture was diluted with 30 mL EtOAc and washed at 0 °C with 15 
mL saturated aqueous NaHCO3. It was then washed by 10 mL saturated brine, and dried over 
Na2SO4. The organic layer was concentrated under 
132 
 
reduced pressure to give crude product, 
which was then subjected to chromatography on silica gel. Elution with hexane-EtOAc (1:1) 
ave diacetate III-37 (26 mg, 54%) and III-38 (16.5 mg, 34%):  
I-37: White solid, mp: 99-101 ºC; Rf  = 0.36 (1:1.5 (v/v) hexane/EtOAc); [α]D20 +26 (c 1.23, 
CHCl3); IR (thin film, cm-1) υ 3471, 3030, 2932, 1731, 1626, 1603, 1574, 1509, 1453, 1432, 
370, 1298, 1228, 1172, 1101, 1039, 963; 1H NMR (CDCl3, 600 MHz) δ 7.85 (d, J = 9.0 Hz, 
H), 7.56 (d, J = 7.2 Hz, 2H), 7.47-7.27 (m, 13H), 7.11 (d, J = 9.0 Hz, 2H), 6.56 (d, J = 2.4 Hz, 
1H), 6.44 (d, J = 2.4 Hz, 1H), 5.28 (s, 2H), 5.15 (s, 2H), 5.07 (s, 2H), 5.06 (ddd, J = 3.6, 3.6, 1.2 
Hz, 1H), 4.70 (dd, J = 10.8, 10.2 Hz, 1H), 4.39 (dddd, J = 3.0, 3.0, 2.4 Hz, 1H), 3.76 (ddd, J = 
g
II
1
2
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.97 
, 1H ), 1.49 (ddd, J = 15.0, 13.2, 3.0 
Hz, 1H), 0.88 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.5, 171.9, 170.1, 162.8, 
160.6, 159.8, 158.8, 154.1, 139.1, 136.4, 135.7, 130.5, 128.8, 128.7, 128.6, 128.4, 128.2, 127.7, 
127.5, 127.4, 126.7, 123.3, 114.8, 110.1, 98.4, 94.0, 77.7, 73.1, 70.8, 70.5, 70.3, 70.2, 33.5, 30.4, 
21.1, 21.0, 17.4; HRMS (ESI) calcd. for [C47H44O11+H]+: 785.2956, Found: 785.2940. 
III-38: White solid, mp: 89-91 ºC; Rf  = 0.47 (1:1.5 (v/v) hexane/EtOAc); [α]D20 -63 (c 1.32, 
CHCl3); IR (thin film, cm-1) υ 3426, 3031, 2930, 1735, 1623, 1603, 1573, 1508, 1453, 1432, 
1367, 1297, 1249, 1224, 1173, 1101, 1040, 962; 1H NMR (CDCl3, 600 MHz) δ 7.90 (d, J = 9.0 
S,2R,3R,4R,6R)-4-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-2-
hydroxy-6-methylcyclohexane-1,3-diyl diacetate (III-2) 
9.6, 6.0, 3.6 Hz, 1H), 2.18 (dddd, J = 14.4, 4.2, 3.0, 1.8 Hz, 1H), 2.11 (s, 3H), 2.01 (s, 3H), 1
(ddqd, J = 13.2, 10.2, 6.0, 3.6 Hz, 1H), 1.85 (d, J = 5.4 Hz
Hz, 2H), 7.56 (d, J = 7.8 Hz, 2H), 7.47-7.27 (m, 13H), 7.11 (d, J = 9.0 Hz, 2H), 6.57 (d, J = 2.4 
Hz, 1H), 6.45 (d, J = 2.4 Hz, 1H), 5.26 (s, 2H), 5.22 (dd, J =9.0, 3.0 Hz, 1H), 5.16 (d, J =11.4 Hz, 
1H), 5.15 (d, J = 12.0 Hz, 1H), 5.08 (s, 2H), 4.92 (dd, J = 9.6, 9.0 Hz, 1H), 4.41 (ddd, J = 4.2, 
3.6, 3.6 Hz, 1H), 4.31 (dd, J = 3.6, 3.6 Hz, 1H), 2.93 (brs, 1H), 2.02 (s, 3H), 2.02 (s, 3H), 1.81 
(ddqd, J = 13.2, 10.8, 6.6, 3.6 Hz, 1H), 1.73 (ddd, J = 14.4, 4.2, 4.2 Hz, 1H), 1.52 (ddd, J = 14.4, 
10.8, 3.0 Hz, 1H), 0.74 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.8, 170.5, 169.5, 
162.8, 160.5, 159.8, 158.8, 154.1, 139.3, 136.5, 136.3, 135.6, 130.5, 128.8, 128.7, 128.6, 128.4, 
128.1, 127.7, 127.6, 127.4, 126.7, 123.3, 114.8, 110.0, 98.3, 94.0, 79.7, 74.5, 73.4, 70.9, 70.8, 
70.5, 70.1, 32.3, 31.0, 20.9, 20.9, 17.2; HRMS (ESI) calcd. for [C47H44O11+H]+: 785.2956, 
Found: 785.2942. 
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To a solution of 19 mg (0.024 mmol) diol III-37 in 2.5 mL THF-EtOH (1:1) was added 23 mg 
Pd/C (10%). The reaction mixture was degassed at -50 to -40 °C using vacuum and refilled with 
H . This procedure was repeated three times, then the bath was removed and the reaction was 
), 2.02 (s, 3H), 1.83 (ddqd, 
 
 
(1S,2S,3S,4R,6R)-4-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-3-
ydroxy-6-methylcyclohexane-1,2-diyl diacetate (III-3) 
2
warmed up to room temperature. The reaction mixture was stirred under a H2 atmosphere for 12 
hours. The reaction mixture was loaded onto silica gel and elution with hexane-EtOAc (1:1) to 
give product (III-2) (7.7 mg, 63%): Yellow solid, mp: 165-167 ºC; Rf = 0.31 (1:3 (v/v) 
hexane/EtOAc); [α]D20 +4 (c 0.51, MeOH); IR (thin film, cm-1) υ 3220, 2961, 1717, 1650, 1607, 
1505, 1441, 1366, 1248, 1210, 1174, 1108, 1084, 1040, 1008, 972; 1H NMR (CD3OD, 600 MHz) 
δ 7.78 (d, J = 8.4 Hz, 2H), 6.94 (d, J = 9.0 Hz, 2H), 6.38 (d, J = 2.4 Hz, 1H), 6.21 (d, J = 1.8 Hz, 
1H), 5.22 (ddd, J = 3.6, 3.6, 1.2 Hz, 1H), 4.73 (dd, J = 10.2, 10.2 Hz, 1H), 4.28 (ddd, J = 3.0, 3.0, 
3.0 Hz, 1H), 3.91 (dd, J = 9.6, 3.0 Hz, 1H), 2.08 (s, 3H J = 13.2, 10.2, 
6.6, 3.6 Hz, 1H), 1.82 (ddd, J = 15.6, 3.6, 3.0, 1.2 Hz, 1H), 1.44 (ddd, J = 16.2, 13.8, 3.0 Hz, 1H), 
0.78 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 179.9, 173.2, 172.0, 166.0, 163.4, 
161.9, 159.4, 158.7, 137.4, 132.1, 122.8, 116.7, 106.1, 100.0, 94.9, 78.8, 78.8, 74.5, 70.4, 34.1, 
32.0, 21.2, 21.0, 18.0; HRMS (ESI) calcd. for [C26H26O11+H]+: 515.1548, Found: 515.1547. 
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To a solution of 20 mg (0.0255 mmol) diol III-38 in 2.5 mL THF-EtOH (1:1) was added 21.6 
mg Pd/C (10%). The reaction mixture was degassed at -50 to -40 ºC using vacuum and refilled 
with H . This procedure was repeated three times, then the bath was removed and the reaction 
 
5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-((1S,5S)-5-methyl-4-oxocyclohex-2-enyloxy)-
H-chromen-4-one ((ent)-III-9) 
2
was warmed up to room temperature. The reaction mixture was stirred under a H2 atmosphere for 
7 hours. The reaction mixture was loaded onto silica gel and elution with hexane-EtOAc (1.5:1) 
to give product (III-3) (9.8 mg, 75%): Yellow solid, mp: 127-129 ºC; Rf = 0.36 (1:3 (v/v) 
hexane/EtOAc); [α]D20 -93 (c 0.75, MeOH); IR (thin film, cm-1) υ 3342, 2927, 1716, 1650, 1607, 
1505, 1437, 1364, 1208, 1171, 1084, 1042, 1008, 972; 1H NMR (CD3OD, 600 MHz) δ 7.79 (d, J 
= 9.0 Hz, 2H), 6.94 (d, J = 8.4 Hz, 2H), 6.38 (d, J = 1.8 Hz, 1H), 6.20 (d, J = 2.4Hz, 1H), 5.06 
(dd, J = 10.2, 3.0 Hz, 1H), 4.94 (dd, J = 10.8, 10.2 Hz, 1H), 4.47 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 
4.26 (ddd, J = 4.2, 4.2, 1.2 Hz, 1H), 2.02 (s, 3H), 1.99 (s, 3H), 1.65 (ddqd, J = 12.6, 10.2, 6.0, 3.6 
Hz, 1H), 1.62 (ddd, J = 15.6, 4.2, 3.0, 1.2 Hz, 1H), 1.50 (ddd, J = 15.0, 13.2, 2.4 Hz, 1H), 0.67 (d, 
J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 180.1, 172.7, 172.2, 166.0, 163.4, 161.7, 159.5, 
158.7, 137.2, 132.2, 122.9, 116.6, 106.2, 99.9, 94.9, 81.3, 75.9, 75.1, 70.8, 32.7, 32.2, 21.0, 20.9, 
17.9; HRMS (ESI) calcd. for [C26H26O11+H]+: 515.1548, Found: 515.1547. 
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85 mg (0.15 mmol) perbenzylated flavonol III-8 and 50 mg (0.22 mmol) α-D-Boc-enone (ent)-
III-4 was suspended in 1.5 mL CH2Cl2 at 0 ºC. A solution of 4.0 mg (0.004 mmol) 
Pd (DBA) •CHCl  and 4.0 mg PPh  (0.015 mmol) in 0.5 mL CH Cl  wad added via a syringe at 
ydroxy-5-methylcyclohex-2-
enyloxy)-4H-chromen-4-one ((ent)-III-34) 
2 3 3 3 2 2
0 ºC. The reaction mixture was stirred at 0 ºC for 30 min and then directly loaded onto a silica gel 
column, elution with hexane-EtOAc (3:1) gave glycosylated enone (ent)-III-9 (86 mg, 84%). Off 
white powder, mp: 63-65 ºC; Rf = 0.60 (1:1 (v/v) hexane/EtOAc); [α]D20 -63 (c 2.2, CHCl3); IR 
(thin film, cm-1) υ 3033, 2931, 1731, 1681, 1625, 1602, 1572, 1508, 1452, 1433, 1375, 1354, 
1297, 1250, 1171, 1100, 1002, 972. 1H NMR (CDCl3, 600 MHz) δ 7.96 (d, J = 8.4 Hz, 2H), 7.58 
(d, J = 7.2 Hz, 2H), 7.46-7.29 (m, 13H), 7.04 (d, J = 9.0 Hz, 2H), 7.04 (dd, J = 10.2, 4.2 Hz, 1H), 
6.59 (d, J = 2.4 Hz, 1H), 6.47 (d, J = 2.4 Hz, 1H), 5.92 (d, J = 9.6 Hz, 1H), 5.28 (s, 2H), 5.14 (s, 
2H), 5.09 (s, 2H), 5.07 (ddd, J = 4.8, 4.2, 4.2 Hz, 1H), 2.60 (dqd, J = 10.2, 7.2, 4.8 Hz, 1H), 2.11 
(ddd, J = 13.8, 4.2, 4.2 Hz, 1H), 1.86 (ddd, J = 14.4, 10.2, 4.8 Hz, 1H), 0.95 (d, J = 6.6Hz, 3H); 
13C NMR (CDCl3, 150 MHz) δ 201.9, 173.7, 162.9, 160.5, 159.8, 158.8, 154.1, 145.6, 138.7, 
136.3, 135.6, 130.4, 130.0, 128.7, 128.7, 128.6, 128.4, 128.2, 127.7, 127.5, 127.4, 126.6, 123.3, 
114.6, 110.0, 98.3, 94.0, 72.8, 70.9, 70.5, 70.1, 37.8, 35.8, 14.7. 
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A solution of 135 mg (0.20 mmol) enone (ent)-III-9 in 15 mL THF at -78 ºC was added 15 mg 
(0.4 mmol) LiAlH4 in two portions. It was stirred at -78 ºC for 1 h and then 3 mL acetone was 
slowly added via syringe into the reaction mixture at -78 ºC. The mixture was stirred at -78 ºC 
(1R,4S,6S)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-yloxy)-6-
ethylcyclohex-2-enyl acetate ((ent)-III-35) 
for 20 min  and  diluted with 20 mL hexane-EtOAc (1:1, v/v) and quenched with 6 mL saturated 
aqueous NaHCO3. The mixture was stirred at 0 ºC for 20 min. The organic layer was separated 
and the aqueous layer was extracted with EtOAc. The pooled organic layer was washed with 
saturated brine and dried over Na2SO4. After removal of the solvent under reduced pressure, the 
residue was subjected to silica gel column chromatography. Elution with hexane-EtOAc (1.5:1, 
v/v) afforded allylic alcohol (ent)-III-34 (118 mg, 89%). Pale yellow solid, mp: 72-74 ºC; Rf = 
0.38 (1:1 (v/v) hexane/EtOAc); [α]D20 -12 (c 2.1, CHCl3); IR (thin film, cm-1) υ 3422, 3064, 3032, 
2927, 1735, 1620, 1601, 1508, 1452, 1373, 1355, 1296, 1249, 1172, 1100, 1041, 1013, 966; 1H 
NMR (CDCl3, 600 MHz) δ 7.99 (d, J = 8.4 Hz, 2H), 7.58 (d, J = 7.2 Hz, 2H), 7.46-7.27 (m, 
13H), 7.05 (d, J = 9.0 Hz, 2H), 6.57 (d, J = 2.4 Hz, 1H), 6.45 (d, J = 2.4 Hz, 1H), 6.03 (dddd, J = 
9.6, 3.6, 1.8, 1.2 Hz, 1H), 5.80 (dd, J = 9.6, 1.8 Hz, 1H), 5.28 (s, 2H), 5.15 (s, 2H), 5.08 (s, 2H), 
4.73 (m, 1H), 3.59 (dd, J = 7.8, 7.2 Hz, 1H), 1.73 (ddd, J = 14.4, 4.2, 3.0 Hz, 1H), 1.63 (ddqd, J 
= 13.2, 9.6, 6.6, 3.0 Hz, 1H), 1.29 (ddd, J = 14.4, 12.0, 4.2 Hz, 1H), 0.79 (d, J = 6.6 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz) δ 174.0, 162.7, 160.2, 159.8, 158.8, 154.0, 139.3, 136.5, 136.4, 135.7, 
135.4, 130.6, 128.7, 128.7, 128.6, 128.4, 128.1, 127.7, 127.6, 127.6, 127.4, 126.7, 123.8, 114.4, 
110.1, 98.2, 94.0, 73.6, 73.5, 70.8, 70.4, 70.1, 34.5, 33.0, 17.8. 
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A solution of 99 mg (0.15 mmol) enone (ent)-III-34 and 1.8 mg (0.015 mmol) DMAP in 2.0 mL 
CH2Cl2 at 0 ºC was added 200 µL (2.0 mmol) pyridine and 94 µL (1.0 mmol) Ac2O via syringe. 
It was stirred at 0 ºC for 2 h and diluted with 20 mL hexane-EtOAc (1:1, v/v) and washed with 5 
(1R,2R,3S,4S,6S)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-
loxy)-2,3-dihydroxy-6-methylcyclohexyl acetate ((ent)-III-36) 
mL 0.5 M aqueous NaHSO4. The organic layer was separated and the aqueous layer was 
extracted with EtOAc. The pooled organic layer was washed with saturated aqueous NaHCO3 
and saturated brine subsequently and then dried over Na2SO4. After removal of the solvent under 
reduced pressure, the residue was subjected to silica gel column chromatography. Elution with 
hexane-EtOAc (3:1, v/v) afforded allylic acetate (ent)-III-35 (103 mg, 98%). Pale yellow solid, 
mp: 61-63 ºC, Rf = 0.30 (hexane/EtOAc 2:1, v/v); [α]D20 +31 (c 3.25, CHCl3); IR (thin film, cm-1) 
υ 3065, 3034, 2958, 2931, 2873, 1732, 1626, 1602, 1508, 1452, 1434, 1372, 1356, 1295, 1242, 
1173, 1101, 1022, 920; 1H NMR (CDCl3, 600 MHz) δ 8.02 (d, J = 9.0 Hz, 2H), 7.58 (d, J = 7.2 
Hz, 2H), 7.47-7.27 (m, 13H), 7.06 (d, J = 9.0 Hz, 2H), 6.58 (d, J = 1.8 Hz, 1H), 6.45 (d, J = 2.4 
Hz, 1H), 6.13 (dddd, J = 10.2, 4.8, 1.8, 1.8 Hz, 1H), 5.71 (dd, J = 10.2, 1.8 Hz, 1H), 5.28 (s, 2H), 
5.15 (s, 2H), 5.08 (s, 2H), 4.88 (dddd, J = 9.0, 1.8, 1.8, 1.8 Hz, 1H), 4.74 (m, 1H), 2.09 (s, 3H), 
1.94 (ddqd, J = 13.2, 9.6, 6.6, 3.0 Hz, 1H), 1.77 (m, 1H), 1.40 (ddd, J = 14.4, 12.6, 4.8 Hz, 1H), 
0.70 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.9, 171.0, 162.7, 160.2, 159.8, 158.8, 
153.8, 139.4, 136.5, 136.4, 135.7, 131.1, 130.5, 129.2, 128.7, 128.7, 128.6, 128.4, 128.1, 127.7, 
127.6, 127.4, 126.7, 123.8, 114.4, 110.1, 98.2, 94.0, 75.2, 73.5, 70.8, 70.4, 70.1, 34.3, 29.5, 21.2, 
17.6. 
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A solution of 103 mg (0.145 mmol) allylic acetate ((ent)-III-35) in 2 mL acetone-t-BuOH (1:1) 
was cooled down to 0 °C. To the solution was added 1 mL NMO-H2O (w/w 1:1), and a small 
piece of crystalline OsO  was added into the mixture. The reaction mixture was stirred at 0 °C 
27.7, 127.5, 127.4, 126.7, 123.4, 114.6, 109.8, 98.3, 94.0, 80.6, 76.9, 72.0, 71.9, 70.8, 70.5, 70.1, 
32.7, 31.0, 21.1, 17.3. 
 
(1R,2R,3S,4S,6S)-4-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-2,3-
ihydroxy-6-methylcyclohexyl acetate ((ent)-III-1) 
4
for 12 hours.  The reaction was diluted with 20 mL EtOAc and then quenched with 2 mL 
saturated Na2S2O3 (aq.) and stirred for 2 h at 0 °C. Then the mixture was passed through a small 
pad of celite/silica gel/sand and washed with EtOAc-MeOH (3:1). The effluent was dried over 
Na2SO4, and concentrated under reduced pressure to give a residue. Chromatography on silica 
gel eluting with hexane-EtOAc (1:1.5) gave diol (ent)-III-36 (89 mg, 82%): White solid, mp: 91-
93 ºC; Rf = 0.12 (1:1 (v/v), hexane/EtOAc); [α]D20 +47 (c 2.95, CHCl3); IR (thin film, cm-1) υ 
3418, 3032, 2929, 1727, 1602, 1508, 1452, 1432, 1372, 1357, 1298, 1247, 1197, 1172, 1099, 
1036, 959; 1H NMR (CDCl3, 600 MHz) δ 7.90 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 7.8 Hz, 2H), 
7.47-7.27 (m, 13H), 7.08 (d, J = 8.4 Hz, 2H), 6.56 (d, J = 2.4 Hz, 1H), 6.45 (d, J = 1.8 Hz, 1H), 
5.26 (s, 2H), 5.15 (s, 2H), 5.08 (s, 2H), 4.80 (dd, J = 7.8, 7.2 Hz, 1H), 4.28 (ddd, J = 5.4, 5.4, 3.0 
Hz, 1H), 4.17 (ddd, J = 5.4, 3.0, 3.0 Hz, 1H), 3.85 (ddd, J = 7.2, 4.2, 4.2 Hz, 1H), 2.86 (d, J = 4.2 
Hz, 1H), 2.08 (s, 3H), 1.80 (m, 1H), 1.69 (ddd, J = 13.8, 5.4, 4.8 Hz, 1H ), 1.41 (ddd, J = 13.8, 
9.6, 3.6 Hz, 1H), 0.81 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 174.1, 171.3, 162.9, 
160.5, 159.8, 158.8, 154.4, 139.2, 136.3, 136.2, 135.6, 130.6, 128.7, 128.7, 128.6, 128.4, 128.2, 
1
d
 To a solution of 26 mg (0.035 mmol) diol (ent)-III-36 in 2 mL THF-EtOH (1:1) was added 26 
mg Pd/C (10%). The reaction mixture was degassed at -50 to -40 °C using vacuum and refilled 
with H2. This procedure was repeated three times, then the bath was removed and the reaction 
med up to room temperature. The reaction mixture was stirred under a H2 atmosphere for 
:1.5) 
; Rf = 0.24 (1:4 (v/v) 
hexane/EtOAc); [α]D20 +34 (c 0.78, MeOH); IR (thin film, cm-1) υ 3217, 2927, 1709, 1650, 1607, 
1497, 1440, 1361, 1258, 1207, 1171, 1085, 1037, 970; 1H NMR (CD3OD, 600 MHz) δ 7.78 (d, J 
= 9.0 Hz, 2H), 6.94 (d, J = 9.0 Hz, 2H), 6.38 (d, J = 2.4 Hz, 1H), 6.20 (d, J = 1.8 Hz, 1H), 4.76 
(dd, J = 10.8, 9.6 Hz, 1H), 4.31 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 4.08 (ddd, J = 3.6, 3.0, 1.2 Hz, 
1H), 3.72 (dd, J = 9.6, 3.0 Hz, 1H), 2.07 (s, 3H), 1.70 (ddqd, J = 13.2, 10.8, 7.2, 3.6 Hz, 1H), 
1.64 (dddd, J = 15.0, 4.2, 3.0, 1.8 Hz, 1H ), 1.50 (ddd, J = 15.0, 12.6, 2.4 Hz, 1H), 0.69 (d, J = 
6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 180.1, 173.5, 166.0, 163.4, 161.8, 159.4, 158.7, 
137.7, 132.2, 123.0, 116.6, 106.2, 99.9, 94.9, 82.1, 79.0, 72.9, 72.3, 33.3, 32.1, 21.2, 18.0. 
clohexane-1,3-diyl diacetate ((ent)-III-37) 
was war
7 hours. The reaction mixture was loaded onto silica gel and elution with hexane-EtOAc (1
to give product (ent)-(III-1) (12 mg, 73%): Yellow solid, mp: 148-150 ºC
 
 
 
 
(1R,2S,3S,4S,6S)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-
yloxy)-2-hydroxy-6-methylcy
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(1R,2R,3R,4S,6S)-4-(5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-4-oxo-4H-chromen-3-
yloxy)-3-hydroxy-6-methylcyclohexane-1,2-diyl diacetate ((ent)-III-38) 
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To a solution of 59 mg (0.080 mmol)  diol (ent)-III-36 in 1 mL CH2Cl2 at 0 °C was added 0.6 
mg (3.2 µmol) p-TsOH•H2O, 35 µL (0.27 mmol) trimethylorthoacetate. After stirring at 0 ºC for 
20 min, 0.5 mL 90% HOAc (aq.) was added at 0 ºC, and the reaction mixture was stirred for 
another 20 min at 0 °C. The reaction mixture was diluted with 20 mL EtOAc and washed at 0 °C 
with 15 mL saturated aqueous NaHCO3. It was then washed with 15 mL saturated brine, and 
dried over Na2SO4. The organic layer was concentrated under reduced pressure to give crude 
product, which was then subjected to chromatography on silica gel. Elution with hexane-EtOAc 
(1:1) gave diacetate (ent)-III-37 (28 mg, 45%) and elution with hexane-EtOAc (1:1.25) gave 
)-III-38 (27.5 mg, 44%):  
)-III-37: White solid, mp: 99-101 ºC; Rf  = 0.27 (1:1.5 (v/v) hexane/EtOAc); [α]D20 -28 (c 
1.46, CHCl3); IR (thin film, cm-1) υ 3474, 3066, 2930, 1732, 1626, 1603, 1574, 1509, 1453, 1433, 
1370, 1298, 1225, 1172, 1100, 1039, 963; 1H NMR (CDCl3, 600 MHz) δ 7.85 (d, J = 9.0 Hz, 
(ent
(ent
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 Hz, 
 2H), 5.06 (ddd, J =3.0, 3.0, 1.8 
Hz, 1H), 4.70 (dd, J = 10.8, 10.2 Hz, 1H), 4.39 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 3.75 (m, 1H), 
2.18 (ddd, J = 15.0, 3.6, 2.4, 1.2 Hz, 1H), 2.10 (s, 3H), 2.01 (s, 3H), 1.97 (ddqd, J = 13.2, 10.8, 
6.6, 4.2 Hz, 1H), 1.85 (d, J = 5.4 Hz, 1H ), 1.49 (ddd, J = 15.0, 12.6, 3.0 Hz, 1H), 0.88 (d, J = 6.0 
Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.5, 171.9, 170.1, 162.8, 160.6, 159.8, 158.8, 154.1, 
139.1, 136.4, 135.6, 130.5, 128.7, 128.7, 128.6, 128.4, 128.2, 127.7, 127.5, 127.4, 126.6, 123.3, 
114.8, 110.1, 98.4, 94.0, 77.7, 73.1, 70.8, 70.5, 70.3, 70.2, 33.5, 30.3, 21.1, 21.0, 17.4. 
 
 
(1R,2S,3S,4S,6S)-4-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-2-
ydroxy-6-methylcyclohexane-1,3-diyl diacetate ((ent)-III-2) 
2H), 7.56 (d, J = 7.2 Hz, 2H), 7.47-7.27 (m, 13H), 7.11 (d, J = 9.0 Hz, 2H), 6.56 (d, J = 2.4
1H), 6.44 (d, J = 2.4 Hz, 1H), 5.28 (s, 2H), 5.15 (s, 2H), 5.07 (s,
(ent)-III-38: White solid, mp: 98-100 ºC; Rf  = 0.38 (1:1.5 (v/v) hexane/EtOAc); [α]D20 +66 (c 
1.95, CHCl3); IR (thin film, cm-1) υ 3436, 3033, 2932, 1735, 1603, 1573, 1508, 1453, 1432, 1366, 
1298, 1248, 1223, 1172, 1100, 1039, 962; 1H NMR (CDCl3, 600 MHz) δ 7.90 (d, J = 8.4 Hz, 
2H), 7.56 (d, J = 7.2 Hz, 2H), 7.47-7.27 (m, 13H), 7.11 (d, J = 9.0 Hz, 2H), 6.56 (d, J = 2.4 Hz, 
1H), 6.45 (d, J = 2.4 Hz, 1H), 5.26 (s, 2H), 5.22 (dd, J =9.0, 3.6 Hz, 1H), 5.16 (d, J =11.4 Hz, 
1H), 5.15 (d, J = 12.0 Hz, 1H), 5.08 (s, 2H), 4.93 (dd, J = 9.6, 9.0 Hz, 1H), 4.42 (ddd, J = 4.2, 
3.6, 3.6 Hz, 1H), 4.32 (dd, J = 4.2, 4.2 Hz, 1H), 2.98 (brs, 1H), 2.02 (s, 3H), 2.02 (s, 3H), 1.80 
(ddqd, J = 13.8, 10.8, 6.6, 4.2 Hz, 1H), 1.73 (ddd, J = 14.4, 4.2, 3.6 Hz, 1H), 1.52 (ddd, J = 14.4, 
11.4, 3.0 Hz, 1H), 0.73 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz) δ 173.7, 170.4, 169.5, 
162.8, 160.4, 159.8, 158.8, 154.1, 139.2, 136.5, 136.3, 135.6, 130.5, 128.7, 128.6, 128.6, 128.4, 
128.1, 127.7, 127.5, 127.4, 126.7, 123.3, 114.7, 110.0, 98.3, 93.9, 79.7, 74.5, 73.4, 70.8, 70.8, 
70.5, 70.1, 32.3, 31.0, 20.9, 20.9, 17.2. 
 
h
 To a solution of 26 mg (0.033 mmol) diol (ent)-III-37 in 1.5 mL THF-EtOH (1:1) was added 26 
mg Pd/C (10%). The reaction mixture was degassed at -50 to -40 °C using vacuum and refilled 
with H . This procedure was repeated three times, then the bath was removed and the reaction 
 
 
(1R,2R,3R,4S,6S)-4-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yloxy)-3-
ydroxy-6-methylcyclohexane-1,2-diyl diacetate ((ent)-III-3) 
2
was warmed up to room temperature. The reaction mixture was stirred under a H2 atmosphere for 
5 hours. The reaction mixture was loaded onto silica gel and elution with hexane-EtOAc (1:1.5) 
to give product (ent)-III-2 (11 mg, 65%): Yellow solid, mp: 167-169 ºC; Rf = 0.11 (1:1.5 (v/v) 
hexane/EtOAc); [α]D20 -5 (c 0.76, MeOH); IR (thin film, cm-1) υ 3200, 2926, 1717, 1650, 1607, 
1503, 1441, 1361, 1248, 1208, 1171, 1109, 1083, 1038, 1008, 972; 1H NMR (CD3OD, 600 MHz) 
δ 7.78 (d, J = 8.4 Hz, 2H), 6.94 (d, J = 9.0 Hz, 2H), 6.38 (d, J = 1.8 Hz, 1H), 6.21 (d, J = 1.8 Hz, 
1H), 5.22 (ddd, J = 3.6, 3.6, 1.2 Hz, 1H), 4.73 (dd, J = 10.2, 10.2 Hz, 1H), 4.28 (ddd, J = 3.0, 3.0, 
3.0 Hz, 1H), 3.91 (dd, J = 10.2, 3.6 Hz, 1H), 2.08 (s, 3H), 2.02 (s, 3H), 1.83 (ddqd, J = 13.2, 10.2, 
6.6, 3.0 Hz, 1H), 1.82 (ddd, J = 15.6, 4.2, 3.0, 1.8 Hz, 1H), 1.44 (ddd, J = 15.6, 13.8, 3.0 Hz, 1H), 
0.78 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 179.9, 173.2, 172.0, 166.0, 163.4, 
161.9, 159.4, 158.7, 137.4, 132.1, 122.8, 116.7, 106.1, 100.0, 94.9, 78.8, 78.8, 74.5, 70.4, 34.1, 
32.0, 21.2, 21.0, 18.0.  
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To a solution of 26 mg (0.033 mmol) diol (ent)-III-38 in 3 mL THF-EtOH (1:1) was added 23 
,
.5. Chapter IV Experimental 
mg Pd/C (10%). The reaction mixture was degassed at -50 to -40 °C using vacuum and refilled 
with H2. This procedure was repeated three times, then the bath was removed and the reaction 
was warmed up to room temperature. The reaction mixture was stirred under a H2 atmosphere for 
7 hours. The reaction mixture was loaded onto silica gel and elution with hexane-EtOAc (1:1) to 
give product (ent)-III-3 (12 mg, 70%): Yellow solid, mp: 147-149 ºC; Rf = 0.47 (1:3 (v/v) 
hexane/EtOAc); [α]D20 +114 (c 0.74, MeOH); IR (thin film, cm-1) υ 3335, 2931, 1716, 1653, 
1608, 1499, 1440, 1363, 1207, 1170, 1085, 1041, 972; 1H NMR (CD3OD, 600 MHz) δ 7.79 (d, J 
= 9.0 Hz, 2H), 6.94 (d, J = 9.0 Hz, 2H), 6.38 (d, J = 1.8 Hz, 1H), 6.20 (d, J = 1.8 Hz, 1H), 5.06 
(dd, J = 9.6, 3.0 Hz, 1H), 4.94 (dd, J = 10.8, 10.2 Hz, 1H), 4.47 (ddd, J = 3.0, 3.0, 2.4 Hz, 1H), 
4.26 (ddd  J = 3.6, 3.6, 1.2 Hz, 1H), 2.02 (s, 3H), 1.99 (s, 3H), 1.66 (ddqd, J = 12.6, 10.2, 6.0, 3.6 
Hz, 1H), 1.62 (ddd, J = 15.0, 3.6, 2.4, 1.2 Hz, 1H), 1.50 (ddd, J = 15.0, 12.6, 2.4 Hz, 1H), 0.67 (d, 
J = 6.6 Hz, 3H); 13C NMR (CD3OD, 150 MHz) δ 180.1, 172.7, 172.2, 165.9, 163.4, 161.7, 159.4, 
158.7, 137.2, 132.2, 122.9, 116.6, 106.2, 99.9, 94.9, 81.3, 75.9, 75.1, 70.8, 32.7, 32.1, 21.0, 21.0, 
17.9. 
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5) (2R,3S,6S)-6-(benzyloxy)-2-methyl-3,6-dihydro-2H-pyran-3-yl tert-butyl carbonate (IV-2
 
A solution of 519 mg (2.38 mmol) allylic alcohol IV-24 and 14.5 mg (0.119 mmol) DMAP in 8 
mL CH2Cl2 at 0 ºC was added a solution of 778 mg (3.57 mmol) Boc2O in 2.5 mL CH2Cl2. Then 
the reaction mixture was stirred at RT for 1 h. It was diluted with 20 mL EtOAc and quenched 
with saturated aqueous NaHCO3 at 0 ºC. The mixture was stirred at 0 ºC for 20 min, then was 
extracted with 100 mL Et2O and the aqueous layer was extracted again with 50 mL Et2O. The 
pooled organic layer was subsequently washed with saturated aqueous NH4Cl, NaHCO3, brine 
and dried over Na2SO4.  After removal of the solvent under reduced pressure, the residue was 
subjected to silica gel column chromatography, elution with hexane-EtOAc (20:1, v/v) afforded 
the carbonate IV-25 663 mg (87%) as white solid: mp 60-62 ºC; Rf (hexanes/EtOAc, 3:1 v/v) = 
0.60; [α]20D +89 (c 2.99, CHCl3); IR (thin film, cm-1) υ 2982, 2935, 1732, 1455, 1370, 1336, 
1317, 1286, 1269, 1254, 1154, 1094, 1049, 1028, 969;  1H NMR (CDCl3, 600 MHz): δ 7.38-7.32 
(m, 4H), 7.29 (m, 1H), 5.93 (d, J = 10.2 Hz, 1 H), 5.82 (ddd, J = 10.8, 2.4, 1.8 Hz, 1 H), 5.06 
(brs, 1H), 4.86 (ddd, J = 9.0, 3.0, 1.8 Hz, 1H), 4.77 (d, J = 12.0 Hz, 1H), 4.60 (d, J = 12.0 Hz, 
1H), 4.01 (dq, J = 9.0, 6.0 Hz, 1H), 1.50 (s, 9H), 1.22 (d, J = 6.0 Hz, 3 H);  13C NMR (CDCl3, 
150 MHz): δ  153.1, 138.1, 129.7, 128.4, 127.9, 127.8, 127.6, 93.7, 82.6, 73.5, 70.1, 64.9, 27.7, 
17.8; HRESIMS: Calcd. for [C18H24O5+Na]+: 343.1516, Found: 343.1517. 
 
 
 
Benzyl (2R,3S,6S)-6-(benzyloxy)-2-methyl-3,6-dihydro-2H-pyran-3-yl carbonate (IV-26) 
 
 A solution of 224 mg (1.03 mmol) allylic alcohol IV-24 in 4 mL CH2Cl2 at RT was added 220 
mg 60% NaH (5.5 mmol) in 2 mL CH2Cl2 which was washed with hexane before use. Then 369 
mg n-Bu4NI (1 mmol) was added to the mixture followed by the addition of 61 mg DMAP (0.5 
mmol). The reaction mixture was stirred at RT for 2 h. It was then diluted with Et2O and washed 
with saturated aqueous NH4Cl and the aqueous layer was extracted with Et2O twice and the 
pooled organic layer was then washed with saturated aqueous NaHCO3, brine and dried over 
Na2SO4. After removal of the solvent under reduced pressure, the residue was subjected silica gel 
column chromatography, elution with hexane-EtOAc (15:1, v/v) afforded the carbonate IV-26 
270 mg (74%) as colorless viscous oil: Rf (hexanes/EtOAc, 3:1 v/v) = 0.44; [α]20D +96 (c 4.48, 
CHCl3); IR (thin film, cm-1) υ 3032, 2979, 2936, 1747, 1497, 1456, 1382, 1250, 1049, 1020, 962;  
1H NMR (CDCl3, 600 MHz): δ 7.41-7.34 (m, 9H), 7.31( m, 1H), 5.96 (d, J = 10.2 Hz, 1 H), 5.85 
J = 9.6, 12.4, 1.8 Hz, 1 H), 5.21 (d, J = 12.6 Hz, 1H), 5.18 (d, J = 12.0 Hz, 1H), 5.08 (brs, 
1H), 4.94 (ddd, J = 9.0, 3.0, 1.8 Hz, 1H), 4.79 (d, J = 12.0 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 
R (CDCl3, 150 MHz): δ  154.7, 
137.9, 135.0, 129.1, 128.6, 128.5, 128.4, 128.2, 128.1, 127.9, 127.6, 93.6, 74.7, 70.1, 69.8, 64.7, 
(ddd, 
4.05 (dq, J = 9.6, 6.6 Hz, 1H), 1.24 (d, J = 6.0 Hz, 3 H);  13C NM
17.8; HRESIMS: Calculated for [C21H22O5+Na]+: 377.1359, Found: 377.1362. 
  
(3aR,4R,6S,7S,7aR)-6-(benzyloxy)-7-iodo-4-methyltetrahydro-3aH-[1,3]dioxolo[4,5-
c]pyran-2-one (IV-27) 
 
90 mmol) allyl carbonate IV-25 in 3 mL HOAc was added 320 mg NIS A solution of 285 mg (0.
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2 h, then another 230 mg (1.0 mmol) NIS was added 
and continued stirring at RT for another 12 h. The reaction mixture was diluted with EtOAc and 
J = 8.4, 7.8 Hz, 1 
H), 4.76 (d, J = 12.0 Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H), 4.40 (dd, J = 9.0, 7.8 Hz, 1H), 4.21 (dd, 
 = 8.4, 6.0 Hz, 1H), 4.05 (dq, J = 9.0, 6.6 Hz, 1H), 1.35 (d, J = 6.0 Hz, 3 H);  13C NMR (CDCl3, 
150 MHz): δ  152.9, 136.6, 128.5, 128.1, 127.9, 101.0, 78.7, 77.1, 70.2, 64.0, 21.0, 18.6; 
14 15 5
 
MgBr2•Et2O catalyzed iodo-carbonation of Boc-carbonate IV-25 
(1.42 mmol) at RT. It was stirred at RT 1
cooled down to 0 ºC and quenched by addition of saturated aqueous NaHCO3. The mixture was 
extracted with EtOAc and the organic layer was washed subsequently with saturated aqueous 
Na2S2O3, brine and dried over Na2SO4.  After removal of the solvent under reduced pressure, the 
residue was subjected to silica gel column chromatography, elution with hexane-EtOAc (5:1, v/v) 
afforded the iodo-carbonate IV-27 335 mg (95%) as white solid: mp 80.5-82.5 ºC; Rf 
(hexanes/EtOAc, 3:1 v/v) = 0.38; [α]20D + 52 (c 2.65, CHCl3); IR (thin film, cm-1) υ 3030, 2980, 
2935, 1839, 1806, 1497, 1454, 1347, 1331, 1147, 1087, 1053, 1021, 970;  1H NMR (CDCl3, 600 
MHz): δ 7.39-7.34 (m, 4H), 7.32 (m, 1H), 5.16 (d, J = 5.4 Hz, 1 H), 4.96 (dd, 
J
HRESIMS: Calculated for [C H IO +Na]+: 412.9856, Found: 412.9859. 
A solution of 31.8 mg (0.1 mmol) allyl carbonate IV-25 and 33.8 mg (0.15 mmol) NIS in 0.8 mL 
CH2Cl2 was added 25.8 mg (0.1 mmol) MgBr2•Et2O at RT. It was stirred at RT 12 h, then 
another 22.5 mg (0.1 mmol) NIS was added and continued stirring at RT for another 24 h. The 
reaction mixture was diluted with EtOAc and cooled down to 0 ºC and quenched by addition of 
saturated aqueous NaHCO3. The mixture was extracted with EtOAc and the organic layer was 
washed subsequently with saturated aqueous Na2S2O3, brine and dried over Na2SO4.  After 
removal of the solvent under reduced pressure, a crude 1H NMR experiment showed that the 
ratio of product and remaining starting material is 2:1. Then the residue was subjected to silica 
gel column chromatography, elution with hexane-EtOAc (7:1, v/v) afforded 10.1 mg iodo-
carbonate IV-27 (26%). 
 
Iodo-carbonation of Cbz-carbonate IV-26 
148 
 
A solution of 35.4 mg (0.10 mmol) allyl carbonate IV-26 in 3 mL HOAc was added 33.8 mg 
IS (0.15 mmol) at RT. It was stirred at RT 12 h, then another 22.5 mg (0.1 mmol) NIS was 
added and continued stirring at RT for another 24 h. Once again 22.5 mg (0.1 mmol) NIS was 
EtOAc and cooled down to 0 ºC and quenched by addition of saturated aqueous NaHCO3. The 
mixture was extracted with EtOAc and the organic layer was washed subsequently with saturated 
aqueous Na2S2O3, brine and dried over Na2SO4.  After removal of the solvent under reduced 
N
added and continued stirring at RT for another 24 h. The reaction mixture was diluted with 
pressure, the residue was subjected to silica gel column chromatography. Elution with hexane-
EtOAc (7:1, v/v) afforded the iodo-carbonate IV-27 20 mg (51%) 
 
(3aR,4R,6S,7aS)-6-(benzyloxy)-4-methyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2-one 
(IV-28) 
O
OBn
O
O
O
 
 A solution of 59 mg (0.15 mmol) iodo-carbonate IV-27 in 2 mL toluene was added 70 µL (0.22 
mmol) TMSS and then quickly 5 mg (0.03 mmol) solid AIBN was added in one portion at 0 ºC. 
The system was then cooled down to ~-50 ºC and degassed with vacuum and refilled with Ar. 
This procedure was repeated three times and then the mixture was heated up to 75 ºC for 40 min. 
he reaction mixture was cooled down to RT, and then directly loaded onto silica gel column.  
 
viscous oil; Rf (hexanes/EtOAc, 2:1 v/v) = 0.29; [α]20D +129 (c 0.93, CHCl3); IR (thin film, cm-1) 
υ 3035, 2975, 2940, 1798, 1454, 1356, 1175, 1152, 1066, 1036, 1023, 919;  1H NMR (CDCl3, 
600 MHz): δ 7.36-7.27 (m, 5H), 4.92 (dd, J = 5.4, 4.8 Hz, 1 H), 4.78 (ddd, J = 7.2, 7.2, 6.0 Hz, 1 
H), 4.71 (d, J = 12.6 Hz, 1H), 4.52 (d, J = 12.0 Hz, 1H), 4.26 (dd, J = 9.0, 7.8 Hz, 1H), 4.01 (dq, 
J = 9.0, 6.0 Hz, 1H), 2.31 (ddd, J = 15.0, 5.4, 5.4 Hz, 1H), 2.19 (ddd, J = 15.0, 7.2, 4.8 Hz, 1 H), 
1.31 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 150 MHz): δ 154.3, 137.2, 128.5, 127.8, 127.7, 94.2, 
T
Elution with hexane-EtOAc (3:1, v/v) afforded carbonate IV-28 17.8 mg (45%) as colorless
77.0, 72.5, 69.3, 63.3, 30.7, 18.5; HRESIMS: Calculated for [C14H16O5+Na]+: 287.0890, Found: 
287.0890. 
 
(2R,3S,4S,6S)-6-(benzyloxy)-2-methyltetrahydro-2H-pyran-3,4-diol (IV-29)65  
 
A solution of 16 mg (0.06 mmol) carbonate IV-28 in 2 mL THF was added 1 mL 2 M NaOH. 
The mixture was stirred at RT for 1 h. It was then diluted with EtOAc and passed through a pad 
f celite-silica gel-sand, eluting with EtOAc-MeOH (3:1, v/v). The effluent was dried over 
Na2SO4. After removal of the solvent under reduced pressure, the residue was subjected to silica 
tOAc (1.5:1, v/v) afforded the α-digitoxoside 
IV-29 12 mg (84%) as colorless oil; Rf (hexanes/EtOAc, 1:1 v/v) = 0.25; [α]20D + 107 (c 1.2, 
CHCl3); IR (thin film, cm-1) υ 3461 (broad), 3090, 3065, 3033, 2975, 2918, 1497, 1454, 1407, 
1235, 1148, 1120, 1101, 1054, 1010, 970;  1H NMR (CDCl3, 600 MHz): δ 7.39-7.35 (m, 2H), 
7.34-7.30 (m, 3H), 4.97 (d, J = 3.6 Hz, 1 H), 4.72 (d, J = 12.0 Hz, 1 H), 4.50 (d, J = 11.4 Hz, 1H), 
o
gel column chromatography, elution with hexane-E
3.96 (brs, 1 H), 3.77 (dq, J = 9.6, 6.0 Hz, 1H), 3.45 (brs, OH), 3.16 (dd, J = 10.2, 3.6 Hz, 1H), 
2.48 (brs, OH), 2.22 (ddd, J = 15.0, 3.0, 1.2 Hz, 1H), 1.94 (ddd, J = 15.0, 3.6, 3.6 Hz, 1H), 1.33 
(d, J = 6.6 Hz, 3 H); 13C NMR (CDCl3, 150 MHz): δ 136.9, 128.6, 128.1, 127.9, 96.4, 72.6, 69.5, 
67.3, 64.7, 35.1, 17.8. 
 
Ethyl 3-acetyl-4-hydroxy-5-oxo-2-(2-oxopropyl)-2,5-dihydrofuran-2-carboxylate (IV-36)54  
O
HO
O
O
O
O
O
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A sample of 49.5 g (0.313 mol) in a 500 mL flask was added a solution of 25.7 g NaOAc (0.312 
150 
 
 24 h. Then it was poured into a mixture of 165g ice and 26 mL 
concentrated H2SO4. Gentle shaking of the mixture resulted in formation of precipitate. Then it 
as cooled down at 0 ºC for 15 min. The mixture was filtered under reduced pressure and the 
duct was directly used for 
next step except that small amount of solid was dried and used for NMR test. White solid: 1H 
NMR (CDCl3, 270 MHz): δ 4.54 (brs, 1H), 4.21 (q, J = 6.9 Hz, 2H), 3.66 (d, J = 17.8 Hz, 1H), 
3.29 (d, J = 17.8 Hz, 1H), 2.50 (s, 1H), 2.15 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H);  13C NMR (CDCl3, 
67.5 MHz): δ 203.7, 194.0, 167.7, 166.8, 149.5, 123.5, 82.9, 63.1, 44.1, 31.1, 30.0, 13.8. 
mol) in 54 mL HOAc and 71 mL H2O at 0 ºC. The bath was removed after complete addition, 
and the mixture was stirred at RT
w
solid was washed with ice cold water (100 mL X 3). The crude pro
 
Methyl 3-hydroxy-5-methylbenzoate (IV-37)54  
 
The crude product IV-36 from last reaction was suspended in 500 mL H2O and 45 g (0.77 mol) 
Mg(OH)2 was slowly added at RT when stirring. The mixture was stirred at reflux for 1.5 h.  The 
hot solution was filtered under reduced pressure and the precipitate was rinsed with warm water. 
The mother liquor was concentrated under reduced pressure to remove the water to afforded 
crude solid product, which was then suspended in 270 mL methanol at RT. 13 mL concentrated 
H2SO4 was added into the mixture when stirring. After addition, the mixture was heated up and 
stirred under reflux for 12 h. Then it was cooled down to 0 ºC and slowly 400 mL saturated 
aqueous NaHCO3 was added followed by addition of another 20 g solid NaHCO3. The mixture 
as extracted with EtOAc (400 mL X 3). The organic layer was washed with saturated brine and 
jected to silica gel column 
chromatography, eluting with hexane-EtOAc (8:1,v/v) afforded methyl ester IV-37 14.5 g (56% 
over three steps) as white solid: 1H NMR (CDCl3, 270 MHz): δ 7.41 (s, 2H), 6.9 (s, 1H), 6.20 
(brs, 1H), 3.90 (s, 3H), 2.33 (s, 3H); 13C NMR (CDCl3, 67.5 MHz): δ 167.7, 155.8, 140.0, 130.9, 
w
dried over Na2SO4. After removal of the solvent, the residue was sub
151 
 
122.6, 121.1, 113.5, 52.4, 21.2. 
 
Methyl 3-(tert-butyldimethylsilyloxy)-5-methylbenzoate (IV-37a) 
 
A solution of 4 g (24.1 mmol) methyl ester IV-37 in 24 ml CH2Cl2 was added 2.46 g (36.2 mmol) 
imidazole at 0 ºC followed by a addition of 3.99 g (26.5 mmol) TBSCl. The ice bath was 
removed and the mixture was then stirred at RT for 2 h. It was diluted with 150 mL hexane-
EtOAc (2:1, v/v) and cooled down to 0 ºC, and then 70 mL H2O was added. After separation, the 
aqueous layer was extracted with hexane-EtOAc (2:1, v/v) (100 mL X 2). The pooled organic 
layer was subsequently washed with saturated aqueous NaHCO3, saturated brine and dried over 
Na2SO4. After removal of the solvent under reduced pressure, the residue was subjected to silica 
gel flash column chromatography. Elution with hexane-EtOAc (50:1, v/v) afforded TBS ether 
IV-37a 6.7 g (100%) as clear oil: Rf (hexanes/E -1tOAc, 3.5:1 v/v) = 0.62; IR (thin film, cm ) υ 
2954, 2931, 2898, 2859, 1724, 1594, 1454, 1435, 1322, 1252, 1226, 1160, 1105, 1035, 982;  1H 
MR (CDCl3, 270 MHz): δ 7.46 (s, 1H), 7.29 (s, 1H), 6.85 (s, 1H), 3.89 (s, 3H), 2.33 (s, 3H), 
13
123.3, 118.0, 52.0, 25.6, 21.2, 18.1, -4.5; HRMS (ESI): Cacld. for [C15H24O3Si+H]+: 281.1568, 
Found: 281.1569. 
 
(3-(tert-butyldimethylsilyloxy)-5-methylphenyl)methanol (IV-38) 
N
0.99 (s, 9H), 0.20 (s, 6H);  C NMR (CDCl3, 67.5 MHz): δ 167.1, 155.5, 139.5, 131.1, 125.5, 
TBSO
OH  
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h. It was cooled down to 0 ºC and diluted with 400 mL Et2O, 
then carefully 3.6 mL 2 M NaOH was added dropwise, followed by the addition of 5.4 mL H2O. 
 d then the precipitate was rinsed with ether. The 
mother liquor was subsequently washed with saturated aqueous NaHCO3, saturated brine and 
dried over Na2SO4. After removal of the solvent under reduced pressure, the residue was 
subjected to silica gel flash column chromatography. Elution with hexane-EtOAc (10:1, v/v) 
afforded benzyl alcohol IV-38 5.4 g (89%) as clear oil: Rf (hexanes/EtOAc, 3:1 v/v) = 0.40; IR 
A solution of 6.7 g (24.1 mmol) ester IV-37a in 48 mL THF was slowly added 1.83 g (48.2 
mmol) LiAlH4  in several portions at 0 ºC. After addition, the ice bath was removed and the 
mixture was then stirred at RT for 3 
The mixture was stirred at 0 ºC for 15 min, an
(thin film, cm-1) υ 3306 (broad), 2956, 2930, 2886, 2859, 1595, 1462, 1315, 1253, 1161, 1042, 
1019, 947;  1H NMR (CDCl3, 270 MHz): δ 6.77 (s, 1H), 6.65 (s, 1H), 6.59 (s, 1H), 4.59 (s, 2H), 
2.30 (s, 3H), 1.72 (s, 1H), 0.99 (s, 9H), 0.20 (s, 6H);  13C NMR (CDCl3, 67.5 MHz): δ 155.7, 
142.1, 139.6, 120.6, 120.0, 115.5, 65.2, 25.6, 21.4, 18.1, -4.4; HRMS (ESI): Cacld. for 
[C14H24O2Si+H]+: 253.1618, Found: 253.1620. 
 
3-(tert-butyldimethylsilyloxy)-5-methylbenzaldehyde (IV-39)66 
 
A solution of 5.4 g (21.4 mmol) benzyl alcohol IV-38 in 33 mL hexane was added 18.6 g (214 
mmol) activated MnO2 at RT. It was stirred at RT for 10 h. The mixture was filtered and the 
precipitate was rinsed with ether. After removal of the solvent under reduced pressure, the 
residue was subjected to silica gel flash column chromatography. Elution with hexane-EtOAc 
(25:1, v/v) afforded aldehyde IV-39 4.5 g (84%) as clear oil: Rf (hexanes/EtOAc, 3:1 v/v) = 0.62; 
1H NMR (CDCl3, 270 MHz): δ 9.90 (s, 1H), 7.29 (s, 1H), 7.12 (s, 1H), 6.92 (s, 1H), 2.37 (s, 3H), 
0.99 (s, 9H), 0.21 (s, 6H); 13C NMR (CDCl3, 67.5 MHz): δ 192.4, 156.2, 140.4, 137.7, 127.3, 
124.2, 117.2, 25.6, 21.2, 18.2, -4.4. 
3-hydroxy-5-methylbenzaldehyde (IV-34)67 
HO
OH  
A solution of 3.94 g (15.8 mmol) TBS ether IV-39 in 20 mL MeOH was added 898 mg (4.73 
mmol) solid p-TsOH•H2O when stirring at RT. The mixture was stirred at RT for 24 h. Then it 
as diluted with 200 mL EtOAc and cooled down to 0 ºC. Into the solution, 20 mL saturated 
aqueous NaHCO  was slowly added. The mixture was stirred at 0 ºC for 10 min. After separation, 
the aqueous layer was extracted with EtOAc and the c
w
3
ombined organic layer was washed with 
saturated brine and dried over Na2SO4. After removal of the solvent, the residue was subjected to 
silica gel column chromatography, eluting with hexane-EtOAc (5:1,v/v) afforded phenol IV-34 
) = 0.42; 1H NMR (CDCl3, 270 MHz): 
δ 9.90 (s, 1H), 7.26 (s, 1H), 7.19 (s, 1H), 6.98 (s, 1H), 2.38 (s, 3H); 13C NMR (CDCl3, 67.5 
MHz): δ 192.9, 156.4, 140.8, 137.6, 124.2, 122.8, 112.2, 21.1. 
 
2.0 g (93%) as white solid: Rf (hexanes/EtOAc, 2:1 v/v
(2S,3S)-tert-butyl 2-amino-3-methylpentanoate (IV-40) 
 
A sample of 2.62 g (20.0 mmol) isoleucine IV-6 was placed in a 40 mL pressure vessel, into 
which a premixed 20 mL THF and 5 mL concentrated H2SO4 was added when stirring. The 
suspension was cooled down to -78 ºC under Ar. Then the inlet of Ar was closed, and isobutene 
was allowed to bubble through the solution via a needle. The bubbling was stopped until about 3 
mL liquid of isobutene was seen floating on the solution. Quickly switch the septum to a 
was poured into a suspension of 100 g ice in 200 mL 1.25 M aqueous NaOH when stirring. The 
pressure gauge and the pressure vessel was sealed. The mixture was stirred at RT for 15 h. The 
solution was cooled down to 0 ºC, and then the pressure was released and quickly the mixture 
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d aqueous NaHCO3 and brine, then was dried over Na2SO4. 
Concentration of the solution resulted in isoleucine t-butyl ester IV-40 2.0 g (54%) as clear oil: 
DCl3, 270 MHz): δ 3.25 (d, J = 4.70 Hz, 1H), 2.03 (brs, 2H), 1.72 (m, 1H), 1.45 (s, 
.2, 28.1, 24.8, 15.6, 11.8. 
 
2-Bromo-8-hydroxynaphthalene-1,4-dione (IV-42)55 
mixture was stirred at 0 ºC for 15 min and extracted with EtOAc twice. The organic layer was 
subsequently washed with saturate
1H NMR (C
9H), 1.21 (m, 2H), 0.93 (d, J = 6.9 Hz, 3H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 67.5 
MHz): δ 174.5, 80.9, 59.3, 39
O
OOH
Br
 
A suspension of 3.0 g (17.2 mmol) juglone (IV-41) in 45 mL HOAc was added 0.9 mL (17.2 
mmol) Br2 when stirring at RT. The mixture was stirred at RT for 15 min. Then it was poured 
into 50 g ice followed by addition of 150 mL H2O. It was stirred at RT for 10 min. The mixture 
was filtered and the solid was washed with cold water, which was then transferred to flask 
followed by addition of 20 mL ethanol. The mixture was stirred at a preheated oil bath (100-110 
ºC) for 10 min and then cooled down to RT. The solid was collected by filtration. 
Chromatography of the crude product on silica gel column, eluting with hexane-CH2Cl2 (1:1, 
v/v), afforded a 3.5 g orange solid mixture (80% total yield), in which contained 81% 3-
bromojuglone (IV-42) and 19% 2-bromojuglone. 
3-bromojuglone (IV-42): Rf (hexanes/EtOAc, 3:1 v/v) = 0.54; 1H NMR (CDCl3, 270 MHz): 
δ 11.73 (s, 1H), 7.68 (dd, J = 7.7, 7.4 Hz, 1H), 7.64 (dd, J = 6.5, 1.0 Hz, 1H), 7.49 (s, 1H), 7.31 
(dd, J = 7.4, 2.2 Hz, 1H); 13C NMR (CDCl3, 150 MHz): δ 182.9, 181.6, 162.1, 141.2, 139.3, 
137.2, 131.7, 124.7, 119.9, 114.0. 
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S,3S)-tert-butyl 2-(8-hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-ylamino)-3-
methylpentanoate (IV-43) 
(2
O
OOH
NH Ot-Bu
O
 
A solution of 253 mg (1.0 mmol) juglone mixture which contain 81% 2-bromojuglone (IV-42) in 
1 mL CH2Cl2 at 0 ºC was added a solution of 234 mg (1.25 mmol) isoleucine t-butyl ester in 1 
mL CH2Cl2 when stirring, followed by addition of 139 µL Et3N (1.0 mmol) in 1 mL CH2Cl2. The 
mixture was stirred at 0 ºC for 15 min and then diluted with 30 mL hexane-EtOAc (1:1, v/v) and 
washed with 6 mL water. The aqueous layer was extracted with hexane-EtOAc (1:1, v/v) 20 mL. 
T
 =
 
 
 
he pooled organic layer was subsequently washed with saturated aqueous NaHCO3, brine and 
dried over Na2SO4. After removal of the solvent, the residue was subjected to silica gel column 
chromatography. Elution with hexane-EtOAc (10:1,v/v) afforded aminojuglone IV-43 240 mg 
(67%) as dark red oil: Rf (hexanes/EtOAc, 3:1 v/v) = 0.60; [α]20D -60 (c 0.59, CHCl3); IR (thin 
film, cm-1) υ 3361, 2967, 2934, 1731, 1680, 1624, 1604, 1509, 1469, 1385, 1368, 1293, 1247, 
1227, 1156, 1041, 918;  1H NMR (CDCl3, 600 MHz): δ 12.95 (s, 1H), 7.61 (dd, J = 7.2, 1.2 Hz, 1 
H), 7.47 (dd, J = 8.4, 7.8 Hz, 1 H), 7.24 (dd, J = 8.4, 1.2 Hz, 1H), 6.57 (d, J = 7.8 Hz, 1H), 5.59 
(s, 1H), 3.87 (dd, J = 8.4, 5.4 Hz, 1H), 1.97 (dqdd, J = 9.0, 7.2, 5.4, 5.4 Hz, 1H), 1.58 (dqd, J = 
13.8, 7.2, 5.4 Hz, 1H), 1.50 (s, 9H), 1.35 (ddq, J = 14.4, 9.0, 7.2 Hz, 1 H);  1.00 (dd, J  7.8, 7.8 
Hz, 3 H);  0.98 (d, J = 6.6 Hz, 3 H);  13C NMR (CDCl3, 150 MHz): δ  189.2, 180.7, 169.1, 161.1, 
147.7, 134.0, 130.5, 125.8, 119.1, 114.8, 100.5, 83.1, 59.7, 37.5, 28.1, 25.9, 15.2, 11.6; 
HRESIMS: Calcd. for [C20H25NO5+H]+: 360.1806, Found: 360.1807. 
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 (2S,3S)-t-butyl 2-(3-bromo-8-hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-ylamino)-3-
methylpentanoate (IV-44)§ 
 
A solution of 152 mg (0.42 mmol) aminojuglone IV-43 in 4 mL CH2Cl2 at 0 ºC was added a 
solution of 24 µL (0.46 mmol) Br2 and 38 µL (0.46 mmol) pyridine in 4 mL CH2Cl2. It was 
stirred at 0 ºC for 10 min, then it was diluted with hexane-EtOAc (1:1, v/v) 80 mL followed by 
addition of 15 mL H2O. The organic layer was separated and subsequently washed with saturated 
aqueous NaHCO3, saturated brine and dried over Na2SO4. After removal of the solvent, the 
residue was subjected to silica gel column chromatography. Elution with hexane-EtOAc 
(20:1,v/v) afforded 2-bromo-3-aminojuglone IV-44 140 mg (76%) as dark red oil: Rf 
(hexanes/EtOAc, 1:1 v/v) = 0.78; [α]20D +20 (c 2.9, CHCl3); IR (thin film, cm-1) υ 3300, 2965, 
2930, 2875, 1725, 1680, 1620, 1605, 1586, 1458, 1237, 1214, 1151, 1131, 1108, ;  1H NMR 
(CDCl3, 600 MHz): δ 12.56 (s, 1H), 7.56 (brs, 1H), 7.46 (dd, J = 8.4, 7.8 Hz, 1 H), 7.22 (dd, J = 
.4 Hz, 1 H), 5.18 (brs, 1H), 1.98 (brs, 1H), 1.62 (dqd, J = 12.6, 7.2, 4.8 Hz, 1H), 1.49 (s, 9H), 
1.37 (ddq, J = 14.4, 9.6, 7.2 Hz, 1 H);  1.01 (dd, J = 7.8, 7.2 Hz, 3 H);  0.96 (d, J = 7.2 Hz, 3 H);  
8.0913. 
 
3-(1,3-dioxan-2-yl)-5-methylphenol (IV-34a)58  
8
HRESIMS: Calculated for [C20H24BrNO5+H]+: 438.0906, Found: 43
HO
OO
 
                                                            
§ An average optical rotation was given due to the unstable data that was obtained. The 13C NMR data was not given due to the broadening of 
most signals of carbons on the quinone part, a copy of the spectra was enclosed in the spetra section. 
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.31; 1H NMR (CDCl3, 270 MHz): δ 6.86 (s, 1H), 6.75 (s, 1H), 6.59 
(s, 1H), 6.06 (brs, 1H), 5.42 (s, 1H), 4.25 (dd, J = 11.6, 4.9 Hz, 2H), 3.96 (ddd, J = 12.2, 10.2, 
.0 Hz, 2H), 2.23 (s, 3H), 2.17 (m, 1H), 1.43 (d, 13.6 Hz, 1H); 13C NMR (CDCl3, 67.5 MHz): δ 
 
2-(3-(methoxymethoxy)-5-methylphenyl)-1,3-dioxane (IV-45)58  
A solution of 1.77 g (13.0 mmol) benzaldehyde IV-34 in 70 mL benzene was placed in a 100 mL 
flask which was equipped with a distillation assembly. Into the solution was added 1.88 mL 
(26.0 mmol) 1,3-propanediol and 123 mg (0.65 mmol) solid p-TsOH•H2O. The mixture was then 
gradually heated up under Ar. The distillation was allowed to proceed until the total volume of 
solution was about 5-10 mL. Then it was cooled down to 0 ºC and diluted with Et2O 130 mL. 50 
mL saturated aqueous NaHCO3 was added to the mixture. The aqueous layer was extracted with 
Et2O and the pooled organic layer was washed with saturated brine and dried over Na2SO4. After 
removal of the solvent, the residue was subjected to silica gel column chromatography, eluting 
with hexane-EtOAc (5:1,v/v) afforded acetal IV-34a 2.11 g (84%) as white solid: Rf 
(hexanes/EtOAc, 2:1 v/v) = 0
2
155.6, 139.7, 139.3, 118.7, 116.7, 110.3, 101.6, 67.3, 25.5, 21.2. 
MOMO
OO
 
A solution of 172 mg (0.89 mmol) phenol IV-34a in 1.5 mL CH2Cl2 at ºC was added 0.55 mL 
(3.33 mmol) DIPEA followed by addition of 150 µL (1.98 mmol) MOMCl. It was stirred at RT 
for 8 h. The mixture was cooled down to 0 ºC and diluted with hexane-Et2O (1:1, v/v) 50 mL. 
Then 10 mL water was added and it was then stirred at 0 ºC for 20 min. The aqueous layer was 
extracted with hexan-Et2O (1:1, v/v) and the pooled organic layer was subsequently washed with 
saturated aqueous NaHCO3, saturated brine and dried over Na2SO4. After removal of the solvent, 
the residue was subjected to silica gel column chromatography, eluting with hexane-EtOAc (6:1, 
v/v) afforded MOM ether IV-45 150 mg (68%) and elution with hexane-EtOAc (3:1,v/v) 
recovered 42 mg starting material (20%). MOM ether IV-45: White solid; Rf (hexanes/EtOAc, 
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 (dtt, J = 13.8, 2.4, 
1.2 Hz, 1H); 13C NMR (CDCl3, 150 MHz): δ 158.7, 141.7, 140.5, 121.7, 118.5, 112.4, 102.9, 
 
(2-(1,3-dioxan-2-yl)-6-(methoxymethoxy)-4-methylphenyl)tributylstannane (IV-46)58  
2:1 v/v) = 0.49; 1H NMR (CDCl3, 600 MHz): δ 6.93 (s, 1H), 6.90 (s, 1H), 6.82 (s, 1H), 5.45 (s, 
1H), 5.14 (s, 2H), 4.19 (dddd, J = 10.2, 4.8, 1.2, 1.2 Hz, 2H); 4.00 (dddd, J = 12.0, 10.2, 2.4, 1.2 
Hz, 2H), 3.43 (s, 3H), 2.30 (s, 3H), 2.13 (dtt, J = 13.8, 12.6, 5.4 Hz, 1H), 1.46
95.7, 68.5, 56.3, 27.1, 21.6. 
MOMO
Bu3Sn
OO
 
A solution of 1.82 g (7.65 mmol) MOM ether IV-45 in 23 mL hexane at ºC was added 4.9 mL 
2.34 M (11.5 mmol) n-BuLi. The mixture was stirred at ºC for 1 h. Then 3.3 mL Bu3SnCl was 
slowly added in to the reaction mixture at ºC. It was stirred at ºC for another 1 h. It was then 
2
NaHCO . The mixture was stirred at ºC for 1 h. The organic layer was separated and the aqueous 
diluted with hexane-Et O (1:1, v/v) 200 mL followed by addition of 60 mL saturated aqueous 
3
layer was extracted with hexane-Et2O (1:1, v/v). The pooled organic layer was subsequently 
washed with saturated brine and dried over Na2SO4. After removal of the solvent, the residue 
i  hexane-EtOAc (25:1,v/v) 
afforded phenylstannane IV-46 1.94 g (49%). Elution with hexane-EtOAc (5:1,v/v) recovered 
650 mg starting material (36%). Phenylstannane IV-46: clear oil; Rf (hexanes/EtOAc, 2:1 v/v) = 
0.78; 1H NMR (benzene-d6, 600 MHz): δ 7.68 (s, 1H), 7.06 (s, 1H), 5.55 (s, 1H), 4.93 (s, 2H),  
3.96 (dd, J = 12.0, 5.4 Hz, 2H), 3.69 (ddd, J = 12.6, 12.0, 2.4 Hz, 2H), 3.24 (s, 3H), 2.14 (s, 3H), 
was subjected to silica gel column chromatography, eluting w th
1.94 (dtt, J = 12.6, 12.6, 4.8 Hz, 1H); 1.74 (m, 6H); 1.48 (m, 6H); 1.29 (m, 6H), 0.98 (t, J = 7.2 
Hz, 9H); 0.75 (d, J = 13.2 Hz, 1H); 13C NMR (benzene-d6, 150 MHz): δ 162.9, 148.1, 140.4, 
125.9, 122.6, 114.4, 103.0, 95.2, 67.5, 56.0, 30.1, 28.3, 26.4, 21.9, 14.4, 13.0. 
 
Naphthalene-1,5-diyl diacetate (IV-48)59  
 
A solution of 5 g (31.2 mmol) naphthalenediol IV-47 in 40 mL pyridine at 0 ºC was slowly 
 for 10 min, then it was poured 
into a 500 mL water when stirring. The solid was collected by filtratin, washing with water 
several times. After being dried by using vacuum, 7.4 g ( 97%) diacetate IV-48 was afforded as 
brown solid: Rf (hexanes/EtOAc, 1:1 v/v) = 0.55; 1H NMR (CDCl3, 270 MHz): δ 7.80 (d, J = 8.4 
Hz, 2 H), 7.52 (dd, J = 8.2, 7.7 Hz, 2H), 7.31 (d, J = 7.4 Hz, 2H), 2.46 (s, 6H);  13C NMR 
added 8.9 mL (125 mmol) AcCl dropwise. It was stirred at RT
(CDCl3, 67.5 MHz): δ  169.2, 146.6, 128.0, 126.0, 119.2, 118.7, 20.9. 
 
6-Bromo-5,8-dioxo-5,8-dihydronaphthalen-1-yl acetate (IV-49)59  
 
2.44 g (10.0 mmol) diacetate IV-48 was suspended in 100 mL HOAc at 50-60 ºC, a solution of 
7.12 g (40 mmol) NBS in 100 mL HOAc and 200 mL H2O was added into the mixture dropwise 
over 1 h. After addition, the reaction mixture was stirred at 60 ºC for 2 h.  It was cooled down to 
RT. Yellow precipitate started to form. Filtration and washing with water. After drying, 1.9 g 2-
f
= 0.46; H NMR (CDCl3, 600 MHz): δ 8.14 (dd, J = 7.8, 1.2 Hz, 1H), 7.77 (dd, J = 7.8, 7.8 Hz, 
1H), 7.42 (dd, J = 7.8, 1.2 Hz, 1H), 7.39 (s, 1H), 2.44 (s, 3H); 13C NMR (CDCl3, 150 MHz): δ 
180.9, 177.4, 169.2, 149.9, 141.4, 138.5, 134.9, 132.6, 130.3, 126.3, 123.1, 21.0. 
 
bromojuglone acetate (IV-49) was obtained (66%). Yellow crystal: R  (hexanes/EtOAc, 2:1 v/v) 
1
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2-Bromo-5-hydroxynaphthalene-1,4-dione (IV-50)59  
 
A solution of 765 mg (2.59 mmol) acetate IV-49 in 26 mL 95% ethanol was added 8.5 mL 1.5 M 
aqueous H2SO4. The solution was stirred under reflux condition for 3 h. It was then cooled down 
to RT and diluted with EtOAc 100 mL and washed with water 150 mL twice. The organic layer 
was subsequently washed with saturated aqueous NaHCO3, saturated brine and then dried over 
Na2SO4. After removal of the solvent, the residue was subjected to silica gel column 
chromatography, eluting with hexane-EtOAc (15:1,v/v) afforded 2-bromojuglone (IV-50) 459 
mg (70%). Orange solid: Rf (hexanes/EtOAc, 2:1 v/v) = 0.51; 1H NMR (CDCl3, 270 MHz): 
δ 11.75 (s, 1H), 7.72 (dd, J = 7.2, 1.2 Hz, 1 H), 7.63 (ddd, J = 7.8, 7.2, 0.6 Hz, 1H), 7.45 (s, 1H), 
7.30 (dd, J = 8.4, 1.2 Hz, 1H); 13C NMR (CDCl3, 67.5 MHz): δ  187.5, 177.2, 161.7, 140.9, 
140.3, 136.4, 130.7, 125.1, 121.0, 114.7. 
 
2-(2-(1,3-dioxan-2-yl)-6-(methoxymethoxy)-4-methylphenyl)-5-hydroxynaphthalene-1,4-
dione (IV-51) 
 
A suspension of 253 mg (1.0 mmol) juglone IV-50, 526 mg (1.0 mmol) stannane IV-46, and 
19.0 mg (0.10 mmol) CuI in 8 mL THF at RT was added a solution of 25.9 mg (0.025 mmol) 
Pd2(dba)3•CHCl3 and 26.2 mg (0.10 mmol) PPh3 in 2 mL THF. The mixture was stirred at 75 ºC 
for 5 h. It was then cooled down to 0 ºC and diluted with 100 mL EtOAc and washed with 
saturated aqueous NaHCO3, saturated brine, then dried over Na2SO4. After removal of the 
solvent, the residue was subjected to silica gel column chromatography, eluting with hexane-
EtOAc (5:1,v/v) afforded coupled product IV-51 310 mg (76%). Orange solid, mp: 44-46 ºC; Rf 
(hexanes/EtOAc, 2:1 v/v) = 0.47; IR (thin film, cm-1) υ 2955, 2925, 2850, 1639, 1455, 1247, 
1148, 1050, 999; 1H NMR (CD3OD, 600 MHz): δ 7.70 (dd, J = 8.4, 7.8 Hz, 1 H), 7.61 (dd, J = 
7.2, 1.2 Hz, 1H), 7.31 (dd, J = 8.4, 1.2 Hz, 1H), 7.12 (brs, 1H), 7.04 (brs, 1H), 6.86 (s, 1H), 5.38 
(s, 1H), 5.08 (d, J = 6.6 Hz, 1H), 5.07 (d, J = 7.2 Hz, 1H), 3.99 (m, 2H); 3.80 (ddd, J = 12.0, 12.0, 
3.0 Hz, 1H), 3.76 (ddd, J = 12.0, 12.0, 2.4 Hz, 1H), 3.33 (s, 3H), 2.38 (s, 3H), 1.94 (ddddd, J = 
13.2, 12.0, 12.0, 4.8, 4.8 Hz, 1H), 1.30 (ddddd, J = 13.2, 2.4, 2.4, 1.2, 1.2 Hz, 1H); 13C NMR 
(CD3OD, 150 MHz): δ 191.7, 184.5, 162.5, 155.9, 150.4, 141.7, 139.2, 138.4, 137.8, 134.0, 
125.0, 121.8, 121.2, 120.4, 116.5, 101.8, 95.9, 68.4, 68.3, 56.6, 26.8, 21.9; HRESIMS: 
Calculated for [C23H22O7+H]+: 411.1438, Found: 411.1440. 
 
3-hydroxy-2-(5-hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-5-methylbenzaldehyde (IV-
53) 
 
A sample of 80 mg (0.20 mmol) MOM ether IV-51 was placed in a 50 mL flask. A premixed 
solution of 5 mL 4.5 M HCl(aq.)/THF (1:1, v/v) was added at RT. The solution was stirred on 
preheated oil bath (65 ºC) for 10 min under Ar.  The reaction mixture was then quickly cooled 
down to 0 ºC, and diluted with 20 mL EtOAc, followed by addition of 20 mL saturated aqueous 
NaHCO3. After separation, the aqueous layer was extracted with EtOAc and the pooled organic 
layer was washed with saturated brine and dried over Na2SO4. After removal of the solvent, the 
residue was subjected to silica gel column chromatography, eluting with hexane-EtOAc (2:1,v/v) 
afforded deprotected product IV-53 14 mg (23%). Orange solid, mp: 144-150 ºC; Rf 
(hexanes/EtOAc, 2:1 v/v) = 0.28; IR (thin film, cm-1) υ 3250 (brs), 2925, 2860, 1670, 1637, 1604, 
1453, 1363, 1310, 1244, 1162, 1047, 900; 1H NMR (CD3OD, 600 MHz): δ 9.8 (s, 1H), 7.71 (dd, 
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J = 8.4, 7.8 Hz, 1 H), 7.60 (ddd, J = 7.2, 1.2 Hz, 1H), 7.33 (q, J = 1.2 Hz, 1H), 7. 32 (dd, J = 8.4, 
1.2 Hz, 1H), 7.09 (d, J =1.2 Hz, 1H), 6.87 (s, 1H), 2.44 (s, 3H); 13C NMR (CD3OD, 150 MHz): δ 
194.1, 191.6, 184.8, 162.5, 156.8, 149.9, 142.6, 137.9, 137.8, 137.6, 134.4, 127.2, 124.9, 123.6, 
120.3, 118.7, 116.7, 21.3; HRESIMS: Calculated for [C18H12O5+H]+: 309.0758, Found: 
309.0759. 
 
Jadomycin A (IV-1)44a 
 
A suspension of 14 mg (0.045 mmol) aldehyde IV-53 in 3 mL toluene was added 51 µL (0.14 
mmol) isoleucine t-butyl ester. The mixture was stirred for 2 days at RT with The flask only 
loosely capped in order that air could get in. The mixture was directly subjected to silica gel 
c
, 1 H), 7.67 (dd, J = 8.4, 
1, 
129.9, 124.4, 122.1, 120.9, 120.9, 114.5, 113.3, 111.1, 87.2, 62.6, 40.0, 25.2, 21.3, 13.8, 11.9; 
 420.1443. 
olumn chromatography. Elution with hexane-EtOAc (8:1,v/v) afforded a crude product, which 
was then treated with 0.15 mL TFA at RT for 1 h. Then it was diluted with 20 mL EtOAc and 
subsequently washed with saturated aqueous NaHCO3 and saturated brine, then dried over 
Na2SO4. After removal the solvent, a NMR experiment showed it’s a mixture of two isomers 
with 6:1 ratio with the cis product as major. The two isomers can’t be separted with silica gel 
column chromatography. Jadomycin A (IV-1): Rf (hexanes/EtOAc, 2:1 v/v) = 0.65; 1H NMR 
(CDCl3, 600 MHz): δ 11.72 (s, 1H), 10.18 (s, 1H), 7.81 (d, J = 7.8 Hz
7.2 Hz, 1H), 7.25 (d, J = 7.2 Hz, 1H), 6.91 (s, 1H), 6.82 (s, 1H), 6.16 (s, 1H), 5.30 (d, J = 3.0 Hz, 
1H), 2.37 (s, 3H), 1.83 (m, 2H), 1.56 (m, 1H), 1.04 (t, J = 7.2 Hz, 1H), 0.45 (d, J =6.6 Hz, 1H); 
13C NMR (CDCl3, 150 MHz): δ 185.7, 183.5, 170.0, 162.0, 154.1, 143.3, 142.1, 137.7, 133.
HRESIMS: Calculated for [C24H21NO6+H]+: 420.1442, Found:
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